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Resumen 
En los últimos años, Internet ha llegado a casi todas las zonas del mundo y nuevas tecnologías 
han sido descubiertas y creadas, especialmente en comunicaciones móviles. Estas tecnologías 
han propiciado el desarrollo y rápida expansión de dispositivos móviles como los smartphones 
y tablets, y, con estos dispositivos, una nueva industria software: la industria de las apps 
móviles. Actualmente hay apps para cualquier aspecto de la vida, videojuegos, educativas, de 
productividad y, por supuesto, apps centradas en el cuidado de la salud. Estas apps 
relacionadas con la salud son parte de lo que se conoce como salud móvil o mSalud, definido 
por la Organización Mundial de la Salud (OMS) como “práctica de salud médica y pública 
realizada con ayuda por dispositivos móviles, como teléfonos móviles, dispositivos de 
monitorización del paciente, asistentes digitales personales (PDAs), y otros dispositivos 
inalámbricos”. Por tanto, el objetivo de las aplicaciones y sistemas de la mSalud es combatir las 
condiciones y enfermedades que minan la salud de los pacientes intentando diagnosticarlas, 
tratarlas o aliviarlas. 
Este trabajo tiene dos objetivos principales. El primero es realizar una revisión de las apps 
móviles existentes centradas en enfermedades o condiciones no comunicables, especialmente 
en el campo de la cardiología. Esta revisión se basó en las condiciones más prevalentes, las 
enfermedades líderes en mortalidad y las enfermedades cardíacas. Fue además 
complementada con una revisión de Sistemas de Ayuda a la Decisión Móviles (SADM). El 
segundo objetivo es el diseño, creación y desarrollo de una app móvil innovadora en el campo 
de la cardiología, con el objetivo de copar un hueco comercial encontrado en la revisión 
anterior. Para llevar a cabo dicho objetivo, varios estudios fueron realizados para solucionar 
los problemas encontrados. La experiencia aprendida es compartida con investigadores y 
desarrolladores con el objetivo de ayudarles en el proceso de creación de apps de mSalud. 
La revisión fue realizada en etapas diferentes y llevada a cabo tanto en sistemas y bases de 
datos académicas (IEEE Xplore, Scopus, Web of Knowledge, PubMed) como comerciales 
(Google play, App Store), siguiendo una serie de requisitos. Se obtuvieron varios resultados, 
como la distribución de trabajo realizado en las distintas enfermedades, la evolución del 
mismo a lo largo del tiempo y algunas clasificaciones de las diferentes apps encontradas. Con 
una de estas clasificaciones obtenida para apps relacionadas con el corazón, se encontró un 
tipo de app muy interesante pero con un desarrollo limitado. Se trata de una app para la 
autogestión de enfermedades y condiciones del corazón. Se vio mucho potencial y se decidió 
crear una app con este objetivo, denominada Heartkeeper. 
Cuando se crea una app de mSalud hay que considerar varios aspectos, además de los 
técnicos. Es importante tener en cuenta la seguridad y la privacidad de manera acorde con los 
datos de los usuarios tratados en la app. Dicha app debe ser testada no solo técnicamente sino 
también desde el punto de vista de la Calidad de Experiencia (Quality of Experience, QoE) del 
usuario y la conformidad con las recomendaciones del sistema operativo elegido. Finalmente, 
es recomendado realizar un análisis ex-ante del impacto económico del uso de la app en una 
región. Todas estas cuestiones fueron planteadas e investigadas, y la experiencia y lecciones 
aprendidas son compartidas con la comunidad académica y los desarrolladores, que pueden 
obtener una ventaja añadida con este trabajo. 
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Abstract 
In the last years, Internet has been reaching almost every zone in the world and new 
technologies have been discovered and created, especially in mobile 
telecommunications. These technologies have propitiated the development and fast 
expansion of mobile devices such as smartphones and tablets, and, with these devices, 
a new software industry: the mobile apps industry. Currently, there are apps for every 
aspect of life, videogames, educational, productivity apps, and, of course, apps focused 
on health care. These apps related to health care are part of what is called mobile 
health or mHealth, defined by the World Health Organization as “medical and public 
health practice supported by mobile devices, such as mobile phones, patient monitoring 
devices, personal digital assistants (PDAs), and other wireless devices”. Hence, the 
objective of mHealth applications and systems is to fight against conditions and 
diseases that undermine the health of the patients trying to diagnose, treat or relieve 
them. 
This work has two main objectives. The first is to perform a review of the existing 
mobile applications focused on non-communicable diseases or conditions, especially in 
the field of cardiology. This review was focused on the most prevalent conditions, the 
diseases that are leading causes of death and heart diseases. This was complemented 
with a review of Mobile Decision Support Systems (MDSS). The second objective is the 
design, creation and development of an innovative mobile application in the field of 
cardiology in order to fill a gap found in the previous review. In order to achieve that 
goal, several researches were performed to solve the problems encountered. The 
experience learned is shared with researchers and developers in order to help them in 
the process of developing mHealth apps. 
The review was performed in different stages and it was done in both academic and 
commercial systems and databases, with a number of requisites. Several results were 
obtained, such as the distribution of work done in the different diseases, the evolution 
of this work along the years and some classifications of the different apps found. With 
one of these classifications obtained for heart related apps, a very interesting type 
with limited research was found. It was an app for the self-management of heart 
diseases and conditions. It was catalogued with high potential by the authors, who 
decided to create an app with this objective named Heartkeeper. 
Several aspects should be considered when creating a mHealth app, apart from the 
technical issues. It is important to consider security and privacy aspects according to 
the users’ data treated in the app. The app should be tested not only in the technical 
aspects, but also from the point of view of the Quality of Experience (QoE) from the 
users and the compliance with the guidelines for the operating system selected. 
Finally, it is recommended to perform an ex-ante analysis of the economic impact of 
the use of the app in a region. All these issues were faced and researched, and the 
experience and lessons learned are shared with the academic community and also 
with developers, who can obtain special advantage from this work.  
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1. Introduction 
1.1. Background 
Since the creation and expansion of the Internet, new technologies have been created in every 
facet of life [1]. As a result, an incredible boost of the mobile technologies has been produced 
in the last decade, being created many new wireless communication technologies. Some 
examples are mobile telecommunication networks (2.5G, 3G, 4G, HSPA+), Wireless Local Area 
Networks (WLAN), Wireless Personal Area Networks (WPAN) including Bluetooth and ZigBee, 
Wireless Body Area Networks (WBAN), Wireless Sensor Networks (WSN), Radio-frequency 
Identification (RFID), and Worldwide Interoperability for Microwave Access (WiMAX) [2-7]. 
These mobile communications, in combination with other technologies have propitiated the 
fast expansion of mobile devices such as smartphones and tablets, especially in developed and 
under-development countries. Currently there are more than 1 billion smartphone units 
worldwide [8]. Taking into account also tablets, there are more than 1.8 billion of global users 
[9] and it is expected to surpass 2 billion in 2016, which is a quarter of the world population 
[10]. Besides, the number of users of mobile devices surpassed the users of desktop devices at 
the end of 2013, which is a clear sign of the users’ preferences of mobile devices over desktop 
systems [9]. To see this evolution, Figure 1 shows the number of smartphones sold to end 
users worldwide from 2007 to 2014. 
This amazing growth of the number of users has propitiated the creation of a new branch in 
the software industry: the mobile applications or apps, understood as programs for 
smartphones and tablets which can be downloaded in the device directly from a commercial 
store. This industry has grown at the pace of smartphone sales and as of July 2014 there were 
3.17 million apps [12] in the most common commercial stores. Figure 2 shows these numbers 
for each different store. As it can be seen, Google Play and Apple App Store have many more 
apps than the rest and, besides, the operating systems these stores use, Android and iOS 
respectively, have the majority of the market share: 76.6% for Android and 19.7% for iOS as 
July 2014 [13]. 
 
Figure 1. Number of smartphones sold to end users worldwide from 2007 to 2014. Source: [11] 
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Figure 2. Number of apps available in leading app stores as of July 2014. Source: [12] 
These apps have different purposes and can be enclosed in different categories: games, 
education, business, lifestyle, travel, etc. There are also apps for health care and medical apps. 
In fact, health and fitness apps are 2.74% of the totality of apps while the medical apps are 
2.08% [14]. As of June 2014, there were almost 43,700 medical apps available only in the Apple 
store and their number is growing each day [15]. 
All these type of apps focused on health care are part of the mHealth or mobile health, which 
was defined by the Global Observatory for eHealth (GOe) of the World Health Organization 
(WHO) as “medical and public health practice supported by mobile devices, such as mobile 
phones, patient monitoring devices, personal digital assistants (PDAs), and other wireless 
devices” [16]. Although PDAs experienced a boom in the 1990s and early 2000s, they have 
been replaced by smartphones and tablets, which are much more extended, as seen before. 
Hence, mobile health can be seen as systems (hardware, software or both combined) that use 
the mobile technologies mentioned for providing or improving the health care of the users. 
mHealth is more than mobile apps for mobile devices. Its potential is rather well documented 
and there are a number of studies related [17-20]. For example, there are systems for 
teleconsulting, for managing electronic medical records, for accessing to information about 
medications, for continuous monitoring of vital signs or those with educational resources for 
specific diseases, diagnosis, treatment and prevention. 
With this framework, it is normal that the mobile technology and applications are now used 
for health care, since health is an essential aspect of every individual. The last scientific and 
medical advances have caused an elderly population and long-term survival of people who 
suffer chronic diseases, thanks to modern treatments and therapies. This has increased not 
only the life expectancy but also the quality of life expectation of health care consumers [21]. 
In 2008, the WHO estimated a total of 56.8 million deaths, of which only 5.1 million were 
produced by injuries. The rest were caused by communicable disease, maternal and perinatal 
conditions as well as nutritional deficiencies (15.6 million deaths), and non-communicable 
conditions (36.1 million deaths) [22]. These diseases are getting more common thanks to the 
mentioned high life expectancy, so they have to be seriously considered. Nevertheless, 
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attention should be focused not only on these diseases and conditions that can cause death, 
but also on those that can produce a disability or loss of health. In this context, it is essential to 
know the prevalence of an illness, known as the number of people who have the condition at 
any moment [23]. 
Of all the non-communicable diseases, the leading causes of death are cardiovascular diseases 
(CVDs), with a total of 17.5 million casualties in 2012, which means 31% of all deaths 
worldwide [24]. Besides, the predictions are not better: more than 23 million people are 
estimated to die annually from CVDs by 2030 [25]. Among them, heart-related diseases have 
special impact in mortality. For instance, ischemic heart disease is especially dangerous, since 
it is responsible for 7.4 million deaths only in 2012. In addition, other heart diseases suppose a 
significant number of deaths, such as inflammatory heart disease or hypertensive heart 
disease.  
It is very clarifying the fact that more people decease of heart malfunction than of AIDS and all 
cancers combined. The number of disabilities these diseases cause is also very important. Only 
ischemic heart disease caused 62,587 million Disability-Adjusted Life Years (DALYs) [26]. All 
these data presented imply colossal costs to the economy of the countries: only in the United 
States these diseases supposed a total of US$320.1 billion in 2011, including health 
expenditures and lost productivity [27].  
In light of these data, it is totally necessary to reduce the numbers of deaths and DALYs that 
CVDS and especially heart diseases cause, not only in health care premises such as primary 
health care facilities, but also in the homes and workplaces of patients. So, it seems that the 
mobile technologies and the mHealth applications mentioned are the perfect tool for meeting 
this objective, with special allusion to the apps focused on cardiology and heart conditions 
available in the commercial stores or under-development. 
1.2. Objective 
The main aim of this work is to research about mobile health systems and apps related to non-
communicable or chronic diseases, especially in the field of cardiology. In order to do so, this 
work is composed by two different parts with several studies in each one. 
The objective of the first part of the work is to obtain the state of the art of the mHealth apps 
for several diseases by performing systematic reviews. Four different reviews are performed, 
but all of them connected by the estimations and documents of the WHO [23]. The first review 
[28-29][A1.1-A1.2] studies the existing applications for mobile devices exclusively dedicated to 
the eight most prevalent health conditions by the last update of the document Global Burden 
of Disease of the WHO [23]. These conditions are Iron-Deficiency Anaemia (IDA), hearing loss, 
migraine, low vision, asthma, diabetes mellitus, osteoarthritis (OA), and unipolar depressive 
disorders.  
The second review [30][A1.3] studies the amount of research and mobile applications 
dedicated to the diseases and conditions that are the leading causes of mortality according to 
the WHO, grouped by different income regions. These are ischemic heart disease; stroke and 
other cerebrovascular diseases; lower respiratory infections; chronic obstructive pulmonary 
disease; diarrheal diseases; HIV/AIDS; trachea, bronchus, and lung cancers; malaria; and 
Alzheimer disease and other dementias. 
Borja Martínez Pérez 
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Since it was seen that CVDs and especially heart diseases are the deadliest and that also cause 
many disabilities, the third state of the art review [31][A1.4] is focused on these heart 
diseases, studying the literature on mobile systems and applications available, as well as the 
apps related to cardiology from the leading app stores, Google Play and Apple App Store.  
The last review [32][A1.5] focuses on the mobile clinical decision support systems and 
applications in order to know the state of the art of these systems, whose function is to link 
health observations with knowledge in order to support the decisions by health professionals 
for improved health care. The methods used for all these systematic reviews are the same: two 
reviews are done in each one, a literature review in academic databases and systems (IEEE 
Xplore, Scopus, PubMed, Web of Knowledge) and a review in the most important commercial 
stores (mainly in Google play and App Store). 
Once known the state of the art of the mobile apps for the deadliest and the most prevalent 
diseases, with a thorough study in apps related to cardiology and heart diseases, and the 
decision support apps, a whole knowledge and classification of the currently available heart 
related apps are obtained. As a result, some types of apps are missing, such as apps for the 
self-management of heart conditions by the own patients. Hence, the next section of this work 
is to design and develop an app that fills this gap found in the market and performs the 
function mentioned. This app is named Heartkeeper (previously named Cardiomanager, as it is 
stated in some studies) and is designed for Android. Additionally, during the development of 
Heartkeeper [33][A1.6], different researches in mobile health with relation to this 
development are performed.  
A tool for measuring the users’ Quality of Experience (QoE) of mHealth applications is created 
in order to improve the quality of the existing apps and the ones to be released [34][A1.7]. This 
tool uses the Likert scale from 1 to 5 and it is applied to Heartkeeper (once finished) in order to 
assess its QoE obtained from its own users. Another tool for measuring the compliance of 
Heartkeeper with Android guidelines created by Cruz Zapata et al. (2014) is also applied to the 
app [35]. With the application of these two tools, Heartkeeper is tested and the results are 
presented in other study [A1.8]. 
Since clinical data from the patients is very sensitive, it is important to use mechanisms and 
techniques to assure the privacy and security of this information. Hence, a study of these 
topics in mobile health applications was performed when doubts related to security and 
privacy arose during the development of Heartkeeper [36][A1.9]. It consists of three parts: a 
study of the existing laws regulating these aspects in two of the most developed zones: 
European Union (EU) and the United States of America (USA), a quick review of the academic 
literature related to this topic, and a proposal of some recommendations for developers in 
order to create mobile health applications that satisfy the current security and privacy 
legislation. 
Finally, it is performed an ex-ante economic impact assessment and a cost-effectiveness 
analysis that the use of Heartkeeper by patients with Heart Failure (HF) would have in the 
Spanish community of Castile and Leon [37][A1.10]. With this study, it is possible to predict the 
costs savings that the introduction and use of Heartkeeper can suppose to the public health 
system of the region mentioned. 
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2. Methods 
The methodology used in this work is different for each type of study performed. However, the 
methods used for any of the 4 reviews done [28-32][A1.1-A1.5] are practically the same with 
some variances. Generally, these methods include a deep literature review and a commercial 
apps review in the different app stores. 
The methods used in the literature review were the following: 
 A search of published papers is developed in several academic systems and databases. 
These systems are IEEE Xplore, Scopus, Web of Science (previously known as Web of 
Knowledge) and PubMed. In the first review, ScienceDirect is also used.  
 The search words are completely related to the topic to study and are defined 
previously, but if the numbers of results obtained is too low, another combination of 
words are used until obtaining a significant number of results. These search strings are 
used only for metadata. 
 The results are limited to a determined period, normally the last 10 years. In the last 
review this period is for 7 years. 
 Specific eligibility criteria are followed. Common requisites were the following: the 
papers should be written in English, should be related to the topic to study and must 
include at least a relevant application or system related to the topic searched. 
 For applying the criteria chosen, the title and the abstract of each paper is read. If 
relevant, it is included in the study; if repeated, it is dismissed; if there are doubts, the 
whole paper is read in order to include it or not in the study. 
The methods used in the commercial reviews are similar to the ones for the literature reviews: 
 The review is done in the most important app stores of mobile devices considering the 
market share of their operating systems. For the initial review Google Play, App Store, 
BlackBerry World, Windows Phone Apps+Games Store and Nokia’s Ovi Store are 
considered. For the second review Ovi Store is not used and for the remaining two 
only Google Play and App Store are considered. 
 The search words are normally the same of the literature review. 
 The search in commercial stores is not limited by a period, so all the apps returned are 
considered.  
 Similarly to the literature review, eligibility criteria are followed. The apps should be in 
English or in the native language of the authors (Spanish), designed for human health, 
not animal health, and focused on the disease or type of app searched. Those apps 
included in the categories of entertainment, games or music are dismissed. In addition 
to these common requisites, other are used depending on the review done. 
 For including or not the app in the study, its title and its description in the store are 
read. If it is irrelevant for the study, or do not fulfil the established criteria it is 
dismissed. 
The flow chart with the steps used for both types of reviews is shown in Figure 3. Additionally, 
in some cases, a classification of categories of apps or systems found in the literature and 
commercial reviews are performed or some papers or apps are selected in order to perform an 
in-depth analysis. To perform that, all the authors convey in order to analyse the relevant 
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papers and apps included in the study and the classification or selection is done together with 
common agreement. 
For the development of the tools for measuring the QoE of mHealth apps [34][A1.7], it is 
decided to use the metric Mean Opinion Score (MOS) as a subjective measure that quantifies 
the perceptual effect of different forms of degradation of the service from the point of view of 
the end-users [38]. The features measured by the tools are: content quality, security, use, 
availability, performance, appearance, learning curve and accuracy of the apps. These tools are 
developed with the collaboration of psychologists. For evaluating them, a sample of 
representative commercial apps from Google Play is chosen, since Google Play it the most used 
store [13], as mentioned. To conduct the evaluation a total of 28 physicians and 112 patients 
collaborate filling in the tools delivered. The results of these evaluations are introduced in the 
program IBM SPSS Statistics [39] in order to obtain statistics from the results. 
 
Figure 3. Flow chart of the methods used in the literature and commercial reviews (Source: 
[31][A1.4]) 
2. Methods 
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The methods used for obtaining the recommendations for developers in privacy and security 
[36][A1.9] are the following. Firstly, the security and privacy laws in mHealth in EU and USA are 
identified and carefully read in order to obtain the main points and acknowledge common 
aspects as well as main differences. Then a literature review of privacy and security aspects in 
apps is performed, including all the papers related to any mechanism or technique for ensuring 
privacy and/or security. The requisites and the methodology for this search are the same as 
the previous literature reviews. Finally, the results obtained in the previous parts of this 
research are used to create privacy and security recommendations for mHealth app 
developers. 
For the design and implementation of Heartkeeper [33][A1.6], the methods used are the 
following. Based on the results obtained from the review of cardiology apps, it is decided to 
create an application for the self-management of heart diseases and conditions. The main 
reason of doing this is because only one app for this heart management is found in Google Play 
and the App Store. Additionally, the most common diseases are included in Heartkeeper: 
ischemic heart disease, valvular heart disease, hypertension, and auricular fibrillation. Other 
aspects that can influence the hearth health are also incorporated: the relations between 
heart and pregnancy, physical activity and diabetes. Heartkeeper was designed with three 
main sections: 
 An informative section with medical information that will help the patients to 
understand their disease, its symptoms and its treatment; and a patient guide in order 
to inform the users about best practices, prohibitions and life style they should adopt 
in order to improve their condition. 
 A section to record the user’s activities (good and bad for their conditions) and health 
measurements in order to act in consequence with them. Examples of these activities 
are rehabilitation, physical activity or excesses (in alcohol or food intakes, for 
example), whereas typical measurements are blood pressure, glucose or cholesterol. 
 A section for registering the users’ medications and the hours that they should have 
them, offering the possibility to establish alarms to warn them. These intakes should 
be registered in order to create a daily record stored in the calendar. 
For the implementation of Heartkeeper it is decided to develop it for Android, from version 
Android 2.3 (API 9), since it is the most extended mobile operating system [13], and the tool 
used for this is the Android Software Development Kit (SDK), which includes the Eclipse 
Integrated Development Environment (IDE) with built-in Android Development Tools (ADT). 
The lessons learned in the privacy and security research are applied to Heartkeeper. Hence, 
some features are included: a disclaimer with information about the app and the treatment of 
data is shown at first launch; the data is stored in the device rather than in a server or in the 
cloud in order to avoid external attacks; the most sensitive data are encrypted by a password-
based algorithm that uses 256-bit Secure Hash Algorithm (SHA) techniques with random data 
input that adds more security in order to make those data inaccessible by intruders. 
The interface is also carefully designed in order to obtain an app attractive to users, trying to 
do it simple and intuitive. The framework of Heartkeeper is shown in Figure 4. 
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Figure 4. Framework of Heartkeeper (Source: [33][A1.6]) 
The validation of Heartkeeper is done by several methods. In an exhaustive testing phase all 
the operations permitted by the app are performed systematically in several devices with 
different screens (3.5, 5, 7 and 10.1 inches) in order to find errors and bugs and assure the 
correct behaviour of the app. The response times of the most time-consuming operations of 
Heartkeeper are also measured in the mentioned devices to check the speed of the app. 
For measuring the compliance with Android guidelines [A1.8] a tool created by Cruz Zapata et 
al. (2014) [35] is used, a questionnaire shown in Table 1, which is based on the layers of web 
design style, behaviour and structure [40]. 
Each question is scored as follows: 1 point if the answer is “yes” for more than 70% of use 
cases of Heartkeeper, ½ point if the answer is positive for 30%-70% of use cases and 0 point if 
the answer is positive for less than 30% of use cases. These questions are responded directly 
by the authors together. 
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Table 1. Questionnaire for measuring the compliance with recommendations by Google 
Q1. Style 
Q1. 1. Is the writing style simple and informal and is the second person used to talk to the 
user? 
Q1. 2. Are pictures used to explain ideas? 
Q1. 3. Are pre-defined icons used for common actions? 
Q1. 4. Does the app adapt to both horizontal and vertical orientations? 
Q2. Behaviour 
Q2. 1. Are the user preferences learned over time? 
Q2. 2. Do the elements react to the user’s gestures by changing color or illumination? 
Q2. 3. Are there confirming messages showing warning information related to actions 
that the user needs to consider? 
Q2. 4. Are there acknowledging messages to let users know that the action they have 
invoked has been completed? 
Q2. 5. Do long tasks show non-stationary activity indicators? 
Q3. Structure 
Q3. 1. Is the app loaded immediately without any splash screen or startup experience? 
Q3. 2. Is the login delayed to allow the user to use a particular functionality first? 
Q3. 3. Are suggested structure patterns used: action/tool bar, tab bar, spinner or 
navigation drawer? 
Q3. 4. Is the navigation consistent when moving between hierarchical screens? 
 
The QoE of the users of Heartkeeper is also obtained using the survey created previously. From 
this tool, only two questions are not used since they were not relevant for Heartkeeper: the 
one related to the regular updates of the app (not included since no update has been done 
until obtaining the QoE), and the one related to the precision of the calculations done (not 
used since Heartkeeper does not perform any calculation). For obtaining the feedback of the 
users, the survey is accessible in a Google form [41] through a button included in the app, so 
every user could access it. The period for collecting responses was from October 2014 to 
February 2015, both included. 
For the ex-ante economic impact assessment of Heartkeeper [37][A1.10], a population sample 
similar to the selected by Naveiro-Rilo et al. (2012) is used [42]. This sample consists of 
patients with documented chronic HF, seen through hospital discharge report done by a 
specialist or by the family doctor, and based on Framingham criteria diagnosis and additional 
examinations such as chest radiography, electrocardiogram and echocardiography. This 
sample belongs to the area of Valladolid, which has a population of more than 200,000 
individuals over 39 years. 
An anonymous census is elaborated with 2000 patients. The sample size is considered for 
estimating dichotomous variables with an overall precision for the health area of 4% and 95% 
confidence, in proportions of 50%. The result is a size of 630 patients. An economic evaluation 
type cost-effectiveness [43-44] is made on a structured Markov model, via a static 
deterministic hypothetical cohort with annual cycles and considering the clinical states shown 
in Figure 5. 
The cost of the tool is estimated in 100 euros, 90 € for the mobile device with 10 € overhead, 
whereas the app is free. For the health care costs, the guide of costs of the Ministry of Health, 
Social Policy and Equality [45] is used. Data on HF incidence is obtained from the Statistics 
Central of the Ministry of Health, Social Policy and Equality [46-47]. Finally, the probabilities of 
death are estimated based on the age-specific mortality rate for 2011 published by the 
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National Statistics Institute [47-48]. The results of this analysis are calculated using the 
incremental cost-effectiveness ratio (ICER), expressed as cost per additional Quality-Adjusted 
Life Year (QALY) obtained. For the construction and the model analysis the software Tree Age 
Pro Suite 2009 is used. 
 
Figure 5. State diagram of the adapted Markov model (Source: [37][A1.10]) 
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3. Results 
In this section the main results of this work are presented, extracted from each study 
performed.  
Firstly, the results obtained from the literature and the commercial review of the systems and 
applications for the most prevalent conditions [28-29][A1.1-A1.2] are presented in Table 2 and 
3 respectively. The last column of both tables indicates the addition of all the matches 
obtained in all the systems for each disease. Table 3 indicates the number of relevant apps out 
of the total number of apps returned in each store. Besides, the results of diabetes and 
depression were divided into results for diabetes mellitus and diabetes in the first case, and 
depression and depressive disorders in the second. 
Table 2. Results of the literature review of the applications for the most prevalent conditions 
 IEEE Scopus ScienceDirect WoK PubMed Total 
Anaemia 2 3 0 1 1 5 
Hearing loss 4 8 0 5 2 9 
Migraine 2 2 0 1 1 3 
Low vision 0 7 1 3 1 9 
Asthma 8 29 1 25 16 36 
Diabetes 
mellitus 
16 112 5 79 53 140 
OA 0 6 1 5 3 6 
Depression 6 22 5 18 13 32 
 
Table 3. Results of the commercial review of the apps for the most prevalent conditions 
 Google 
Play 
iTunes BlackBerry Windows 
Phone 
Ovi 
Store 
Total 
Anemia 7/74 7/21 0/0 0/0 0/0 14 
Hearing loss 17/42 32/37 0/0 3/5 - 52 
Migraine 57/201 46/102 5/6 4/8 0/0 112 
Low vision 33/43 30/46 0/0 1/1 - 64 
Asthma 44/226 57/124 6/7 4/14 1/2 112 
Diabetes Diabetes >1000 605 33 81 40 >1759 
Diabetes 
mellitus 
19/67 17/21 0/0 2/3 15/40 53 
OA 16/46 5/16 0/0 2/2 1/1 24 
Depression Depression >1000 419 13 69 35 >1536 
Depressive 
disorders 
1/5 0/0 0/0 0/0 - 1 
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Similarly, the outcomes from the literature and commercial review of the applications for the 
deadliest diseases [30][A1.3] are shown in Tables 4 and 5 respectively. These tables are similar 
to the Tables 2 and 3. The last row of Table 5 shows the total number of apps returned in each 
store. 
Figure 6 shows three graphs, each one for a different region (low-income, middle-income and 
high-income region), indicating the percentage of the number of apps found in the stores for 
each of the top 6 causes of death in each region, excluding the rest. 
Table 4. Results of the literature review of the applications for the deadliest diseases 
 IEEE Scopus Wok PubMed Total 
LRI 5 11 5 2 12 
Diarrhoeal diseases 0 2 0 0 2 
HIV/AIDS 3 15 6 4 18 
IHD 24 31 27 8 49 
Malaria 1 4 2 2 4 
Stroke and other cerebrovascular diseases 5 16 10 4 19 
COPD 3 8 6 1 10 
Trachea, bronchus, lung cancer 1 2 1 1 2 
Alzheimer and other dementias 8 22 12 4 24 
 
Table 5. Results of the commercial review of the apps for the deadliest diseases 
 Google play iTunes BlackBerry 
World 
Windows 
Phone Store 
Total 
LRI 5/57 1/17 0/0 0/0 6 
Diarrhoeal diseases 12/88 8/12 0/0 0/5 20 
HIV/AIDS 54/238 56/121 7/8 7/19 124 
IHD 60/249 44/79 3/4 4/21 111 
Malaria 12/51 7/25 1/2 2/8 22 
Stroke and other 
cerebrovascular diseases 
27/>1000 45/530 4/46 3/105 79 
0/0 0/2 0/0 0/0 0 
COPD 20/50 17/37 0/0 1/3 38 
Trachea, bronchus, lung 
cancer 
0/0 0/1 0/0 0/0 0 
0/1 0/0 0/0 0/0 0 
14/88 14/54 1/3 0/2 29 
Alzheimer and other 
dementias 
38/175 25/96 1/2 6/14 70 
32/185 23/70 0/0 3/10 58 
Total apps per store 274 240 17 26  
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Figure 6. Percentage of apps (%) related to the top 6 causes of death of each different zone: (a) 
low-income zone, (b) middle-income zone and (c) high income zone (Source: [30][A1.6]) 
From the review of mobile applications and systems related to cardiology [31][A1.4], a total of 
406 papers and 710 apps are found, 439 available for iOS and 271 for Android. Table 6 shows 
the classification of the relevant papers by their content, which also shows the number of 
articles for each category. Similarly, Table 7 and Table 8 shows the classification of the apps 
found, sorted by their functions. 
  
  
(a) (b) 
 
(c) 
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Table 6. Classification of the results of the literature review of mobile applications related to 
cardiology 
Type of system/application Articles 
Vital signs monitoring system 55 
ECG (Electrocardiography)/cardiac signal detection/classification algorithms 44 
Heart monitoring system 37 
ECG/Heart monitoring system trial/evaluation 28 
Remote heart monitoring system 25 
Heart monitoring system with alerts 17 
Cardiac rehabilitation mobile system 16 
ECG data transmission 14 
Blood pressure measurement/monitor system 13 
Remote management/monitoring of implanted pacemakers/cardiac devices 11 
Teleconsultation system 10 
Remote and local heart monitoring system 8 
Exercising/sports related heart monitoring system 7 
Innovative heart rate monitor 7 
Arrhythmia detection system 7 
Sensors evaluation/state of the art 6 
Surveys/states of the art of cardiology systems 5 
Heart rate & blood pressure monitoring system 5 
Remote heart monitoring system with alerts 5 
Atrial fibrillation detection system 5 
Heart failure detection system 5 
Phonocardiography mobile system 5 
Remote and local heart monitoring system with alerts 4 
Breath monitoring system 4 
ECG data compression technique 4 
Automatic music selector to maintain a target heart rate 4 
Alerts and location of heart attacks 4 
CPR instructions through mobile phone trial 4 
CPR instructions/reminder through mobile phone 4 
Applications for promotion of healthy behaviours 4 
System for measuring/reducing stress 3 
Personal lifestyle and health management system 3 
Fetal heart monitoring system 3 
ECG data encryption/authentication/privacy 3 
Cardiac rehabilitation mobile system trial 3 
Exercising/sports related heart monitoring system evaluation 3 
Mobile medical applications for chronic diseases 2 
Pocket-size images interpretation 2 
First aid/resuscitation app evaluation 2 
Apps for hypertension in smartphones 2 
Emotional states detection through measuring heart rate differences 2 
Weight control in high-risk heart failure population 2 
Medications management 2 
Telemetry-based system for monitoring rats' vital signs 1 
Heart attack self-test app 1 
Trial for comparing follow-up of hypertensive patients 1 
Study about the correlation music-heart rate variability 1 
App for improving Basic Life Support (BLS) 1 
Non-invasive tissue classifier 1 
Share of vital signs in a social network 1 
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Table 7. Classification of the apps related to cardiology of the commercial review (part 1) 
Type of app Number 
Heart Rate Monitor 94 
Algorithm/calculator/predictor 85 
Informative guide 41 
Educational ECG/Interpretation aid of ECG 37 
News/journal 34 
Blood pressure tracker 30 
External devices heart rate monitor 22 
CPR (Cardiopulmonary Resuscitation) instructions 21 
Educational anatomy 17 
Medicine students education 17 
Guide/book 17 
Health tips 17 
Diagnosis & treatment guidelines 14 
Echocardiography reference 14 
Professionals & students education 14 
Medicine exam preparation 13 
General education 11 
Diagnosis aid 10 
Animated guide 9 
Heart sounds reference 9 
Blood pressure & heart rate monitor 9 
Cardiology medical reference 8 
Medical images reference 8 
Catheter reference 8 
Guide of professional commercial devices 7 
Stethoscope/educational stethoscope 7 
AED (Automated External Defibrillator) location 6 
Professionals education 6 
Clinical trials 6 
ECG cases reference 5 
Hypertension reference/guidelines 5 
Procedures in emergency cases 5 
Patients’ history/ECGs/images 4 
Surgeon aid/training 4 
Professionals connections, knowledge/cases share 4 
Angiography reference/guide 4 
Auscultation reference 4 
Heart rate monitor for exercising 4 
Fetal heart rate monitor/interpretation 4 
Heart rate calculator 4 
Ultrasound video reference 4 
Resuscitation instructions/guide 4 
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Table 8. Classification of the apps related to cardiology of the commercial review (part 2) 
Type of app Number 
Educational/explanations for patients 3 
ECG sending 3 
Log procedures 3 
Diseases prevention guide 3 
Heart rate monitor with external devices for exercising 3 
Professionals guidelines 3 
Audio reference 2 
ECG signal transformer 2 
Location of cardiac emergencies 2 
Blood pressure measurement with external devices 2 
CPR and AED instructions 2 
Prescribing drugs 2 
AED training 2 
Pulse measurement aid 2 
Hospitals 2 
Instructions/training CPR & AED location 2 
Perfusion reference 2 
Arrhythmia reference 2 
Acute coronary syndrome reference 2 
Stent guide/reference 2 
Prosthesis guidelines 1 
Teleconsultation 1 
Upload ECG from a commercial monitor 1 
Medications reminder 1 
Treatment guide 1 
Stand-alone or with external device heart rate monitor 1 
Auto-diagnosis 1 
Cardiac rehabilitation guide 1 
Anesthesia management 1 
Social network 1 
Atrial fibrillation guidelines 1 
AED training with simulation of external device 1 
Blood pressure prevention & treatment exercises 1 
Condition management 1 
Congenital heart defects reference 1 
Clinical examination guide 1 
Blood pressure measurement 1 
Driving guidelines for cardiac patients 1 
 
The last review done was related to mobile clinical decision support systems and applications 
[32][A1.5]. A total of 92 relevant papers and 192 commercial apps are found, 171 on Google 
play and 21 on the App Store. Table 9 shows the classification of these apps sorted by medical 
field. 
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Table 9. Classification of apps in the commercial review sorted by medical field 
Medical field Number 
General medicine 47 
Drugs information 16 
Emergencies 12 
Paediatrics 11 
Cardiology 7 
Oncology 7 
Psychiatry/Mental health 7 
HIV 6 
Infectious diseases 6 
Lab values 6 
Neurology 6 
Haematology 5 
Cardiovascular 4 
Dermatology/Wounds 4 
Gynaecology 4 
Radiation therapy/Radiology 4 
Gastroenterology 3 
Anaesthesia 3 
Hepatitis 3 
Nutrition 3 
Orthopaedics 3 
Respiratory system 3 
Surgery 3 
Urology 3 
Diabetes 2 
Geriatrics 2 
Imaging 2 
Albuminuria 1 
Day time somnolence 1 
Dysanatremia 1 
Endocrinology 1 
Hospital 1 
Insomnia 1 
Nephrology 1 
News/Research 1 
Ophthalmology 1 
Sclerosis 1 
 
Before initiating the process of designing Heartkeeper, a tool for measuring the QoE of 
mHealth applications [34][A1.7] is created. This tool is a survey that uses the Likert scale with 
the following values: 1. Strongly disagree, 2. Disagree, 3. Neither agree nor disagree, 5 Strongly 
agree [49]. It is presented in Table 10. This tool is tested with 13 different mHealth applications 
available in Google play, obtaining satisfactory results. Besides, another tool for not finishes 
apps is also designed considering only its content quality, which can be seen in Table 11. 
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Table 10. Survey to measure the QoE of finished mHealth apps 
CONTENT QUALITY 
1 Does it make the function that you expected? 1 2 3 4 5 
2 Can you do the same without the application? 1 2 3 4 5 
3 Does the application receive updates regularly? 1 2 3 4 5 
4 Do you think the data are reliable? 1 2 3 4 5 
5 Can you identify with this application health problems? 1 2 3 4 5 
6 Do you have possibility to send information about your status to your doctor? 1 2 3 4 5 
7 Do you have better quality of life by using this application? 1 2 3 4 5 
SECURITY 
8 Do you think that this application has appropriate security methods to protect data that 
are introduced? 
1 2 3 4 5 
9 Do you think that the data obtained with this application are sufficiently protected? 1 2 3 4 5 
EASE OF USE 
10 Do you find what you need? 1 2 3 4 5 
11 Do you think that the traditional method used so far is more difficult or does not exist?  1 2 3 4 5 
12 Is this application useful for monitoring the disease? 1 2 3 4 5 
AVAILABILITY 
13 Do you have the guarantee of access to the application and its data at any time? 1 2 3 4 5 
PERFORMANCE 
14 Do you think you might have a more optimized performance? 1 2 3 4 5 
15 Do you find some kind of error or problem while using the application? 1 2 3 4 5 
APPEARANCE 
16 Do you find adequate the appearance of this application? 1 2 3 4 5 
17 Would you change or add something from this application? 1 2 3 4 5 
LEARNING 
18 Do you think that the time for learning the use of the application is appropriate? 1 2 3 4 5 
PRECISION 
19 Do you think the calculations done by this application are correct? 1 2 3 4 5 
 
Table 11. Survey to measure the QoE of not finished mHealth applications (research) 
CONTENT QUALITY 
1 Would you use the app if developed? 1 2 3 4 5 
2 Do you think that in the future it can be useful to society? 1 2 3 4 5 
3 Do you think it will improve the quality of life of the users? 1 2 3 4 5 
4 Will this future application help in treating diseases? 1 2 3 4 5 
 
The most interesting results of the study of the privacy and security aspects in mobile health 
apps [36][A1.9] in the EU and the EEUU are shown in Table 12 and Table 13. There are two 
main laws that regulate these issues, which are the EU Data Protection Directive 95/46/EC 
from 1995 and the American Health Insurance Portability and Accountability Act (HIPAA) from 
1996. Table 12 shows a summary of the most restrictive points of these laws, sorted by 
different requirements, whereas Table 13 gathers some recommendations for app developers 
in order to guarantee the privacy and security of the users’ information. 
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Table 12. Laws requisites regarding privacy and security in mHealth applications 
Cover data The data that must be covered are that information that can be used to 
identify a person. It includes ID numbers, physical, physiological, mental, 
economic, genetic, social, medical, cultural factors regarding to the past, 
present or future of the patient. 
Information 
requirements 
Before providing their Personal Health Information (PHI), users must be 
informed about the identity of the person/entity that will use the PHI, the 
purposes of the collecting, the entity’s privacy practices, whether the 
provision is compulsory or voluntary, the rights they have to access/modify 
the data and a contact method for more information or complaints. This 
information must be given directly to a parent or legal tutor in case of children 
under 13. 
Consent 
requirements 
The user/patient’s consent to the data collecting must be obtained by the 
entity, when this collecting can not be justified by a statutory ground. The 
entity is enhanced to obtain this consent written. In the case of children under 
13, they can not consent their data collection, being their parents or legal 
tutors the ones to do this. 
Data 
retention 
Generally, PHI should be kept only the necessary time for the purpose that 
was collected and must be erased once the purpose is reached. Entities must 
also include a clear data retention policy as part of their security procedures. 
Security The entities are required to implement and maintain appropriate technical, 
administrative, physical and organizational security measures to protect PHI 
from accidental or unlawful loss and unauthorized access or disclosure. Since 
health data is very sensitive, the security must be higher. 
Breach 
notification 
obligations 
In case of a personal data breach, the entities must notify it to the competent 
authority as well as the user whose data has been compromised without 
unreasonable delay, especially when the breach may have adversely affected 
to the user. In cases of massive breaches, the media should be also notified. 
Data 
transfers 
Entities need the users’ consent to transfer their personal data to another 
entity or a third party, even when this transfer is necessary to complete one of 
the purposes of the data collecting, unless the transfer is allowed by law. 
 
Heartkeeper can be considered the most important and tangible result of this work. It is the 
result of the process of development of a mobile application for the self-management of heart 
conditions and diseases by the own patients [33][A1.6], and all the lessons learned in the 
previous studies has been considered. It is designed for Android and Figure 7 shows some 
screenshots. 
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Table 13. Security and privacy recommendations for mHealth applications 
Property Minimum requirements Recommended requirements 
Access control The access control to the PHI must be patient-
centric. The users should be able to allow or 
forbid access to their information at any 
moment. 
It is preferable to create a role-based access, 
giving reading possibilities to some roles and 
adding limitations to other ones. 
Authentication The authentication must be done with a unique 
ID and a password only known by the user. This 
ID can be linked to a Public Key Infrastructure 
(PKI), preferable Rivest, Shamir and Adleman 
(RSA) system and/or a symmetric key used for 
encryption.  
The password used must be complex, with at 
least seven characters and a combination of 
letters and numbers, including one 
capitalized letter and a special character. It is 
better to employ multifactor authentication 
to complement the ID/password 
identification when possible: using an item 
the user possesses (smart key) or a physical 
feature such as fingerprint. 
Security and 
confidentiality 
Use Advanced Encryption Standard (AES) to 
encrypt PHI. The cryptographic key used must 
have at least 128 bits. This method offers better 
encryption times than other techniques. 
It is better to improve the security using a 
key of 192 or 256 bits. 
Integrity At least, a symmetric key-based authentication 
code must be used, for example AES. 
A public key-based digital signature is 
preferred. Under no circumstances 
watermarking methods must be used with 
medical images since they can deteriorate 
the quality of them and even provoke bad 
diagnoses. 
Inform patients Before the collection and use of PHI, the app 
should present a privacy police informing the 
patients about the identity of the entity that will 
use the data, the purpose of the collection, the 
privacy methods used, the rights they have and 
a contact method. If the users accept this police 
they give their consent to the data collection. It 
must include a section for children under 13, 
requiring the consent of a legal tutor. 
The policy should be easy to understand, 
concise and clear, since users are not fond of 
reading large legal documents in an app. It is 
highly recommended to leave the policy 
accessible for the user at any moment in the 
app. 
Data transfer Use Transport Layer Security (TLS) with 128-bit 
encryption methods. It is also possible to use 
Virtual Private Networks (VPNs). 
It is preferable to use TLS with 256-bit 
encryption methods. It is also very 
recommendable to show an icon in the app 
notifying the transfer of data.  
Data retention The retention policy should be included in the 
privacy policy to inform the patients. The data 
should be kept only the necessary time for the 
initial purpose. 
When the purpose is achieved, the PHI must 
be erased and the user should be notified. 
The entity should provide a mechanism to 
let the user check that the data has been 
deleted. 
BANs 
communication 
At least cryptographic methods must be used in 
securing the BSNs for authentication and key 
distribution. The mobile device (smartphone) 
can be identified and authenticated by its 
International Mobile Equipment Identity (IMEI) 
or its Subscriber Identity Module (SIM) card 
number. 
Biometric patterns of the user can be 
utilized to encrypt and decrypt the 
symmetric key, which can facilitate the 
connection of the BSNs to the mobile device.  
Breach 
notification 
In case of a PHI breach, the competent authority 
as well as the user affected must be notified as 
soon as possible (1-3 days). The entity must help 
the user in order to relieve the consequences 
the breach may have caused.  
It is important to compensate the user 
affected in order to compensate the possible 
damage done. In cases of breaches affecting 
a significant number of users, the media 
must be notified to inform of the problem. 
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(a) Main page of Heartkeeper (b) Creation of a medication register 
  
(c) Calendar activities (d) Graph with the registers of pulse 
Figure 7. Screenshots of Heartkeeper 
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As mentioned in the Methods section, Heartkeeper is tested in several ways. Hence, Table 14 
shows the mean value of 10 measurements of the response times of the app in nanoseconds 
when performing specific actions.  
The application of the tool for measuring the compliance of Heartkeeper to Android guidelines 
[A1.8] for each feature provides some results, presented in Figure 8, whereas the score 
averages obtained for each block with the tool for measuring the Heartkeeper users’ QoE are 
shown in Figure 9. 
For calculating the economic impact of the introduction of Heartkeeper in the region of Castile 
and Leon [37][A1.10] some previous calculations are needed. The characterization of the cost 
of a heart failure patient is made considering the report by the Ministry of Health Care, Social 
Policy and Equality [50]. Besides, costs are adjusted to 2011. The breakdown of costs 
associated to a heart failure patient is shown in Table 15. Considering this, the cost analysis of 
the two scenarios (without the introduction of Heartkeeper and with it) is shown in Table 16. 
Table 14. Mean times (ns) of a total of 10 measurements of some operations with Heartkeeper 
 Samsung GT-S6500 Sony Xperia Z Samsung Galaxy Tab 3 
Launch 211.826.000,24 110.205.078,20 56.673.023,80 
Encryption 2.200.953.999,60 788.012.696,50 728.293.863,35 
Decryption 2.319.032.666,40 708.050.537,40 650.942.188,80 
Activity DB writing  49.139.777,80 100.712.367,34 72,071391,29 
Activity DB reading  25.261.667,00 44.937.134,50 6.549.713,25 
Medicines DB reading with 
9 registers 
15.697.500,95 14.175.415,20 10.826.702,42 
Blood test graph drawing 
with 11 registers 
122.416.667,26 258.453.369,65 59.414.637,15 
 
 
Figure 8. Average score obtained per block with the tool for measuring the compliance of 
Heartkeeper with Android guidelines (Source: [A1.8]) 
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Figure 9. Score average obtained per block with the tool for measuring the Heartkeeper users’ 
QoE (Source: [A1.8]) 
Table 15. Analysis of the cost of health states of the established Markov model 
States Unitary cost 
Treatment - 
Hospitalization (including health stabilization) 13.889,79€ 
Outpatient care 1.413€ 
Re-entry 12.434,4€ 
Monitoring 577,92 
 
Table 16. Ex-ante global impact analysis of the introduction of Heartkeeper for the 
management of HF 
States Without Heartkeeper With Heartkeeper 
Hospitalizations (including 
health stabilization) 
13.889€ 8.333€ 
Outpatient care 1.413€ 1.413€ 
Re-entry 12.434€ 9.256€ 
Monitoring and treatment 577 0 
TOTAL per patient 28.315€ 19.012€ 
TOTAL sample 17.895.080€ 12.015.584€ 
ICER - 9.303 
 
According to [50], Heartkeeper is able to reduce the number of hospitalizations by 60% and 
the average stays by 73%. Additionally, the changes in the behaviour of the patients by the use 
of Heartkeeper mean a 33% reduction in the cost of management of the disease, which will be 
complemented with an increase in the efficiency in this management. 
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4. Discussion and Conclusions 
In this section the most relevant conclusions extracted from the different studies of this work 
will be presented.  
Some conclusions can be obtained from the literature and commercial review of the 
applications for the most prevalent conditions [28-29][A1.1-A1.2] and the leading causes of 
death [30][A1.3]. First of all, there are many more results returned in the commercial review 
than in the literature review, which means that the economic motivation is stronger than the 
research one. Secondly, comparing the number of apps available on each store, it is obvious 
that Android and iOS are the preferred operating systems by app developers. Windows Phone 
is the third in number of apps whereas Ovi Store (currently disappeared) and Blackberry World 
have a very small number of apps related to these conditions and diseases. 
Focusing on the most prevalent conditions, a huge difference can be observed in the number 
of mobile applications depending on the considered condition. Hence, some conditions have 
more than 1000 apps, such as diabetes and depression while other varies in a range between 
14 and 112 apps. Surprisingly, the most prevalent condition (IDA) is the second with less 
research and the first with less commercial apps. On the other hand, two of the less prevalent, 
such as diabetes and depression, are the most researched and commercially utilized. This can 
be explained by two reasons: the first is that diabetes and depression are common conditions 
of developed countries whereas IDA is common in underdeveloped zones; the second is that 
there is a big social conscience of diabetes and depression, much more than the social 
conscience of IDA. Following these findings, the four most prevalent conditions have less work 
than the remaining four, apart from OA. 
Focusing on the deadliest diseases, there are two differentiated groups. On one hand, there 
are 4 diseases with the majority of work done, which are Alzheimer and other dementias, 
heart diseases, HIV/AIDS, and stroke and other cerebrovascular diseases. On the other hand, 
the rest of the diseases have much less work. 
Comparing the number of work done for disease with the position in cause of death for the 
different zones, the following conclusions are obtained. The leading cause in high-income 
zones, heart diseases, is one of the most researched, which is logical since developers normally 
focus on typical diseases of developed zones [51]. However, the first and second causes of 
death in low-income countries, LRI and diarrheal diseases, have very little research. This is 
because they are not common (diarrheal diseases) in developed countries or there is no use of 
an app for them (LRI), so that their research is not worthwhile, in addition to the fact that in 
low-income zones (where diarrheal diseases and LRI are common) the technology for mobile 
devices is not widespread [52].  
In contrast, HIV/AIDS is the opposing case. It is in the top 6 of low- and middle-income zones 
but not among the first causes of death in high-income countries, but it is the second disease 
with more work done. The reason is similar to what happened with diabetes and depression, 
HIV/AIDS is very popular and have a big social conscience not only in underdeveloped zones 
but also in in richer countries [53], so it has the attention of developers and the general 
population.  
The most striking case is the one with trachea, bronchus and lung cancers. They are the third 
cause of death in high-income zones, but they have very few apps dedicated. The reason is not 
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clear since cancer in general is a common matter with an enormous social conscience, specially 
these cancers since they are consequences of smoking [54]. Hence, developers have the 
opportunity to fill this empty space by creating apps for these types of cancer. 
From the results obtained in the review of mobile applications related to cardiology [31][A1.4], 
several findings can be extracted. Focusing on the literature review, there are 198 papers 
related to heart monitoring systems including vital signs, which means almost half of all the 
papers found. This is a clear indicator that the most researched area is the linked to these 
heart monitoring systems. 
From the commercial review, it can be seen a big distance between the first two positions in 
the classification (heart rate monitors and calculators) and the rest of the apps, when 
considering the number for each category. Contrasting with these types, there are others 
categories with very few apps, such as guides for cardiac rehabilitation and apps for the self-
management of a heart condition of disease. For this reason, it was decided to design and 
develop a mobile app with this last purpose. 
Some interesting findings can be obtained from the results of the review of mobile decision 
support systems [32][A1.5], especially from the commercial review. The most common field of 
these applications is general medicine, followed by others such as drugs prescribing, 
emergency services tasks and paediatrics. Focusing on the specialties, the ones with more apps 
are cardiology, oncology, psychiatry, neurology and infectious disease (especially HIV). As seen 
previously, these specialties involve some of the leading causes of death (ischemic heart 
disease, HIV/AIDS and trachea, bronchus and lung cancers), the most prevalent conditions 
(unipolar depressive disorders) and the most disabling diseases (Alzheimer, Parkinson). In 
addition, almost half of these apps are developed for medical specialists. 
The QoE tools [34][A1.7] are created in the form of surveys because they are very common, 
useful and easy to answer. A similar thing occurs with Likert scale, so it is decided to use it as 
well in the creation of these tools. Besides, the use of Likert scale adds the possibility of 
introducing the data obtained in statistical programs. Another important aspect taken into 
account was the length of the surveys, since users can get tired or bored when answering too 
many questions. Hence, the tool is limited to 19 questions that can be completed in 1-2 
minutes. Therefore, the main problem faced is to create a survey that covers every aspect of 
an app but with a limited length. The QoE tool is tested with a number of different types of 
mHealth applications and a total of 140 users. Among them, 127 are positive about the tool, so 
it is confirmed as useful for assessing the QoE of mHealth apps. 
From the study of the privacy and security in mHealth apps [36][A1.9], some conclusions can 
be obtained. First of all, the laws that regulate these aspects were approved a long time ago 
(1995-1996), before the appearance of the mHealth technology. Therefore, these laws are 
based in obsolete technology only applicable to the eHealth field, so currently these laws are 
too open and too old and need to be renewed considering the current technologies and 
problems. 
In Table 13 a short list with recommendations for developers is shown, in order to create apps 
that respect the users’ privacy and security. It is suggested to apply the recommended 
requisites, not only the minimum requirements, but, in the end, developers must evaluate 
their apps and assess its impact in the security and privacy in order to use the necessary 
techniques to guarantee these issues. However, this is not a stand-alone guide; it should be 
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seen as a complement of standards in security and privacy such as ISO/IEC 27001/2013 [56] 
about information security management and other related documents [57]. 
The production of the app Heartkeeper [33][A1.6] was done by performing all the steps 
needed to create a mobile app with guarantees. Firstly, a market research is performed in 
order to know the existing types of apps related to cardiology; then Heartkeeper is designed, 
with its functions and appearance; the implementation phase is next, with special 
consideration about the security and privacy of the app; finally, Heartkeeper is tested and 
validated to fix bugs and errors before its release in Google play. In this validation, it is seen 
that the launch of the app takes about 2 milliseconds in the worst case, which is much less 
than 2 seconds, as recommended [55]. The encryption/decryption of the user’s personal data 
is the most time-consuming, about 2.3 seconds in the oldest device used and less than 1 
second in newer devices. However, this operation is performed occasionally, so it can be 
concluded that Heartkeeper provides fast responses. 
Heartkeeper can be improved by including the possibility to link external devices such as 
wearable or smart devices to it by wireless technologies (Bluetooth, NFC), in order to detect 
and take automatically measurements such as the blood pressure or heart rate, but this idea 
has not been performed yet since these external sensors are normally expensive and the 
majority of heart patients do not usually have them, so it was decided to develop a Minimum 
Viable Product (MVP) ready for its use by patients and leave the addition of this functionality 
for a later phase, when Heartkeeper is thoroughly evaluated and improved. 
The application of the tool for the compliance with Android guidelines [A1.8] to Heartkeeper 
gives a score of 9, which is included in the High Quality Group, according to Table 17, extracted 
from [35]. This means that Heartkeeper is an app that obeys the recommendations for Android 
in many cases. However, the scores obtained for each block indicates that the structure of the 
app is perfect according to Android guidelines, but the style and behaviour of Heartkeeper 
need some improvements. 
On the other hand, the application of the tool for measuring the users’ QoE to Heartkeeper 
[A1.8] gives interesting conclusions. All the average scores obtained for each question are 
good, all over 3, which indicate the satisfactory QoE that Heartkeeper provides. The best 
valued aspects are its general appearance, its learning curve and the fact that the description 
in Google play corresponds to the reality. However, some aspects should be improved: a 
number of users indicated that they can do the functions of Heartkeeper using traditional 
methods, some sections in the app are difficult to find and its performance can be improved. 
This information is very valuable and these aspects will be revised in next updates of 
Heartkeeper. 
Table 17. Quality Groups by the score obtained from the tool for measuring the compliance 
with Android guidelines  
Score Quality Group 
12-13 Very High 
8.5-11.5 High 
5-8 Moderate 
1.5-4.5 Low 
0-1 Very Low 
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From the ex-ante economic evaluation [37][A1.10] the following conclusions are obtained. A 
saving for the Public Health Care System of Castile and Leon of approximately 6 million euros 
would be generated with a total investment of 63,000 €, which corresponds to a saving of 
0.31% of the total health expenditure in this region [58]. Therefore, the introduction of 
Heartkeeper for the control of HF would have an impact not only in better management of the 
disease but also in generating savings of 33% of the total cost related to HF. This saving had an 
impact in the Health Care System and in the economy, because there are also gains in 
efficiency of the system. 
As indicated, the main purpose of Heartkeeper is to help heart disease patients with the 
management of their diseases, which means an improvement in their quality of life. However, 
not only patients can benefit from it, but also providers and stakeholders. A company that 
develops health apps can obtain profits in several ways. They can sell their apps in the 
commercial stores and get paid for each download, but this method is only recommended 
when an app has been strongly promoted or when it has been adopted by an important 
institution or collective, such as physicians or nurses, who have enough power to oblige other 
groups to adopt that app. Either way, a powerful advertising marketing is needed, which can 
not be affordable by most companies. Other method to obtain profits from the health apps 
(and all types) is selling them for free but introducing ads in them, which can be specific ads if 
the target of the people who will use an app is well known [59-60]. The application of this way 
of commercialization is recommended initially in order to obtain a significant part of the 
market, and when the app is extended and commonly known, a premium version without 
advertising can be offered by a reasonable price. Hence, users are able to choose the most 
suitable version for each one. Of course there are other methods such as offering an app for 
free but with micropayments in it, or for a short period of time but when this period expires, 
the user needs to pay in order to continue using the app. However they are typical methods of 
aps containing video games so they are not recommended for a health app. 
To sum up, the main result of this work is the mHealth app Heartkeeper, which is intellectually 
protected by the Spanish Patent and Trademark Office. During its designing, creation and 
development, some doubts arose and several researches were performed in order to find 
solutions to the problems found. As a result, important lessons were learned about mHealth 
applications and their development, so the authors wanted to present them to the academic 
community and, especially, to apps developers expecting that these findings will help them in 
their works. These experiences and results obtained from the design, development and 
evaluation of Heartkeeper were the following: the creation and evaluation of a tool for 
measuring the QoE of mHealth apps; the correct methods and implementations of the 
different phases of the whole process of the creation and evaluation of a health app; an study 
of the privacy and security systems commonly used in applications of this type, and a guideline 
with recommendation about these topics; and a study for measuring the ex-ante economic 
impact of the implementation of a mHealth app, which can be useful for app developers. In 
addition to these lessons learned and shared with the academic community, another 
important result obtained is the review of the state of the art developed for the mobile apps 
designed for the most critical diseases in terms of prevalence and mortality, with special 
attention to heart diseases.  
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5. Limitations and Future Lines 
5.1. Limitations 
This work presents a number of limitations. Focusing on the first part of the work, the study of 
the state of the art, the existing limitations are typical of these types of reviews. The process of 
extracting the data presented a significant risk of uncertainty. Occasionally, the inclusion of a 
paper or an app in the study is not easy because the text is not clear and it can be 
misunderstood. To avoid this possible error, we enhanced the assessment process with 
independent verification. 
Some limitations were found and addressed (if possible) in the commercial reviews. 
Occasionally some searches did not return relevant results or return very few, such as the case 
of “ischemic heart disease”, so other search strings similar to the used and related to the 
disease were used (“heart disease” for example). In other cases, there were too many results 
and a more specific definition of terms was needed in order to delimit them. 
Another important limitation in the commercial review was the language used for the search 
strings, especially in the review of the deadliest diseases in different income zones. Ideally, at 
least the most important low- and middle-income countries languages should have been used 
to obtain all the apps developed in these languages. However, we only focused on the use of 
English, since it is the most extended and used worldwide. Additionally, apps whose 
summaries were in Spanish (the native language of the author) were included in the studies. 
For the second part of the work, the development and evaluation of Heartkeeper, there are 
also some limitations. Focusing on the development, an important limitation is that 
Heartkeeper is only available for Android handheld devices, not for iOS devices such as iPhone 
and iPad. This fact limits its use in a significant number of mobile devices. Another limitation is 
that Heartkeeper is only available in Spanish and English, so people who do not dominate 
these languages can have problems when managing the app. Nevertheless, English is the 
language commonly used internationally, as mentioned, and Spanish is one of the languages 
most used, so this limitation is not critical. The last limitation of this part is that the 
development of Heartkeeper was done without direct contact with heart disease patients. 
However, the developers were constantly in contact with cardiologists, who were in turn in 
contact with patients and passed to the developers their knowledge and experience about the 
main problems that patients usually have. Hence, developers have an indirect contact with 
patients. 
In the evaluation of the QoE of Heartkeeper, the number of users who respond (24 users) is 
very small, so the results can not be taken as definitive, but they can be illustrative about the 
potential of Heartkeeper. In a next work, a survey with approximately 100 users will be done in 
order to confirm the results obtained in this work. 
5.2. Future lines 
There are several future lines to do, all of them related to the evaluation and improving of 
Heartkeeper. The first future work is, as mentioned, to perform a more complete survey with a 
significant number of patients in order to corroborate the data obtained. It will be done with 
the supervision of their doctors in a clinical environment in order to control every possible 
aspect. This survey will be also complemented with another one with the purpose of proving 
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the impact and efficacy of Heartkeeper in the health of its users. In fact, this survey is already 
being performed and it is currently accessible from the app [41]. 
An essential future work in order to spread Heartkeeper is making it available for other OS, 
especially for iOS. Hence, it is necessary the development of Heartkeeper for this OS. There are 
two possibilities: create a native app for iOS or create a hybrid app, which is an app developed 
using HTML and javascript with its container created for iOS. However, since Heartkeeper was 
created natively for Android, it will be also exported natively to iOS. Additionally and as 
mentioned in the previous section, Heartkeeper can be adapted in order to be connect to 
external wearable/smart devices using NFC or Bluetooth, enhancing the possibilities of the app 
and making easier the measures by the patients. 
Finally, other future line is to compare Heartkeeper with other similar apps to demonstrate its 
relevance and to obtain interesting data from these comparisons. However, the main problem 
to do this line is that Heartkeeper is unique and this assessment will be done with other heart 
disease related apps whose main function will be possibly different to the purpose of 
Heartkeeper. 
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Abstract
Background: New possibilities for mHealth have arisen by means of the latest advances in mobile communications and
technologies. With more than 1 billion smartphones and 100 million tablets around the world, these devices can be a valuable
tool in health care management. Every aid for health care is welcome and necessary as shown by the more than 50 million
estimated deaths caused by illnesses or health conditions in 2008. Some of these conditions have additional importance depending
on their prevalence.
Objective: To study the existing applications for mobile devices exclusively dedicated to the eight most prevalent health
conditions by the latest update (2004) of the Global Burden of Disease (GBD) of the World Health Organization (WHO):
iron-deficiency anemia, hearing loss, migraine, low vision, asthma, diabetes mellitus, osteoarthritis (OA), and unipolar depressive
disorders.
Methods: Two reviews have been carried out. The first one is a review of mobile applications in published articles retrieved
from the following systems: IEEE Xplore, Scopus, ScienceDirect, Web of Knowledge, and PubMed. The second review is carried
out by searching the most important commercial app stores: Google play, iTunes, BlackBerry World, Windows Phone Apps+Games,
and Nokia's Ovi store. Finally, two applications for each condition, one for each review, are selected for an in-depth analysis.
Results: Search queries up to April 2013 located 247 papers and more than 3673 apps related to the most prevalent conditions.
The conditions in descending order by the number of applications found in literature are diabetes, asthma, depression, hearing
loss, low vision, OA, anemia, and migraine. However when ordered by the number of commercial apps found, the list is diabetes,
depression, migraine, asthma, low vision, hearing loss, OA, and anemia. Excluding OA from the former list, the four most
prevalent conditions have fewer apps and research than the final four. Several results are extracted from the in-depth analysis:
most of the apps are designed for monitoring, assisting, or informing about the condition. Typically an Internet connection is not
required, and most of the apps are aimed for the general public and for nonclinical use. The preferred type of data visualization
is text followed by charts and pictures. Assistive and monitoring apps are shown to be frequently used, whereas informative and
educational apps are only occasionally used.
Conclusions: Distribution of work on mobile applications is not equal for the eight most prevalent conditions. Whereas some
conditions such as diabetes and depression have an overwhelming number of apps and research, there is a lack of apps related to
other conditions, such as anemia, hearing loss, or low vision, which must be filled.
(J Med Internet Res 2013;15(6):e120)   doi:10.2196/jmir.2600
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Introduction
Since the creation of the Internet, its massive use, especially in
developed countries, has generated new forms of technology in
almost every aspect of life [1]. One of these aspects is health
care; Internet technologies have initiated major advances in
telemedicine and telehealth, now present in every modern health
care organization [2]. In the field of telehealth, eHealth has
arisen as a paradigm involving the concepts of health,
technology, and commerce, with commerce and technology as
tools in the service of health [3]. Chang Liu et al (2011) perceive
eHealth applications as the software applications that provide
tools, processes, and communications in order to support
electronic health care practice [4]. In addition to this, with the
advent of wireless communications, there are no longer barriers
of space and time between health care providers and patients
[5]. The use of new wireless communications technology, such
as mobile telecommunications networks (2.5G, 3G, 4G,
HSPA+), Wireless Local Area Networks (WLAN), Wireless
Personal Area Networks (WPAN) including Bluetooth and
ZigBee, Wireless Body Area Network (WBAN), Wireless
Sensor Networks (WSN), Radio-frequency Identification
(RFID), and Worldwide Interoperability for Microwave Access
(WiMAX), has greatly boosted telemedicine and eHealth [5-12].
In this context and thanks to these advances in communications,
a new term arises: mHealth, a component of eHealth. The Global
Observatory for eHealth (GOe) of the World Health
Organization (WHO) defines mHealth or mobile health as
“medical and public health practice supported by mobile devices,
such as mobile phones, patient monitoring devices, personal
digital assistants (PDAs), and other wireless devices” [13].
While new wireless technologies were being developed, new
mobile devices were being created. In this way, PDAs, tablets,
and smartphones appeared on the market. Although PDAs
experienced a boom in the 1990s and early 2000s, they have
been replaced by smartphones and tablets with new functions
and utilities, which are common now in developed countries
[4]. There are already more than 1.08 billion smartphones of a
total of 5 billion mobile phones around the world, with 80% of
the population having a mobile phone [14]. Regarding tablets,
International Data Corporation (IDC) conducted research on
their shipments showing 70.9 million shipments of tablets
worldwide in 2011 and an estimated 117.1 million and 165.9
million in 2012 and 2013 respectively [15]. Thus, there is great
opportunity for mHealth in using these mobile devices and, in
fact, a significant number of mHealth applications have been
already developed for these platforms.
Telecommunications technology aside, it is clear that there is
still a long way to go in defeating illness. In 2008, WHO
estimated a total of 56.8 million deaths and only 5.1 million of
them were caused by injuries. The rest were caused by
communicable disease, maternal and perinatal conditions and
nutritional deficiencies (15.6 million deaths), and
noncommunicable conditions (36.1 million deaths) [16].
Nevertheless, attention should be focused not only on the
diseases that cause death, but also the diseases or conditions
that can cause a disability or loss of health. In 2004, 2.9% of
the world’s population were severely disabled, and 12.4% were
moderately long-term disabled. In this context, it is essential to
know the prevalence of an illness or condition, ie, the number
of people who have the condition at any moment [17].
According to WHO’s latest update (2004) of the Global Burden
of Disease (GBD) [17], the most prevalent conditions are
iron-deficiency anemia (IDA), hearing loss, migraine, low
vision, asthma, diabetes mellitus, osteoarthritis (OA), and
unipolar depressive disorder. The prevalence of each condition
is shown in Figure 1. IDA represents 50% of the total cases of
anemia (even though both terms are usually used
interchangeably, they are not the same). The biggest percentage
of affected can be found in underdeveloped and developing
zones, in Africa, South East Asia, and Western Pacific, most
of them women of reproductive age and children [18-20]. There
are two types of hearing loss: moderate or greater hearing loss,
which affect 275.7 million individuals, and mild hearing loss,
with 360.8 million individuals [21-24]. Migraines are the most
prevalent chronic neurological disorder in adults [25], with 11%
of affected in Western countries [26-30].
The Global Data on visual impairment 2010 [31] indicates 246
million people with low vision and 39 million blind, equaling
a total of 285 million people with any type of visual impairment
[32-34]. Asthma is the most common chronic disease in
childhood, and most asthma-related deaths take place in poor
and developing countries [35-38]. It is estimated that 347 million
people have diabetes mellitus [39], commonly named diabetes,
but different from diabetes insipidus [40-55]. OA is the most
prevalent musculoskeletal disease, and it is thought that 9.6%
of men and 18% of women over 60 years have this condition
[56-59]. Finally, there are more than 350 million individuals
with any unipolar or bipolar depressive disorder [60-63].
To date, there are many published articles about types of
wireless connections for mobile devices [8,9,64,65], articles
about evaluations of apps for specific objectives [66-68], and
reviews of apps of a determined device, software, or field
[4,69,70], but there are not articles about the deadliest or the
most prevalent conditions and diseases. Hence, the main aim
of this paper is to study the existing applications for mobile
devices exclusively dedicated to the eight most prevalent
conditions [17] and to analyze a sample of the apps for each
condition. The goal was to find the number of apps related to
each condition, their common features, comparing the
commercial ones with those used in research, and finding
possible gaps in the development of these types of applications
and whatever else might arise. For these purposes, a review has
been done consisting of two steps: (1) research of published
articles containing specific target strings, obtained by search
queries in a number of databases, and (2) research of
applications related to these conditions in mobile phone
application stores.
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Figure 1. The 8 most prevalent conditions by the WHO.
Methods
Two different reviews were developed. The first was a literature
review and the second, a commercial applications review. Both
were current as of April 2013. Finally, one app for each review
and each condition was chosen for an in-depth analysis and
comparison.
Literature Review
The literature review was developed on the following systems
and databases: IEEE Xplore, Scopus, ScienceDirect, Web of
Knowledge, and PubMed. After trying several combinations of
words and expressions, the following combinations of terms
were sought in the metadata field on each of these databases:
“condition name” AND mobile AND (applications OR
application OR apps OR app); m-health AND “condition name”;
“mobile phone” AND “condition name”; smartphone AND
“condition name”, where “condition name” is the name of each
of the most prevalent conditions as they are issued by [17]. The
results are limited to the last 10 years, from 2003 forward. The
eligibility criteria were the following: publications not centered
on applications using mobile phones or devices were dismissed,
as were Web applications not optimized for mobile phone
displays. Only papers published in English were studied. Papers
on applications for several different diseases or conditions were
rejected except for those with an important part of the
application dedicated to the related condition. Some aspects
were added due to the lack of sufficient results when executing
some searches: instead of the search strings with
“iron-deficiency anemia”, just “anemia” was used and the British
term “anaemia”. Similarly, on IEEE Xplore, the search string
with “anemia” was changed for the string anemia AND
applications. Finally, the strings with “unipolar depressive
disorders” were replaced by strings with “depressive disorder”,
“depressive disorders”, “depressive episodes”, “depressive
episode”, and “depression”.
Commercial Apps Review
The second review, the study of the commercial applications,
was carried out on the application stores of the most popular
smartphones brands [14,71] which are, in descending order of
market share, Google play of Google Android [72], Apple
iTunes [73], BlackBerry World of BlackBerry (previously RIM
or Research In Motion Limited) [74], Windows Phone
Apps+Games Store of Microsoft [75], and Nokia’s Ovi Store
[76].
For this research, the name of the condition was searched (eg,
“hearing loss”) and the eligibility criteria used were the
following: applications not centered on the specific condition,
not in English, or those included in the category of games,
entertainment, or music were dismissed, as well as applications
designed for pets or animals, and applications that are actually
journals or magazines about the condition. During the search,
the following issues were faced:
• On iTunes, apps for iPod and iPhone were separate from
the ones for iPad, hence only apps for the first ones were
searched, excluding the apps exclusively designed for the
Apple tablet.
• Instead of “iron-deficiency anemia”, the word searched was
“anemia” due to the lack of results.
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• The Ovi search engine does not handle search phrases nor
logical operators such as “AND” or “OR” correctly;
therefore, the results for “hearing loss” and “low vision”
were totally distorted and these results were not considered.
In the case of “diabetes mellitus”, no problems were
presented because both words are very specific about the
condition.
• In the case of diabetes mellitus, the strings “diabetes
mellitus” and “diabetes” were used.
• For “unipolar depressive disorders”, instead of this string,
“depressive disorders” and “depression” were used because
of the absence of results.
• There were some issues with Google play: when searching
for “depression” and “diabetes”, the store indicated at least
1000 results but showed only 480. Google was asked about
this conflict and the issue is still under investigation, but it
is assumed that the first number is the correct one (>1000).
In other cases such as the search for anemia, a certain
number of results had been found but while exploring the
results pages, the last pages (usually between one and three)
were blank. Consequently, the number indicated by the
store was different from the number of apps shown. In these
cases, the number of apps shown was the one used.
• In the case of depression and diabetes, only the first 20
applications were analyzed due to the number of results;
therefore, there is potential for completely new investigative
work.
Eligibility Criteria for the In-Depth Analysis and
Procedure
For the in-depth analysis, two applications were chosen for each
condition: one obtained from the literature research and the
other from the commercial apps review.
For the mobile applications found in publications, we decided
to study the most recent paper on each condition taking into
account only the year. In the case of two or more articles
published in the same year, the final article was selected,
considering the impact factor of the journal, where it is published
(a conference article is considered at a lower level than journal
articles), and its number of citations. If, again, two or more
articles were published in the same journal and had the same
number of citations, these papers were read and the most
interesting according to the authors’ opinion was chosen.
Articles about reviews of several apps or with insufficient
information about the app were dismissed. If the app studied
was available in stores, it was downloaded and personally tested
on an iPhone 4 in the case of an iOS app or a Samsung Galaxy
S SCL GT-I9003 in case of an Android app.
To evaluate the papers, after reading them individually, the
authors convened to discuss opinions and fill in a table of
features. For apps available on the market, one of the authors
downloaded them for a joint evaluation at the meeting.
In the case of commercial apps, we preferred to choose apps
from the same store for every condition and to use the store
with the most extended software for smartphones. Therefore,
Google play was selected because Android fulfilled this
prerequisite [71]. For each condition, it was determined to opt
for the first relevant free app with a rating, by users, of 3 or
more stars, which Google play shows when searching by the
condition sorted by popularity. In addition, another prerequisite
was that the app had to be designed for patients, not for health
care providers. This way, the most popular free app related to
the condition with an evaluation over the mean and designed
for the general public was analyzed. However, in the case of
anemia, every result with a rating of 3 stars or more was aimed
at caregivers; hence, we made an exception where the selected
app was not intended for patients and did not fulfil all the
previous requisites. The apps were tested on a Samsung Galaxy
S SCL GT-I9003.
For the analysis of the commercial apps, the procedure followed
was similar to the one developed with the research papers. The
authors downloaded them on the mentioned mobile phone
Samsung Galaxy S before meeting to study the apps together
and complete the previously initiated table of features.
Results
Mobile Applications in Literature
The results of relevant papers on each database and each
condition are shown in Table 1. The last row contains the
number of different papers found for each condition.
Diabetes was the most investigated condition followed by
asthma and depression. There is a significant gap between these
three conditions and the rest since the next most investigated
conditions were hearing loss and low vision with 9 different
publications; this contrasts significantly with the 32 papers on
depression. The order of the remaining conditions is: OA sixth,
anemia seventh, and migraines last.
Mobile Applications in Stores
The findings on the commercial apps review are shown in Table
2. It shows the number of relevant applications out of the total
number of applications found in each store. In the case of
diabetes mellitus and depression, the results obtained were
separated by “diabetes mellitus” and “diabetes” in the first case,
and “depressive disorders” and “depression” in the second case.
The last row shows the addition of all the applications located
in all the stores for each condition, but it is important to note
that some of the applications designed for a specific system
were also designed for other systems. Thus, an application
developed for Apple iOS can also be developed for Android or
Windows Phone, for example.
These results illustrate that the store with most apps is Google
play, followed closely by iTunes. The rest of the stores have
fewer apps for the conditions searched. Windows Phone
Apps+Games Store is the third in number of applications, and
it seems that Ovi Store has more applications than BlackBerry
World, although that is not clear because of the malfunction of
its searching engine mentioned in the Methods section.
Comparing the number of conditions, it is obvious that the
conditions with more applications are diabetes and depression.
After these two, migraine and asthma are equal with 112 apps,
followed by low vision, hearing loss, OA, and finally anemia.
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Analysis of a Sample of Reference Apps
The papers and the commercial apps studied are summarized
in Table 3 [77-97]. Figures 2 to 9 show snapshots from the
commercial apps.
Tables 4 and 5 show the results from the analysis of some
characteristics of the selected applications.
Table 1. Results of the literature review.
DepressionOADiabetes melli-
tus
AsthmaLow visionMigraineHearing lossAnemia
601680242IEEE
226112297283Scopus
51511000ScienceDirect
18579253151WoK
13353161121PubMed
326140369395Total
Table 2. Results of the commercial apps review.
DepressionOADiabetesAsthmaLow visionMigraineHearing
loss
Anemia
Depressive
disorders
DepressionDiabetes
mellitus
Diabetes
1/5>100016/4619/67>100044/22633/4357/20117/427/74Google
Play
0/04195/1617/2160557/12430/4646/10232/377/21iTunes
0/0130/00/0336/70/05/60/00/0BlackBerry
0/0692/22/3814/141/14/83/50/0Windows
-351/115/40401/2-0/0-0/0Ovi Store
1>15362453>1759112641125214Total
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Table 3. Summary of the papers and commercial apps.
DescriptionName of the paper/appHealth condition
Paper about the app SickleSAM, designed for Android, whose purpose is moni-
toring the school attendance of children affected by sickle cell disease, which
usually causes anemia
Activity and school attendance monitoring system
for adolescents with Sickle cell disease [77]
Anemia
App for caregivers that provides some educational tools for the diagnosis and
management of different types of anemia in adult patients
MD Series: Anemia - Free [78]
Article presenting a software application called OtoID used in a PDA connected
to an audiometric unit for monitoring hearing change because of ototoxic medi-
cation and others factors, using a testing protocol called Sensitive Range for
Ototoxicity (SRO)
Mobile software Apps support personalized-SRO
and serial monitoring with results indicating early
detection of hearing loss [79]
Hearing loss
App with a hearing test that uses sounds of different frequencies in order to
check the user’s hearing
Hearing Tests [80]
Application for behavioral migraine management for iPad called iBMM, which
can be used for learning relaxing and pain management techniques, tracking
migraine attacks and contacting a counselor
From a traditional behavioral management pro-
gram to an mHealth app: Lessons learned in devel-
oping mHealth apps for existing health care pro-
grams [81]
Migraine
App for tracking headache attacks by creating a diary of them, with its triggers,
symptoms and medications used, and it also allows emailing these notes to the
doctor
My Headache Log Pro [82]
The authors use VizWiz [84] for assisting people with vision impairments in
matching garments and being dressed in a fashion way, with the advice of some
volunteers
Crowdsourcing subjective fashion advice using
VizWiz: Challenges and opportunities [83]
Low vision
Keyboard design for Android smartphones with big keys, high contrast, helpful
colors, and audio aid, specially developed for people with visual problems
A.I.type EZReader Theme Pack [85]
The authors talks about an app called m.Carat [87] developed for Android and
iOS, consisting of several modules in which asthma and allergic rhinitis (ARA)
patients can read news about ARA, record daily events and medications, quantify
the level of control of their ARA, and note tasks or reminders
Control of Allergic Rhinitis and Asthma Test
(CARAT): dissemination and applications in pri-
mary care [86]
Asthma
Guidance for asthmatic patients and relatives in order to know and take control
over their condition. It has a section dedicated to patients and other dedicated
to parents or carers of asthmatic children
SIGN Asthma Patient Guide [88]
The authors develop the app for iOS and Android Type 1 diabetes friend: alcohol
guide [90,91], which tries to educate young people with type 1 diabetes about
alcohol, meeting clinical guidelines
The development of an innovative mobile
phone App for Type 1 diabetes alcohol education
[89]
Diabetes
App for managing diabetes by tracking several data, such as blood glucose and
pulse, medication, exercise, and weight
OnTrack Diabetes [92]
Paper about a system called PAGAS (Portable and Accurate Gait Analysis
System), which includes an Android app in a smartphone connected via Bluetooth
to a sensor positioned on the foot and whose purpose is monitoring the gait of
patients with altered gait because of different health conditons
PAGAS Portable and accurate gait analysis system
[93]
OA
App with information and animated exercises specially designed for osteoarthritis
of knee
Osteoarthritis of knee [94]
The authors use in their study the application VirtualClinic - The Get Happy
Program [96] for iOS, which is a cognitive therapy intervention for the manage-
ment of depression through a comic book story in which users will learn how
to manage their depression
CBT for depression: a pilot RCT comparing mo-
bile phone vs computer [95]
Depression
App that contains many quotes for helping depressed people and even allows
users to write and share their own thoughts
Positive Thinking [97]
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Table 4. Analysis of features (Part 1) of the selected apps.
Data visualizationClinical/Non-
clinical
Internet requirementClassRatingNameCondition
GraphsClinicalNoTracking-SickleSAM (not commer-
cial)
Anemia
TextBothNoEducational4.9MD Series: Anemia –
Free
Text, graphsClinicalNoDiagnosis-OtoID (not commercial)Hearing loss
TextNonclinicalNoDiagnosis3Hearing Tests
Video, graphs, textBothSome functionsEducational, guide-
lines, monitoring
-iBMM (not commercial)Migraine
Text, graphsBothOnly for sending
mails
Monitoring4.1My Headache Log Pro
Photos, text, audioNonclinicalYesAssistive4.5VizWizLow vision
Text, audioNonclinicalNoAssistive4.4EZReader Theme Pack
Graphs, text, picturesNonclinicalSome functionsMonitoring, assistive-m.CaratAsthma
Text, picturesNonclinicalSome functionsInformative, guide-
lines
4.9SIGN Asthma Patient
Guide
Text, photosNonclinicalSome sectionsEducational, informa-
tive
-Type 1 diabetes friend:
alcohol guide
Diabetes mellitus
Text, graphsBothOnly for sending
mails
Monitoring4.5OnTrack Diabetes
Text, graphsBothNoMedical results-PAGAS (not commer-
cial)
Osteoarthritis
Text, videoNonclinicalNoTreatment5Osteoarthritis of knee
Pictures, comic, textNonclinicalUnknownEducational, guide-
lines
-VirtualClinic – The Get
Happy Program
Depression
TextNonclinicalSome functionsKind of treatment4.3Positive thinking
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Table 5. Analysis of features (Part 2) of the selected apps.
PublicInterfaceFrequency of useInteraction with
users
Therapist interventionContext awarenessName
School childrenSimpleContinuousNoYesUser, locationSickleSAM (not com-
mercial)
Anemia special-
ists
Not intuitiveOccasionalNo-NoMD Series: Anemia –
Free
Ear specialistsBasicRegularNoYesAmbient noiseOtoID (not commercial)
GeneralBasicOccasionalNoNoNoHearing Tests
GeneralNot intuitiveFrequency of migraine
attacks
NoYesNoiBMM (not commer-
cial)
GeneralComplex, sev-
eral functions
Frequency of migraine
attacks
NoPossiblePreferences, loca-
tion
My Headache Log Pro
GeneralSimpleFrequentYes, several waysNoLocationVizWiz
GeneralBasicEvery time keyboard is
used
NoNoLanguageEZReader Theme Pack
GeneralComplexConstantNoNoUser, preferences,
language
m.Carat
GeneralBasicOccasionalNoNoNoSIGN Asthma Patient
Guide
Young people
(aged 18-21)
SimpleOccasionalNoNoNoType 1 diabetes friend:
alcohol guide
GeneralNormal, sever-
al functions
Several times per dayNoPossiblePreferencesOnTrack Diabetes
GeneralBasicRegularNoPossibleSensorPAGAS app (not com-
mercial)
GeneralSimpleFrequentNoNoNoOsteoarthritis of knee
GeneralSimpleRegularNoNoUnknownVirtualClinic – The Get
Happy Program
GeneralBasicRegularNoNoPreferencesPositive thinking
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Figure 2. Snapshot of MD Series: Anemia–free.
Figure 3. Snapshot of hearing tests.
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Figure 4. Snapshot of My Headache Log Pro.
Figure 5. Snapshot of AI type EZReader theme pack.
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Figure 6. Snapshot of SIGN asthma patient guide.
Figure 7. Snapshot of OnTrack Diabetes.
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Figure 8. Snapshot of Osteoarthritis of knee.
Figure 9. Snapshot of Positive thinking.
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Discussion
The results of the literature and the commercial reviews show
several interesting conclusions. First, the literature review
indicates that there are few results compared to the commercial
review. This means that the development of mHealth apps has
a commercial and economic motivation more than a research
motivation. Maybe it would be better to merge both, ie, first
developing an app while investigating and then using it for
commercial purposes.
Another important finding is the difference in the number of
mobile applications for different conditions. There are conditions
with more than 1000 apps, such as diabetes or depression while
there are others with a range between 14 and 112 apps. The
most prevalent condition (anemia) is surprisingly the second
with less research and the first with less commercial apps, while
two of the less prevalent (diabetes and depression) are the object
of a huge number of applications and research. This may be
because the majority of IDA cases are located in underdeveloped
or developing countries [17,18] where smartphones or tablets
are not as widely spread as in the developed countries, and
therefore, it is not worthwhile developing apps for IDA.
Meanwhile, diabetes or unipolar depression are common
conditions associated with modern lifestyles typical of developed
zones where there is a strong social conscience of these
conditions. However, this is not borne out when comparing the
numbers of those affected by diabetes or depression and by IDA
in developed countries, because IDA is more extended in these
zones than the others. Hence, the probable explanation for this
lack of apps for IDA is that the social conscience of it is much
less than that of the others and, therefore, it is underinvestigated.
For this reason, in light of the numbers, it could be profitable
and worthwhile creating apps for IDA.
Following the previous finding, the four most prevalent
conditions have fewer apps and research than the remaining
four, excluding OA. In addition, there is an important social
factor for some of the most prevalent conditions, such as hearing
loss or low vision. Therefore, it seems that there is a lack in the
research on apps for these conditions and an opportunity for
developers.
Contrasting the literature review with the commercial review,
it is worth highlighting the cases of asthma and migraines. In
the literature, asthma has more results than depression, but it
has far fewer results in the commercial review. The opposite
occurs with migraines, which move from the last position in
number of literature results to the third position in the
commercial review. Therefore, there is more work done on
commercial apps for migraines than in research apps, as opposed
to the situation for asthma.
Finally, comparing the number of apps available on each store,
it is clear that application developers prefer Android and iOS
for their projects, followed distantly by Windows Phone. Ovi
Store and BlackBerry World suffer from a significant lack of
apps, which means that developers are not interested in these
markets. This is somewhat surprising in the case of BlackBerry
since it is the third smartphone platform in market share [71];
hence, there may be an opportunity for developers to fill this
empty space in BlackBerry’s app store.
Determined criteria were followed in order to select the latest
apps published in literature and the most popular and best valued
by users’ apps in commercial stores. The goal was to choose a
sample of reference apps to analyze. These findings are given
below.
The majority of apps are for monitoring, assistance, or informing
about the condition. In general, apps for diabetes, migraines,
and asthma are designed for monitoring the condition, and many
have informative sections (or stand-alone informative apps).
Apps for low vision are principally assistive, and the aim of
most apps for depression is to raise the mood of the affected in
several ways. But there are also informative and educational
apps, which cover the other conditions, except for anemia, for
almost every app is aimed for professional caregivers. For OA,
there are an equal number of educational tools and apps with
remedies or exercises for managing the pain, and for hearing
loss the apps are divided between apps for hearing checks and
informative apps.
Table 4 shows that for most apps, the Internet is not required
or only required for some functions such as sending emails,
which is useful for circumstances or situations where an Internet
connection is not available. However, there are apps where an
Internet connection is required, eg, for VizWiz. Typically the
apps are not designed only for clinical purposes; proof of this
is that only some apps developed for research are intended for
clinical use. Others can have nonclinical and clinical use (always
with the consent of the professional caregiver), but the majority
have nonclinical purposes. In addition, there is a link between
clinical apps and therapist intervention: if the app is clinical,
the therapist intervention is needed. If the app is applicable for
both clinical and nonclinical use, the therapist intervention is
possible, but not obligatory. With respect to users’ interaction,
most of the apps do not have this functionality and work as
stand-alone apps. Only those conditions that can be relieved in
some way with the collaboration of other affected individuals
or a determined community of users, such as depression or
diabetes, have apps with modules used for these
communications.
According to the results, the preferred method of data
visualization is text, followed by graphs and pictures or photos.
Whereas text visualization is used in almost every case, the use
of graphs is common in monitoring or tracking applications in
order to show data in a more comfortable and visual way.
Something similar occurs with pictures and videos, which are
normally used in apps with educational or informational
purposes, while audio is a typical aid of low vision apps and is
also used for hearing tests in hearing loss apps. Apps with only
text visualization or with text and pictures have generally a
basic or simple interface, whereas those with graphs or more
than two visualization types have a more complex interface,
not necessarily intuitive at first use. It is not shocking for apps
with several types of data visualization to have a complex
interface with several functions, but it is surprising that some
of them have such unintuitive ones. Developers need to be
careful when designing the interface and its use.
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Generally there is no relation between the type of apps and the
types of context awareness. Only location awareness can be
linked to tracking and monitoring apps where it is important to
state the place where an event occurs. For frequency of use,
monitoring and assistive apps have a continuous or very frequent
use, depending in some cases, such as migraine or asthma, on
the frequency of the attacks. The same happens with apps
designed to provide some kind of treatment. On the other hand,
educational or informative apps are used more infrequently. It
might be a good idea to merge monitoring and educational tools
in the same app in order to improve frequency of use, number
of users, and economic profit, but always with special attention
to the interface design. Finally, the majority of the apps analyzed
are aimed for the general public who are affected by each
condition, which is logical because usually developers do not
want to reduce their user circle.
For future work there are various paths to take. It is necessary
to fill the lack of anemia apps by creating one aimed for patients,
first educational and informative and then exploring other
possible opportunities. Another field to populate is related to
low vision and hearing loss apps because, as said before, there
are few compared with other less prevalent conditions.
Nevertheless, in this case it is important to carefully select the
intended user because most people with severe hearing loss or
low vision problems are over 60 years old in developed countries
and do not usually use a smartphone [98]. Hence, designing an
assistive app for a 16-50 year-old deaf/blind (or with a severe
disability) target group that typically has smartphones can be
very useful for the user and even profitable for the developers.
In addition to this, the possibilities for creating assistive apps
in these fields are enormous.
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Abstract—In the last years, significant improvements in 
communications and technology have boosted the m-health to 
the point of being available thousands of health apps for 
smartphones and tablets. The main aim of this paper is to 
develop a study of the existing apps in the most important 
commercial stores for the 5 most prevalent health conditions 
issued by the last update of the Global Burden of Disease by the 
World Health Organization, understanding prevalence as the 
number of individuals who have the disease or condition at any 
moment. These conditions are iron-deficiency anemia, hearing 
loss, migraine, low vision and asthma. For this objective, it has 
been carried out a review of the apps for these conditions on 
the most important apps stores and an in-depth analysis of a 
sample of reference apps related to them. 356 relevant apps 
were found on the stores Google play, iTunes, BlackBerry 
World and Windows Phone Apps+Games in February 2013. 
From these apps, the most relevant of each condition by specif-
ic selection criteria were selected for being analyzed. Some 
interesting findings could be deduced from the results ob-
tained. There is an alarming low number of apps for Black-
Berry compared to the rest of systems. Despite anemia is the 
most prevalent condition, there are very few apps for it and no 
one aimed for patients. There are more apps for migraine and 
asthma than for the rest and they are divided into informative 
and monitoring apps whereas the majority of those for hearing 
loss and low vision are assistive.  
Keywords—apps, m-health, prevalent health conditions, 
smartphones’ stores, World Health Organization. 
I. INTRODUCTION  
A. Background 
The health is the most important matter in the life of an 
individual. If one is not healthy other issues lacks impor-
tance, hence humans have been always studying aspects of 
health and medicine. In the last decades, the irruption of the 
Internet, and the important advances in wireless communi-
cations have propitiated the creation and the expansion of 
m-health [1]. The more than 6 billion mobile phone sub-
scriptions worldwide out of which 1.08 are smartphones [2-
4] (not to mention the tablets) make these mobile devices an 
exceptional opportunity for providing health care every-
where and at every moment by using apps designed for 
health care [5].  
But even with the last advances in these fields, there are 
still many diseases affecting people worldwide. According 
to the last Global Burden of Disease [6] by the World 
Health Organization (WHO), 58.8 million deaths occurred 
globally in 2004 and, out of every 10 deaths, only one was 
caused by injuries. In this year, there were also 18.6 million 
people severely disabled and 79.7 million moderately dis-
abled. It has especial importance the prevalence of a disease 
or health condition, understood as the number of individuals 
who have the disease or condition at any moment. 
The main aim of this paper is to study the commercial 
apps of the most important apps stores exclusively dedicat-
ed to the 5 most prevalent conditions by [6] and to carry out 
an analysis of features of a representative selection of the 
apps for each condition. The remainder of the paper is struc-
tured as follows. Next subsection is about the 5 most  
prevalent conditions. The following section describes the 
methodology used. After this, there are shown the results 
obtained from the review of the stores and the analysis of 
the mobile applications. Finally the discussions and conclu-
sions are presented. 
B. The Most Prevalent Conditions 
The 5 most prevalent conditions by [6] are iron-
deficiency anemia, hearing loss, migraine, low vision, and 
asthma. Figure 1 shows the prevalence in million individu-
als of each condition and below there is a brief description 
of these conditions. 
 
 
Fig. 1 Prevalence of the most prevalent conditions by the WHO 
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Incorrectly, it is common to use the concepts anemia and 
iron-deficiency anemia (IDA) indistinctively, but they are 
not the same: anemia has its source in several causes to-
gether or isolated, but the most important contributor is iron 
deficiency [7]. IDA has also multifactorial sources, but all 
of them result in the fact that there is not enough absorption 
of iron by the person, no matter the cause. IDA’s conse-
quences are diminished exercise capacity, immune dysfunc-
tion, impaired thermoregulation and gastrointestinal distur-
bances, among others. [7-8].  
Hearing loss or hearing impairment is defined by the 
WHO as “the inability to hear as well as someone with 
normal hearing”. This includes minor hearing loss to deaf-
ness [9]. There are various types of hearing loss and some 
of the most common causes are congenital, infectious dis-
eases, excessive noise, ototoxic medications, head or ear 
injuries and presbyacusis. The effects of this condition have 
social and economic consequences, not only in individuals, 
but also in communities [10-11]. 
Although the pathophysiology of migraine is not totally 
known, it has its origins in an “activation of a mechanism 
deep in the brain which causes release of pain - producing 
inflammatory substances around the nerves and blood ves-
sels of the head” [12]. It is not known why these attacks 
occur periodically and what process finishes spontaneously 
these attacks. Some common characteristics of migraine are 
strong headache, nausea and intolerance for some light and 
noise conditions. These episodes entail important social and 
economic negative aspects [12-14]. 
Understood as visual acuity less than 6/18 and equal or 
better than 3/60 due to refractive errors, cataracts, glaucoma 
or macular degeneration, low vision cause difficulties in 
almost every aspect of the life of the person: things we see 
normal such as dressing, walking, communicating and inte-
racting can be very hard for people with low vision, not to 
mention blind [15-17]. 
The WHO defines asthma as “a chronic disease charac-
terized by recurrent attacks of breathlessness and wheezing, 
which vary in severity and frequency from person to per-
son” [18]. The causes are not fully understood, but it is 
known that the genes and the environment are very impor-
tant in its development. 75-80% of all asthmatic cases are 
caused by a response to an allergy and the triggers of asth-
ma attacks are inhaled particles [18-20]. 
II. METHODS 
The research of the apps were carried out in the most im-
portant application stores [21-22] which are, in descending 
order of market share of operative systems for smartphones, 
Google play of Google Android [23], iTunes of Apple [24], 
BlackBerry World of BlackBerry (previously known as 
RIM or Research In Motion Limited) [25] and Windows 
Phone Apps+Games Store of Microsoft [26]. 
The name of the condition was searched but if the search 
returned few or no results, it was tried other name, as hap-
pened with iron-deficiency anemia, searching just “anemia”. 
The criteria of selection of apps were the following: appli-
cations had to be in English or in the language of the coun-
try where the search was executed (Spanish), focused on the 
sought condition, not included in the categories of enter-
tainment, games or music, designed for human care (not 
veterinarian) and not being magazines or journals. 
During the search we faced two issues. The first was that, 
on iTunes, apps for iPod and iPhone were separated from 
the ones for iPad, therefore only apps for the first one were 
searched. The second difficult was a problem with the web 
page of Google Play [23]. In some searches, the site said 
that a certain number of results have been found but while 
exploring the pages of the results the last pages were blank, 
being the number returned different from the number of 
apps showed. In these cases it was considered the last one. 
For the in-depth analysis an application was chosen for 
each condition. It was decided to select apps for Android as 
it is the most extended software in smartphones [21-22]. For 
each condition, the first relevant free app with a rating by 
users of 3 or more stars which Google play showed when 
searching by the condition and sorted by popularity was 
selected. Furthermore, another requisite was that the app 
had to be developed for patients, not for health care profes-
sionals. So, summing up, the app chosen for analysis was 
the most popular free one associated to the condition with 
an evaluation over the mean and designed for patients. Nev-
ertheless, all the results with a rating of 3 stars or more in 
the case of anemia were created for caregivers, so just in 
this case the app chosen did not fulfill the last requisite of 
being aimed for patients. The apps were tested on a Sam-
sung Galaxy S SCL GT-I9003. 
III. RESULTS 
A. Review of Commercial Apps 
Table 1 includes the results of the review, showing the 
number of significant apps out of the total number of appli-
cations found in each store for each condition. The last row 
shows the addition of all the apps found for store and the 
last column contains the addition of all the apps found for 
condition. It is important to state that the last does not mean 
the total number of apps for a specific condition  
because there are apps designed for several systems. For 
example, one app found on iTunes can also be found on 
Google play.  
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Table 1 Results of the apps review 
 Google 
play 
iTunes BlackBerry Windows Total 
Anemia 7/74 7/21 0/0 0/0 14 
Hearing 
loss 
17/42 32/37 0/0 3/5 52 
Migraine 57/201 46/102 5/6 4/8 112 
Low 
vision 
33/43 30/46 0/0 4/8 64 
Asthma 44/226 57/124 6/7 4/14 112 
Total 158 172 11 15  
 
In light of the results, it is obvious that iTunes and 
Google play are the stores with more apps, followed distant-
ly by Windows Phone Apps+Games and being BlackBerry 
World the last. Comparing the conditions by their numbers 
of apps, migraine and asthma are the ones with more apps, 
followed by low vision and hearing loss. Finally, anemia is 
the last. 
B. Analysis of Representative Apps 
The commercial apps that fulfill the requisites explained 
in the Methods section and, therefore, selected for the in-
depth analysis were: MD Series: Anemia – Free [27]; Hear-
ing Tests [28]; My Headache Log Pro [29]; A.I.type 
EZReader Theme Pack [30] and SIGN Asthma Patient 
Guide [31]. 
MD Series: Anemia – Free is an app designed for care-
givers which provides several tools for the diagnosis and 
treatment of different types of anemia in adult patients. 
These tools have an educational purpose [27]. Hearing Tests 
is basically a hearing examination which uses sounds of 
diverse frequencies to provide to the user an auto-diagnosis 
for his hearing. [28]. My Headache Log Pro is a diary where 
the user can note the headache attacks suffered, with its 
triggers, symptoms and medications used, permitting also to 
email these records to the doctor [29]. A.I.type EZReader 
Theme Pack is a keyboard design for Android smartphones 
with bigger keys than the ones of normal keyboards, higher 
contrast, helpful colors and even audio aid which reproduc-
es what the user have written, and it is specially developed 
for people with visual problems, [30]. SIGN Asthma Patient 
Guide is a guide for both asthmatic patients and relatives in 
order to help families to know and take control over this 
condition. For this purpose, it has two sections, one dedicat-
ed to patients and other dedicated to carers of asthmatic 
children [31]. Figure 2 shows some snapshots of the apps 
analyzed. 
  
(a) (b) 
 
(c) (d) 
 
(e) 
Fig. 2 Snapshots of (a) MD Series: Anemia – Free, (b) Hearing Tests, (c) 
My Headache Log Pro, (d) A.I.type EZReader Theme Pack and SIGN 
Asthma Patient Guide. 
In Table 2 there are shown the results of the analysis of 
some characteristics of the selected applications. 
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Table 2 Analysis of features of the representative apps 
 MD 
Series: 
Anemia 
Hearing 
Tests 
My Head-
ache Log 
Pro 
A.I.type 
EZ-
Reader 
SIGN 
Asthma 
Rating 4.9 3 4.1 4.4 4.9 
Class Educa-
tional 
Diagno-
sis 
Monitoring Assistive Informa-
tive 
Internet 
requirement 
No No Only for 
mails 
No Some 
functions 
Clini-
cal/Non-
clinical 
Both Non-
clinical 
Both Non-
clinical 
Non-
clinical 
Data visua-
lization 
Text Text Text, graphs Text, 
audio 
Text, 
pictures 
Context 
awareness 
No No Preferences, 
location 
Language No 
Therapist 
intervention 
- No Possible No No 
Frequency 
of use 
Occa-
sional 
Occa-
sional 
Frequency 
of attacks 
Conti-
nuous 
Occa-
sional 
Interface Complex Basic Complex Basic Basic 
Public Special-
ists 
General General General General 
IV. DISCUSION AND CONCLUSIONS  
Several interesting findings can be extracted from the re-
sults. The most striking is that the most prevalent condition 
(IDA) is the one with less apps while the less prevalent 
(asthma) is the one with the highest number of apps (with 
migraine). This can be explained by two facts. The first is 
that the majority of the cases of IDA are located in under-
developed or developing countries [6, 32] where smart-
phones or tablets are not spread so it is not worthwhile  
developing apps for IDA. However, this fact alone does not 
explain the situation because IDA is even more extended 
than asthma in developed countries and it is necessary a 
second fact: there is not a social conscience of IDA as 
strong as the one formed for asthma and, therefore, it is 
under-investigated. For these reasons and in light of the 
numbers, it can be profitable to create apps for IDA or ane-
mia in general, filling this gap in the market. 
Excluding the case of IDA, the conditions with more 
apps are migraine and asthma whereas hearing loss and low 
vision have less apps, despite hearing loss is more prevalent 
than migraine and asthma, and low vision is more prevalent 
than asthma. These results can be explained by the sort of 
treatment these conditions have. On one hand, hearing loss 
and low vision are conditions that affect human senses and 
can be easily treated in most cases with hearing aid and 
glasses respectively, or even with surgical operations. On 
the other hand, migraine and asthma have not cure and, in 
fact, the origin of these conditions is unknown [12, 14, 18-
19], therefore the treatment consists of monitoring the at-
tacks of the conditions and the use of some medication for a 
better management and control [13, 20]. Developers may 
have seen this point and used it for developing apps for 
monitoring these conditions, whereas this type of apps can-
not be used for hearing loss or low vision, explaining the 
difference in the numbers of apps for these conditions. 
Comparing the number of apps available in each store, 
Android and iOS are the systems with more apps, followed 
distantly by Windows Phone, whereas BlackBerry is the 
one with less apps. This classification corresponds with the 
market share except the case of BlackBerry, which is  
the third smartphone platform in market share over Win-
dows Phone [21-22]. It seems that developers are not spend-
ing their time in this platform and this can be both cause and 
consequence of the loss of market share of BlackBerry. 
From the review and the analysis of the apps it can be 
said that, in general, apps for anemia are aimed for aiding in 
its diagnosis whereas apps for hearing loss are divided in 
two types: hearing checks and informative apps. As it was 
mentioned previously, apps for migraine and asthma are 
designed for monitoring and there are also informative apps. 
Low vision has principally assistive apps.  
Usually, Internet is not required or just needed for some 
functions such as sending emails, which is an advantage in 
situations where the Internet connection is not available. 
Normally, the apps are not designed for clinical purposes, at 
least not only for them. In addition to this, if an app is for 
non-clinical use then there is no therapist intervention but if 
it can have both clinical and non-clinical use, the therapist 
intervention can be possible.  
The preferred method of data visualization is text, which 
is used in every case and can be combined in some occa-
sions with graphs, common in monitoring apps to show data 
in a more comfortable way, and pictures, normally used in 
apps with informational or educational aims. Audio is 
usually used in low vision apps and in hearing loss apps for 
hearing tests. The interface is connected to data visualiza-
tion in the way that apps with only text or with text and 
pictures have a simple interface whereas apps with graphs 
have a complex one. The exception occurs with the app for 
anemia, which has a complex use, even not instinctive at 
first sight. 
As it can be seen, there is no relation between the type of 
apps and the context awareness. Focusing on frequency of 
use, monitoring and assistive apps have a continuous or 
very frequent use and in some cases, such as migraine, it 
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depends on the frequency of the attacks. On the other hand, 
apps for diagnosis and educational or informative apps are 
used more occasionally. Finally, all the analyzed apps are 
aimed for general public, excluding the one for anemia 
which is designed for specialists. This is normal because 
developers want the most number of users for its applica-
tions, not focusing only on a specific type of users.  
For future work, various lines can be followed. It was 
seen that there are no apps for anemia aimed for patients so 
it can be a good idea to design and create one, which can be 
educational and informative and, this way, fill this gap in 
the market. Another way of action can be developing appli-
cations for low vision or hearing loss, since there are few 
apps compared with other health conditions such as asthma 
and migraine.  
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Abstract
Background: The advances achieved in technology, medicine, and communications in the past decades have created an excellent
scenario for the improvement and expansion of eHeath and mHealth in particular. Mobile phones, smartphones, and tablets are
exceptional means for the application of mobile health, especially for those diseases and health conditions that are the deadliest
worldwide.
Objective: The main aim of this paper was to compare the amount of research and the number of mobile apps dedicated to the
diseases and conditions that are the leading causes of death according to the World Health Organization grouped by different
income regions. These diseases and conditions were ischemic heart disease; stroke and other cerebrovascular diseases; lower
respiratory infections; chronic obstructive pulmonary disease; diarrheal diseases; HIV/AIDS; trachea, bronchus, and lung cancers;
malaria; and Alzheimer disease and other dementias.
Methods: Two reviews were conducted. In the first, the systems IEEE Xplore, Scopus, Web of Knowledge, and PubMed were
used to perform a literature review of applications related to the mentioned diseases. The second was developed in the currently
most important mobile phone apps stores: Google play, iTunes, BlackBerry World, and Windows Phone Apps+Games.
Results: Search queries up to June 2013 located 371 papers and 557 apps related to the leading causes of death, and the following
findings were obtained. Alzheimer disease and other dementias are included in the diseases with more apps, although it is not
among the top 10 causes of death worldwide, whereas lower respiratory infections, the third leading cause of death, is one of the
less researched and with fewer apps. Two diseases that are the first and second of low-income countries (lower respiratory
infections and diarrheal diseases) have very little research and few commercial applications. HIV/AIDS, in the top 6 of low-income
and middle-income zones, is one of the diseases with more research and applications, although it is not in the top 10 in high-income
countries. Trachea, bronchus, and lung cancers are the third cause of death in high-income countries but are one of the least
researched diseases with regard to apps.
Conclusions: Concerning mobile apps, there is more work done in the commercial field than in the research field, although the
distribution among the diseases is similar in both fields. In general, apps for common diseases of low- and middle-income countries
are not as abundant as those for typical diseases of developed countries. Nevertheless, there are some exceptions such as HIV/AIDS,
due to its important social conscience; and trachea, bronchus and lung cancers, which was totally unexpected.
(JMIR Mhealth Uhealth 2014;2(1):e1)   doi:10.2196/mhealth.2779
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Introduction
The advances in science and medicine in developed countries
have caused an elderly population and long-term survival of
individuals who suffer chronic diseases due to modern
treatments and cures. This has increased the quality of life
expectation of health care consumers [1]. For satisfying this
expectation, there have been important improvements in health
care delivery supported by the use of the Internet, also known
as eHealth, defined by the International Telecommunication
Union as the paradigm that encompasses all of the information
and communication technologies necessary to make the health
system work [2,3]. This paradigm has evolved significantly to
the point of creating mobile health (mHealth) as a branch of
eHealth.
There are many definitions of mHealth. For some authors it is
an area of eHealth that provides health services and information
via mobile technologies such as mobile phones and PDAs [4,5];
for others, the term is defined as “emerging mobile
communications and network technologies for healthcare
systems” [6]. What is clear is that mobile devices are used for
providing health care. More important than the definitions are
the impressive development and dissemination this field has
been achieving, to the point that Atienza et al (2011) have
suggested that mobile health may be the “killer app” for
cyberinfraestructure for health in the current century [7]. The
reality is that important advances in technology and
communications have been achieved in the past few years and
mHealth has taken advantage of them [8-12]. mHealth is
supported by many mobile telecommunications technologies,
such as 3G (third generation) or 4G (fourth generation)
technologies, for example [13-18].
The potential for mHealth applications is rather
well-documented [19-21]; for example, move away from
face-to-face visits at the doctor’s office, access to a wide array
of educational resources including information on
disease-specific topics and general self-management tools, view
your own electronic medical record, access information relative
to medications, and continuous surveillance of vital or
physiological signs.
In addition to this, advances in technology for smartphones and
tablets have caused their incredible growth, especially in
high-income countries. There were 6 billion mobile
subscriptions in 2011 and more than 1.7 billion mobile phones
sold in 2012, 712.6 million of which were smartphones. With
these numbers, it is obvious that these devices must be used in
the field of mHealth to assist every person with one of these
gadgets. Indeed, mHealth is already using them as shown by
the great number of health applications currently available
[22-25].
These devices can be especially useful for the prevention and
management of those diseases that cause high rates of mortality.
The World Health Organization (WHO) estimated a total of
56.8 million deaths in 2008 and, excluding 5.1 million that were
caused by injuries, the remainder were produced by diseases
and health conditions [26]. Some of the leading causes of death
are presented in Figure 1, which shows the percentage of deaths
caused by these diseases and distributed according to different
income zones [27].
The 6 leading causes of death for each zone and worldwide in
2008 are shown. When these diseases have 0% deaths
represented in determined zones of Figure 1, it means that the
diseases are not among the top 10 in this zone, but not that there
are not deaths caused by those illnesses. Some data are presented
below.
Considering randomly 1000 individuals dead in 2008,
statistically 159 would have come from high-income countries,
677 from middle-income countries, and 163 from low-income
countries [28]. Cardiovascular diseases (CVDs) are the deadliest
diseases—17.3 million people died from CVDs in 2008,
representing 30% of all global deaths [29]. Among these
diseases, ischemic heart disease (IHD) is the leading cause of
death globally with an estimated 7.3 million deaths [30-34].
Stroke produces not only death, but also disabilities and high
probabilities of death in the future. Its burden is projected to
rise from approximately 38 million DALYs (disability-adjusted
life years) worldwide in 1990 to 61 million DALYs in 2020
[35-38].
Lower respiratory infections (LRI) are the leading causes of
child mortality in the world, producing 1/5 of mortality in
children under 5 years. The respiratory syncytial virus (RSV)
is the single most important cause of severe respiratory illnesses
in children and can provoke pneumonia, which causes 90% of
these deaths due to the virus [39-43]. Sixty-five million people
had chronic obstructive pulmonary disease (COPD) and more
than 3 million died in 2005 [44-48]. Diarrheal disease is a major
problem in developing countries and the second leading cause
of mortality in children under 5 years of age, killing 1.5 million
children every year [49-52].
Human immunodeficiency virus/acquired immunodeficiency
syndrome (HIV/AIDS) is a major global public health issue. In
2011, there were 34 million people living with HIV and 1.7
million of whom died because of it. The political commitment,
social mobilization, and HIV/AIDS funding done by almost
every country in the past years have contributed to the total of
95 million people tested in 2010 and more than 8 million
receiving antiretroviral therapy [53-57]. According to the WHO,
there were 219 million cases of malaria and 660,000 deaths in
2010 [58-60]. However, other studies have worse numbers:
Murray et al (2012) estimated 1.24 million deaths globally in
2010 [61].
Cancer caused 7.6 million deaths worldwide in 2008, with the
majority caused by lung cancer (1.37 million deaths). Tobacco
is the most important risk factor for developing cancer (not only
lung cancer), causing 22% of cancer deaths and 71% of lung
cancer deaths [62-65]. There are 35.6 million individuals
suffering from dementia and 477,000 annual deaths worldwide.
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Among the different dementias, Alzheimer disease is the most
common with a contribution of 60%-70% of the cases and a
median life expectancy of 7.1 years [66-70].
The main aim of this paper is to continue the research begun
by the authors about mobile apps for the most prevalent health
conditions [71], focusing on the diseases and conditions that
are leading causes of death by the WHO grouped according to
different income regions [27]. For this purpose, two reviews
have been done. The first was a literature review carried out by
searching published articles in several systems, and the second
was a review of commercial apps done in the most important
mobile phone apps stores considering the market share of the
operative systems used for smartphones. The main objective is
to find out which diseases are more researched and which have
more apps, comparing these findings with their weight in
mortality, not only globally but also distributed according to
different income regions. This study is only limited to a general
search of applications, without studying or analyzing them due
to the significant extension of that work, which is enough for
additional research.
Figure 1. Percentage of deaths caused by the leading causes of death grouped by zones.
Methods
Overview
In April 2013, two reviews were developed: a literature review
and research in commercial applications stores. The procedures
used for each review are explained below.
Literature Review
For the literature review, a search of published papers was
developed in the following databases and systems: IEEE Xplore,
Scopus, Web of Knowledge, and PubMed. When searching for
a specific disease, a combination of search words was used. If
the number of results obtained was too low, another combination
of words was used until a more significant number of results
was obtained. These terms were used on all the systems
mentioned. The process was repeated with each disease studied.
The search strings were used only for metadata and the article
search was limited to the past 10 years, from 2003.
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Table 1. Terms used in the literature search strings of each disease.
Term2Term1Disease
applicationlower respiratory infectionsLRI
applicationrespiratory infections
application/apprespiratory diseases
applicationdiarrhoeal diseasesDiarrheal diseases
applicationdiarrheal diseases
application/appdiarrhea
application/appdiarrhoea
application/appHIV/AIDSHIV/AIDS
HIV
application/appischaemic heart diseaseIHD
applicationischemic heart disease
application/appheart disease
application/appmalariaMalaria
application/appstrokeStroke and other cerebrovascular diseases
cerebrovascular disease
application/appchronic obstructive pulmonary diseaseCOPD
copd
application/apptrachea cancerTrachea, bronchus, lung cancers
bronchus cancer
lung cancer
respiratory system cancer
application/appAlzheimerAlzheimer and other dementias
dementia
Figure 2 shows a flowchart with the steps followed in both
literature and commercial reviews. All the systems returned
1113 results, with 624 repeated or with an irrelevant title for
this study. Of the remaining 489 papers, 118 were dismissed
after reading their abstract or the whole paper when necessary.
Finally, a total of 371 papers (33.3%) were selected as relevant.
For considering a paper relevant, it had to fulfil some criteria:
it must be focused on applications using mobile phones or
devices, it must be written in English, and it has to be about a
mobile app or apps designed for the sought condition. This
means that papers centered on applications for several and
different diseases were dismissed even if one of the illnesses
treated was the one sought.
For the search strings, in some cases Britain and US terms for
the same word were used to ensure that every relevant document
was revealed. The combinations of words used were the
following: Term1 AND mobile AND Term2, Term1 AND
m-health; Term1 AND “mobile phone”; Term1 AND
smartphone; where Term2 was app or/and application and for
Term1 it was used the terms used for each disease that is shown
in Table 1.
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Figure 2. Flow chart of the steps followed in the reviews.
Commercial Apps Review
The second review was carried out in the most important
applications stores of the smartphones industry considering the
market share of the operative systems for smartphones
[23-25,72]. In descending order of this market share, the stores
are Google play of Google Android [73], iTunes of Apple [74],
BlackBerry World of BlackBerry [75], and Windows Phone
Apps+Games Store of Microsoft [76].
The process is similar to the one followed in the literature
review. Table 2 shows the different terms used in the search of
the applications related to each disease and the flowchart of
Figure 2 shows the steps followed in the commercial review.
A total of 2958 apps were initially found although, after
checking whether the apps were relevant to the study and
whether some conditions were fulfilled, only 557 (18.8%) met
these requirements. The requisites to include an app in the study
were applications not in English or with the description in a
different language from English or the one of the country where
the search was done (Spanish) were dismissed, the same as those
included in the categories of games, music, or entertainment.
Applications that use flashcards for helping medical students
in their exams and applications for conferences were also
dismissed.
Table 2. Strings used in the search of commercial apps for each disease.
Search StringDisease
respiratory infectionsLRI
diarrheal diseaseDiarrheal diseases
HIVHIV/AIDS
“heart disease”IHD
malariaMalaria
stroke; “cerebrovascular disease”Stroke and other cerebrovascular diseases
”chronic obstructive pulmonary disease”; copdCOPD
“trachea cancer”; “bronchus cancer”; “lung cancer”Trachea, bronchus, lung cancer
alzheimer; dementiaAlzheimer and other dementias
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Results
Mobile Apps in Literature
The results of relevant papers for each condition and each
system are presented in Table 3. The last column shows the
total number of different papers found on all the systems. The
results of the search of the respiratory system cancers can be
broken down into nine results for lung cancer and no results for
the rest of the search strings (trachea cancer, bronchus cancer,
and respiratory system cancer).
In light of the results, heart diseases are the most researched
ones. It is followed by HIV/AIDS, Alzheimer and other
dementias, and stroke and other cerebrovascular diseases. LRI
and COPD hold the fifth and sixth places, respectively, in
descending order of research done and the last places are for
malaria, trachea, bronchus, lung cancers, and diarrheal diseases
with very little investigation; only 28 articles among them.
The majority of papers found were relative to the design,
development, or implementation of mobile systems, whole
systems [77], complement systems to a mobile phone [78], or
part of the system [79]. There are also evaluations and
validations of these mobile systems [80]. Other types with a
great number of papers found are interventions using mobile
systems [81], apps [82], or mobile phones [83] and the studies
and evaluations of these interventions [84]. Another type of
paper found, but less frequent, are those dedicated to
applications for smartphones, with add-on complements [85]
or without them [86] and reviews of the existing apps for a
specific objective [87].
Table 3. Results of the literature review.
TotalPubMedWokScopusIEEEDisease
2439219LRI
30130Diarrhoeal diseases
864238774HIV/AIDS
12132478141Heart diseases (IHD)
1689151Malaria
36913307Stroke and other cerebrovascular diseases
23710205COPD
93472Trachea, bronchus, lung cancers
537204916Alzheimer and other dementias
Mobile Apps in Stores
The findings of the commercial apps review are revealed in
Table 4. Each cell shows the number of relevant apps out of the
total number of results found in each commercial store. The last
row contains the addition of the applications found for all the
diseases at each store and the last column presents the addition
of the applications found at all the stores for each sought disease.
Nevertheless, this number does not represent the total number
of different apps in all the stores, because there are apps
developed by the same creator for different operative systems,
being the same (or similar) app for different smartphones
software. For example, the application AIDSinfo HIV/AIDS
Glossary, created by the National Library of Medicine at
National Institutes of Health (NIH) [88], is available on iTunes
[89] and on Google play [90].
There are some diseases issued by the WHO that are actually a
group, so in Table 4 these groups are divided into its illnesses.
This way, the groups stroke and other cerebrovascular diseases
and Alzheimer and other dementias are divided each one into
two rows, one for stroke and cerebrovascular diseases and
another for Alzheimer and dementia, respectively. The same
occurs with the group trachea, bronchus, and lung cancers, split
into three rows corresponding to the three types of cancer.
Focusing on the number of applications for each disease, the
ones with more apps are Alzheimer and other dementias with
128, followed closely by HIV/AIDS. The third position is for
heart diseases with 111 applications and the fourth is for stroke
and other cerebrovascular diseases despite the fact that there
are no results for cerebrovascular diseases. After a gap of more
than 40 apps, COPD holds the fifth position and trachea,
bronchus, and lung cancers the sixth, although there are no apps
for the two first mentioned cancers, only for lung cancer. The
seventh and eighth positions are malaria and diarrheal diseases,
and the last is LRI with only 6 apps.
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Table 4. Results of the commercial apps review.
TotalWindows Phone StoreBlackBerry WorldiTunesGoogle playDisease
60/00/01/175/57LRI
200/50/08/1212/88Diarrheal diseases
1247/197/856/12154/238HIV/AIDS
1114/213/444/7960/249Heart diseases (IHD)
222/81/27/2512/51Malaria
793/1054/4645/53027/480Stroke
00/00/00/20/0Cerebrovascular diseases
381/30/017/3720/50COPD
00/00/00/10/0Trachea cancer
00/00/00/00/1Bronchus cancer
290/21/314/5414/88Lung cancer
706/141/225/9638/175Alzheimer
583/100/023/7032/185Dementia
2617240274Total apps per store
The main types of apps for LRI are guides and calculators for
health care professionals, although there are also some
informative apps for patients. In the case of diarrheal diseases,
the most common apps are natural and personal remedies as
well as some guides. Referring to HIV/AIDS, there are many
guides for health care professionals, patients and public in
general, centering, in this case, on educational aspects. There
are also a significant number of apps with news regarding
HIV/AIDS. The great majority of apps for heart disease are
heart rate monitors for patients and algorithms and calculators
for specialists [91]. The principal focus of malaria apps is to
use the smartphone as a mosquito repellant, followed by
informative apps about it. The most usual apps for stroke and
other cerebrovascular diseases are stroke detectors and stroke
scale calculators. There are also some informative apps.
Referring to COPD, the majority of apps are informative and
guides for health care professionals, followed by some COPD
trackers and apps for learning to use inhalers, both destined for
patients. Focusing on lung cancer (there are no specific apps
for the rest of cancers studied), most apps are destined for cancer
stage determination and help in its diagnosis for professionals.
For patients, informative apps are common. Finally, typical
apps for Alzheimer and other dementias are games useful for
their prevention, supportive apps for patients and relatives, as
well as trackers and apps for auto-checking the status of a
dementia.
Figure 3-5 show three graphs, which present the percentage of
the number of apps found in the applications stores for each of
the top 6 causes of death for each region, excluding the rest of
the total (100%).
The diseases with a higher percentage of apps in low-income
and middle-income countries are heart diseases (IHD) and
HIV/AIDS, whereas in high-income countries these diseases
are Alzheimer and other dementias, and heart diseases (IHD).
LRI is the disease with the least percentage of apps in all the
zones, followed by diarrheal diseases in low- and middle-income
countries and trachea, bronchus, and lung cancers in
high-income countries.
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Figure 3. Percentage of apps (%) related to the top 6 causes of death of the low-income zone.
Figure 4. Percentage of apps (%) related to the top 6 causes of death of the middle-income zone.
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Figure 5. Percentage of apps (%) related to the top 6 causes of death of the high-income zone.
Discussion
Principal Findings
Some important conclusions can be obtained from the analysis
of the results. Comparing the numbers of the literature review
with the numbers of the commercial apps review, it is clear that
there is more work done in the commercial field than in the
research field. This is quite logical because the main objective
of developers is earning money with their apps and, therefore,
they focus on commerce. However, to create a good application,
it is necessary to do some research [92], and this research can
be a market study and/or an investigation about the application
itself, including aspects such as the type of application, the
necessity to cover, or the target public, among others.
Unfortunately, what can be extracted from the results of this
study is that most developers only do the market investigation
or they do not publish the results of their studies while
developing their apps. Contrasting the literature review with
the commercial review, there are two differentiated groups. On
one hand, there are four diseases with the highest percentage
of work done in developing research and applications. These
diseases are Alzheimer and other dementias, heart diseases,
HIV/AIDS, and stroke and other cerebrovascular diseases. The
numbers of the commercial apps review for the first three
diseases mentioned before are similar and over 100 apps while
for stroke and other cerebrovascular diseases the number of
apps is much higher than the rest, which enforces the idea of
two groups. On the other hand, the second group is formed by
the rest of diseases, having much less work done in both research
and commercial fields.
Another piece of information extracted from this comparison
is that the position held by a disease in number of apps or papers
found is similar in both reviews, with a maximum difference
of two positions except for LRI with the fifth and ninth positions
in the literature and commercial reviews, respectively. Hence,
for the majority of the studied diseases, there is a concordance
in the proportion of work done for each disease in both fields,
which means that both researchers and developers generally
agree on the importance given to each disease.
Contrasting the order of diseases according to the number of
apps and papers and by mortality worldwide, there are some
interesting issues. The most striking is that the diseases with
more commercial apps, Alzheimer and other dementias, are not
included in the top 10 causes of death worldwide. Therefore,
why is there so much effort and work done in these illnesses?
As exposed below, the answer is easy: Alzheimer and dementias
are typical of high-income countries [27] where there is a social
conscience of these illnesses and the population is very much
aware of the consequences and dysfunctions that they cause, as
shown by the great number of associations worldwide [93,94].
This reason, added to the facts that the majority of developers
and developers groups are located in these countries [95-97]
and designing apps for richer zones is more profitable, explains
this issue.
The contrary occurs with LRI. Worldwide, this disease is the
third leading cause of death, but the reviews carried out in this
study show that its numbers do not correspond with this position
(it is the fifth disease more researched and the last in commercial
stores). This can be explained by several reasons: the first is
that it is the first cause of death in low-income countries but it
is not among the top 3 in middle- and high-income countries
and, because developers are generally aware of these countries
[95-97], this disease is not a priority for them. However, the
previous reason alone is not enough to explain this case because
LRI is the fourth and the fifth cause of death in middle- and
high-income countries, respectively, above others such as
HIV/AIDS, which has more apps and research.
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Another important reason is that this disease is typical of
children younger than 5 years old [40] and, as a result,
developers have no reasons to create apps for LRI patients. One
option could be the design of apps for parents, although people
in developed zones are not very aware of this disease as they
are with other illnesses such as HIV/AIDS [54,98] or diabetes
[99], not giving it the importance it really deserves so it is
underinvestigated. In addition, in developed zones, children are
vaccinated against RSV [42], the most important cause of LRI.
Thus, the combination of the previous reasons explains this
situation.
There are other similar cases to the previous two, but not so
extreme. Hence, as happens with Alzheimer, HIV/AIDS holds
the second position in both reviews but it is only the sixth cause
of death [54,98]. On the other hand, diarrheal diseases hold the
fifth position in mortality but only the eighth and the last
position in the commercial and literature review, respectively,
quite similar to the case of LRI but more obvious, due to the
fact that it is the second leading cause of death in children
younger than 5 years old [49] and, in this case, it is not among
the deadliest diseases in high-income countries [26,27].
Limitations
This study presents some limitations in the methodology
followed for each review, typical for this type of revision [100].
The process of extracting the data presented a significant risk
of uncertainty. Occasionally, the inclusion of a paper or an app
in the study is not easy because the text is not clear and it can
be misunderstood. To avoid this possible error, we enhanced
the assessment process with independent verification. Thus,
one author developed the search of literature papers, a second
author developed the commercial review, and a third author
inspected the results to check for possible errors.
The search results of the literature review were restricted to the
past 10 years, from 2003 to the present day. This restriction did
not affect the study because before 2003 there was a rather low
number of smartphones and mobile devices, only dedicated to
business, without commercial stores and health care applications
as we know them today [101,102]. In addition, only papers
dedicated exclusively to the disease searched were included in
the study. Hence, there are papers dedicated to several diseases
that can contain interesting information regarding the diseases
studied dismissed.
Some limitations were found and addressed (if possible) in the
commercial review. The results of the search of respiratory
infections included some infections not specific to the lower
respiratory system; hence, a discrimination of these results was
necessary to select apps specific for lower respiratory infections.
Searching on iTunes, diarrheal disease provides no results, so
in this case diarrhoea and diarrhea were used as search strings.
The same was tried in the search of this disease on BlackBerry
World but it returned no results. Because the disease name is
so specific, no other terms could be used to obtain more results
relative to it.
In the search of IHD, “ischemic heart disease” returned only 48
apps, very few for the most important cause of mortality. Hence,
it was resolute to search only “heart disease” even though IHD
is a specific type of heart disease. With this combination of
words we found 353 apps, a much more significant number of
apps. In addition to this, apps of diets or recipes were not
included in the study, but those dedicated exclusively for
cholesterol management were included because high cholesterol
is a cause of heart malfunctions.
When inspecting the stores about trachea, bronchus, and lung
cancers, apps for treatment or assistance in general cancer
management that includes the searched cancer were taken into
account. However, apps for quitting smoking were not studied
despite the fact that smoking is the most important cause of
lung cancer. We made this decision because there are other
motivations to quit smoking, not only lung cancer, and those
apps are not centered on the cancer itself.
In the case of Alzheimer and other dementias, there were a
number of games designed for their prevention, although, as
mentioned before, only those not included in the category of
games were valid for the study (medical, health category). We
did this because the majority of the found games included in
the category games were not specifically designed for Alzheimer
prevention and only took the commercial advantage of saying
that they were useful for this purpose.
There were two issues with Google play. The first was that, in
some searches, the store indicated that a certain number of
results have been found but, while exploring the results pages,
the last were blank. Because the number returned by the store
and the real number of apps were different, we decided to use
the last one, the number of applications shown. The other issue
was that, when searching for stroke, the store returned more
than 1000 results but only 480 apps were shown. In this case,
the number used was the second one, 480. This last issue could
affect our study because there are probably more apps apart
from the 480 shown by Google. The current version of the store
does not present these problems.
Another important limitation in the commercial review was the
language used for the search strings. One of the objectives of
this paper is to find and compare the existing apps for expressly
mortal diseases in different income regions. Ideally, at least the
most important low- and middle-income countries languages
should have been used to obtain apps only developed in these
languages. However, we only focused on the use of English,
obtaining all the apps developed for this particular language,
because it is the most extended and used worldwide. This barely
affected the study of diseases typical of high-income countries
because English is commonly used and extended there.
Nevertheless, many results were shown in Spanish, because the
stores detect the place where the search has been done, showing
the apps and their summaries in the language of that place, if
possible. In these cases, the apps were also included in the study,
if relevant.
It is important to indicate that the search of IHD has actually
become a search of “heart disease” in general, due to the lack
of results with IHD alone in both reviews. Hence, we will talk
about heart diseases instead of IHD. Nevertheless, it does not
affect the study, because the applications found are for general
heart diseases, including the one searched.
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Conclusions
Comparing the number of apps and research done for disease
with the position in cause of death for the three different zones,
some interesting conclusions can be extracted. The leading cause
worldwide and in middle- and high-income countries, heart
diseases (IHD), is one of the most researched and with more
apps, a logical fact because developers focus on typical diseases
in high-income countries [98-100]. However, there are two
diseases, the first and second of low-income countries, which
have very little research and fewer commercial applications.
These diseases are LRI and diarrheal diseases. The reason is
the one mentioned previously: these illnesses are not common
(diarrheal diseases) or there is no use of an app for the diseases
(LRI), so that their research is not worthwhile, not to mention
the fact that they are common in low-income zones where the
technology for smartphones and tablets is not widespread
[103,104] and, therefore, there are no market opportunities.
Another interesting case is what happens with HIV/AIDS, which
is in the top 6 of low- and middle-income zones but even not
being among the first 10 causes of death in high-income
countries, it is the second disease with more research and
applications. In this case, the illness is very popular not only in
poor and developing zones but also in richer countries [101] in
a way that, despite the fact that it is not one of the worst diseases
in mortality in these rich countries, it has the attention of
developers (as the numbers of this study show) and the
population as a whole. At least, in this case all the countries can
feature these apps for HIV/AIDS if they have the means needed.
The most curious case is the one with trachea, bronchus, and
lung cancers. They are the third cause of death in high-income
countries, but are included in the least researched diseases with
regard to apps. The reason is not clear, because cancer in general
is a common matter and there is a huge amount of information
and applications about it. In fact, the search for “cancer” on the
App Store returns 896 apps and 500 on Google play. Moreover,
specifically these types have also an important social conscience
principally for being consequences of smoking [63,64].
Therefore, it can be considered a good opportunity for
developers to fill this empty space in mobile apps for health
care.
Focusing on the types of the predominant apps for each disease,
there is a common one for all of them: the informative apps,
which can be for patients as well as for health care professionals.
Excluding these apps, the rest have different purposes depending
on the disease. Hence, developers have tried to take advantage
of the characteristics of each illness. They centered on
prevention in diseases with no cure or with a cure based on
medications where no mobile phone aid is needed such as
Alzheimer and dementias, with games useful for their
prevention; and malaria, with mosquito-repellant apps. There
are also several apps for HIV/AIDS focused on the prevention
with educational apps for the public (and others for patients).
Health care professionals are the objective of the apps designed
for LRI, stroke, and lung cancer, which offer aid in the diagnosis
or the assessment of the stage/status of the diseases. Finally, in
the cases of diarrhea and COPD the majority of apps (excluding
the informative ones) are designed for treatment: personal
remedies for diarrhea (mild diarrheas), and COPD trackers as
well as educational apps for the use of inhalers.
Finally, the enormous difference in the number of applications
found in the distinct stores is surprising. Google play and iTunes
are clearly the ones with more apps followed by far by Windows
Phone Apps+Games and BlackBerry World, as previously
observed [71]. The case of BlackBerry is unusual: in November
2012, it had a market share of 7.3% [72], but it barely has
applications for the diseases searched. On the other hand,
Microsoft Phone had less market share (3% in November 2012
[72]) but more apps, yet much less than the number of apps of
Google play and iTunes. As a result, a great number of users of
BlackBerry and Windows Phone would abandon their phones,
changing them for others that have the maximum number of
apps available. Indeed, this is already happening [72] and can
be a reason for the lack of apps for Windows Phone and
BlackBerry, because developers are discouraged from creating
apps for these stores.
For future work, several things can be done. It is possible to
develop a mobile app for LRI because of the absence of apps
related to it and its importance in mortality (third cause of death
worldwide). It can include the most common infections such
as bronchitis or pneumonia. Another possibility is to fill the
empty space in mobile apps related to the trachea, bronchus,
and lung cancers, for example developing an assistive and
informative application for aiding patients who are being treated
for these cancers.
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Abstract
Background: Cardiovascular diseases are the deadliest diseases worldwide, with 17.3 million deaths in 2008 alone. Among
them, heart-related deaths are of the utmost relevance; a fact easily proven by the 7.25 million deaths caused by ischemic heart
disease alone in that year. The latest advances in smartphones and mHealth have been used in the creation of thousands of medical
apps related to cardiology, which can help to reduce these mortality rates.
Objective: The aim of this paper is to study the literature on mobile systems and applications currently available, as well as the
existing apps related to cardiology from the leading app stores and to then classify the results to see what is available and what
is missing, focusing particularly on commercial apps.
Methods: Two reviews have been developed. One is a literature review of mobile systems and applications, retrieved from
several databases and systems such as Scopus, PubMed, IEEE Xplore, and Web of Knowledge. The other is a review of mobile
apps in the leading app stores, Google play for Android and Apple’s App Store for iOS.
Results: Search queries up to May 2013 located 406 papers and 710 apps related to cardiology and heart disease. The most
researched section in the literature associated with cardiology is related to mobile heart (and vital signs) monitoring systems and
the methods involved in the classification of heart signs in order to detect abnormal functions. Other systems with a significant
number of papers are mobile cardiac rehabilitation systems, blood pressure measurement, and systems for the detection of heart
failure. The majority of apps for cardiology are heart monitors and medical calculators. Other categories with a high number of
apps are those for ECG education and interpretation, cardiology news and journals, blood pressure tracking, heart rate monitoring
using an external device, and CPR instruction. There are very few guides on cardiac rehabilitation and apps for the management
of the cardiac condition, and there were no apps that assist people who have undergone a heart transplant.
Conclusions: The distribution of work in the field of cardiology apps is considerably disproportionate. Whereas some systems
have significant research and many apps, other important systems lack such research and lack apps, even though the contribution
they could provide is significant.
(JMIR Mhealth Uhealth 2013;1(2):e15)   doi:10.2196/mhealth.2737
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Introduction
According to reports from the World Health Organization, an
estimated 51 million people died in 2008 from any type of
disease, communicable and noncommunicable, with the latter
causing the most deaths. Among them, the worldwide leaders
in mortality are cardiovascular diseases (CVDs), with 17.3
million deaths in 2008 alone, representing 30% of all deaths
globally. Moreover, these deaths occur in a disproportionate
way, with more than 80% occurring in low- and middle-income
countries. Regrettably, no better outlook is expected, since it is
estimated that more than 23 million people will die annually
from CVDs by 2030 [1-5].
Ischemic heart disease (or coronary heart disease) is especially
fatal among CVDs, responsible for 7.25 million deaths in 2008.
Further, there are more heart-related diseases with a significant
fraction of deaths, such as hypertensive heart disease and
inflammatory heart disease. In fact, more people die of heart
malfunction than of AIDS and all cancers combined. The
contribution of these diseases to disabilities is notable—62,587
million Disability-Adjusted Life Years (DALYs) are due to
coronary heart disease. These data mean massive costs to the
economy of all countries, being estimated at US$448.5 billion
in the United States alone in 2008 [2,6-8].
In light of such statistics, it is imperative that we reduce these
numbers, not only in health care environments such as hospitals
or primary health care facilities, but also in patients’ homes and
workplaces. To meet this objective, mHealth, defined as “the
use of mobile computing and communication technologies in
health care and public health” [9], is of utmost importance. For
that same reason, the latest advances in mHealth [10-13] and
wireless technologies [14-16] have been used, resulting in
improvements in several different aspects, from health to
financial [17,18].
To aid in this initiative, it is important to acknowledge the use
of smartphones and tablets as devices that have become essential
to users in recent years. In numbers, there were more than 6
billion mobile subscriptions and more than 1.7 billion mobile
phones sold in 2012 alone, of which 712.6 million were
smartphones [19-21]. The International Data Corporation (IDC)
estimated 70.9 million shipments of tablets globally in 2011
and predicted 117.1 and 165.9 million in 2012 and 2013
respectively [22]. With such growth, it was only a matter of
time before the use of these devices would be adopted for
mHealth, in the form of mobile applications or apps. Focusing
only on the most important app stores, in terms of the market
share of smartphone operating systems [23,24], the App Store
[25] for Apple iOS has close to 20,000 apps in the category of
Health & Fitness and more than 14,000 in Medicine. Android’s
Google play [26] has more than 11,000 apps in the Health &
Fitness section and roughly 5000 in the Medical apps section
[27].
The aim of this paper is to conclude research on mobile
applications for the most important diseases and health
conditions, which we began previously with a study about
mobile applications for the most prevalent health conditions
[28]. This time we focus on the deadliest illness: heart disease.
The main objective of this paper is to study the literature on
existing mobile systems and applications, as well as cardiology
apps currently available on the cited app stores. In the first part
of the research, a review of published articles was performed
across several systems and databases and was complemented
in the second part with a search of apps in the Apple and Google
app stores. The objective was to classify the results in order to
see the progress as well as the lack of applications and systems,
focusing specifically on commercial apps (ie, those apps
available on app stores). Other secondary objectives were to
obtain information regarding the prices of these apps and their
target users. Since there are no published reviews on this specific
topic, the results may be of considerable interest for developers
and researchers wanting to investigate further or to create a new
app.
Methods
Two reviews were developed and took place up to May 2013.
The first was a review of existing mobile systems and
applications in the field of cardiology found in the literature,
and the second, a study of commercial apps related to cardiology
found in the leading app stores.
Review of Mobile Systems and Applications for
Cardiology in Literature
To perform the literature review, the following systems and
databases were used: Scopus, IEEE Xplore, Web of Knowledge,
and PubMed. The methodology followed is presented in Figure
1 and also applies to the commercial apps review. In this section,
the objective was to search for relevant papers in different
systems. The following combinations of search terms were used
in the metadata field: “term1” AND mobile AND (application
OR app); “term2” AND mhealth; “term2” AND smartphone;
and “term2” AND “mobile phone”, where “term1” and “term2”
could be different words. The words used for “term1” were
heart disease, heart failure, infarction, arrhythmia, heart attack,
coronary disease, angina, fibrillation, cardiology, hypertension,
heart transplant, and heart transplantation. For “term2”, the
terms used were cardiology and heart.
The results were limited to the last 10 years, from 2003 to the
present day, and the eligibility requisites used were the
following: only papers published originally in English were
studied. Publications about mobile systems or applications not
focused on cardiology or designed for more than 3 different
fields were dismissed, but if the application was intended for 3
disciplines or fewer with being cardiology one of them, then it
was included in the review. Similarly, papers regarding systems
for many diseases (not only cardiac diseases) were rejected.
Articles with algorithms for classification, detection,
compression, encryption, or authentication of ECG data (or
other types of heart signs) were studied, but publications about
the possible influence of the electromagnetic fields irradiated
by mobile phones in the heart rate or in implanted cardiac
devices were dismissed.
When the selection of papers was finished, the authors convened
in order to classify the articles in different categories by reading
their abstracts as well as the whole article when required. Once
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this process was completed, a revision was done and similar
categories were merged to obtain a more condensed
classification.
Figure 1. Flow chart of the methods followed in the literature and the commercial reviews.
Review of Apps for Cardiology in Commercial App
Stores
The second review was a search of apps related to cardiology
in the two leading commercial stores for smartphones [23,24]:
the Apple App Store and Google play.
The methodology used in this review is the same used in the
previous one, shown in Figure 1, although in this case exploring
apps in commercial stores, instead of papers in databases. The
search terms used for both stores were heart and cardiology.
The eligibility requisites used for this review were the following:
apps not in English or in the language of the place where the
search was executed (Spanish) were dismissed, the same as
those with their summary in a different language from the two
mentioned. Only applications focused on cardiac issues were
studied. Games, music, apps for cholesterol management or
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losing weight, apps for animals, and apps for congresses or
conferences were dismissed, but apps related to hypertension
were included in the study.
In the App Store, since the apps are separated for iPod and
iPhone and for iPad, only the first ones were searched, although
in many cases they were also available for iPad. During the
search on Google play, some problems arose. When searching
by “cardiology” or “heart”, the store indicated that there were
at least 1000 results, although it showed only 480. Google was
asked about this discrepancy and the issue is still under
investigation; hence, it was decided to use other search words
in order to obtain the highest number of apps related to
cardiology in this store. These words were infarction, heart
attack, heart failure, heart disease, fibrillation, coronary heart,
angina, and arrhythmia. Additionally, in some of these new
searches on Google play, it was indicated that a certain number
of results has been found but, when exploring the pages of the
results found, the last pages (usually between one and three)
were blank. This issue did not affect the review since the apps
studied are the ones shown, although it is not known if there
were more apps that were not visible due to this error.
Once the selection of cardiology-related apps was complete,
the authors convened again to sort the apps by their purpose in
different types, by reading the summary and explanation given
by the stores and downloading them when the explanation
specified was not clear enough. In these cases, the smartphones
used were an iPhone 4 if the app was designed for iOS and a
Samsung Galaxy S SCL GT-I9003 in the case of an app for
Android. Finally, revisions were done in order to shorten the
classification, similar to the process followed in the literature
review.
Results
Mobile Systems and Applications for Cardiology in
Literature
A total of 406 relevant papers were found in all the databases
and systems used. The classification of the papers by their
content is shown in Table 1, which also shows the number of
articles for each category.
In Figure 2, the percentage of papers found by their year of
publication, from 2003 to 2012, is shown. It can be seen that
the publications increased every year until 2011, decreasing
slightly in 2012.
Apps for Cardiology in Commercial Stores
A total of 710 relevant apps were found in the App Store and
Google play, although we note that some apps are available in
both stores. In this study, these apps are counted separately.
Hence, 439 apps are available for iOS and 271 for Android. The
majority of the apps for iOS are found in the categories of
Medicine (303) and Health & Fitness (111), whereas the
remaining are included in Utilities (8), Education (7),
Entertaining (3), Lifestyle (2), Sports (2), Books (1), Reference
(1) and Social network (1). The apps for Android are found in
the categories of Medical apps (188), Health & Fitness (65),
Education (8), Lifestyle (7), and Books & Reference (3). The
classification of these apps sorted by their functions and in
decreasing order are shown in Table 2.
If the classification was performed taking into account the target
public to whom the app is destined, another sort was conducted.
Figure 3 shows the number of apps sorted by target users for
each app store.
To understand Figure 3, it is necessary to explain the difference
between the “general public” and “everyone”. General public
is used for common users—normal people not necessarily
affected by heart disease. It does not include health care
professionals. On the other hand, everyone includes all groups.
It is used for apps intended for a specific type of user, such as
medical students but that can also be used by other users, such
as professionals or the average person for example.
Finally, statistical values on the prices of the apps separated by
commercial store are summarized in Table 3. For the mean,
mode, and median values, the study is divided into two groups:
one group shows all the apps found and the other shows only
the apps that are not free.
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Table 1. Classification of the results of the literature review.
ArticlesType of system/application
55Vital signs monitoring system
44ECG (electrocardiography)/cardiac signal detection/classification algorithms
37Heart monitoring system
28ECG/heart monitoring system trial/evaluation
25Remote heart monitoring system
17Heart monitoring system with alerts
16Cardiac rehabilitation mobile system
14ECG data transmission
13Blood pressure measurement/monitor system
11Remote management/monitoring of implanted pacemakers/cardiac devices
10Teleconsultation system
8Remote and local heart monitoring system
7Exercising/sports related heart monitoring system
7Innovative heart rate monitor
7Arrhythmia detection system
6Sensors evaluation/state of the art
5Surveys/states of the art of cardiology systems
5Heart rate & blood pressure monitoring system
5Remote heart monitoring system with alerts
5Atrial fibrillation detection system
5Heart failure detection system
5Phonocardiography mobile system
4Remote and local heart monitoring system with alerts
4Breath monitoring system
4ECG data compression technique
4Automatic music selector to maintain a target heart rate
4Alerts and location of heart attacks
4CPR instructions through mobile phone trial
4CPR instructions/reminder through mobile phone
4Applications for promotion of healthy behaviors
3System for measuring/reducing stress
3Personal lifestyle and health management system
3Fetal heart monitoring system
3ECG data encryption/authentication/privacy
3Cardiac rehabilitation mobile system trial
3Exercising/sports related heart monitoring system evaluation
2Mobile medical applications for chronic diseases
2Pocket-size images interpretation
2First aid/resuscitation app evaluation
2Apps for hypertension in smartphones
2Emotional states detection through measuring heart rate differences
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ArticlesType of system/application
2Weight control in high-risk heart failure population
2Medications management
1Telemetry-based system for monitoring rats’ vital signs
1Heart attack self-test app
1Trial for comparing follow-up of hypertensive patients
1Study about the correlation music-heart rate variability
1App for improving basic life support (BLS)
1Non-invasive tissue classifier
1Share of vital signs in a social network
Figure 2. Percentage of papers found per year of publication.
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Table 2. Classification of apps in the commercial review by function.
NumberType of app
94Heart rate monitor
85Algorithm/calculator/predictor
41Informative guide
37Educational ECG/interpretation aid of ECG
34News/journal
30Blood pressure tracker
22External devices heart rate monitor
21CPR (cardiopulmonary resuscitation) instructions
17Educational anatomy
17Medicine students education
17Guide/book
17Health tips
14Diagnosis & treatment guidelines
14Echocardiography reference
14Professionals & students education
13Medicine exam preparation
11General education
10Diagnosis aid
9Animated guide
9Heart sounds reference
9Blood pressure & heart rate monitor
8Cardiology medical reference
8Medical images reference
8Catheter reference
7Guide of professional commercial devices
7Stethoscope/educational stethoscope
6AED (automated external defibrillator) location
6Professionals education
6Clinical trials
5ECG cases reference
5Hypertension reference/guidelines
5Procedures in emergency cases
4Patients’ history/ECGs/images
4Surgeon aid/training
4Professionals connections, knowledge/cases share
4Angiography reference/guide
4Auscultation reference
4Heart rate monitor for exercising
4Fetal heart rate monitor/interpretation
4Heart rate calculator
4Ultrasound video reference
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NumberType of app
4Resuscitation instructions/guide
3Educational/explanations for patients
3ECG sending
3Log procedures
3Diseases prevention guide
3Heart rate monitor with external devices for exercising
3Professionals guidelines
2Audio reference
2ECG signal transformer
2Location of cardiac emergencies
2Blood pressure measurement with external devices
2CPR and AED instructions
2Prescribing drugs
2AED training
2Pulse measurement aid
2Hospitals
2Instructions/training CPR & AED location
2Perfusion reference
2Arrhythmia reference
2Acute coronary syndrome reference
2Stent guide/reference
1Prosthesis guidelines
1Teleconsultation
1Upload ECG from a commercial monitor
1Medications reminder
1Treatment guide
1Stand-alone or with external device heart rate monitor
1Auto-diagnosis
1Cardiac rehabilitation guide
1Anesthesia management
1Social network
1Atrial fibrillation guidelines
1AED training with simulation of external device
1Blood pressure prevention & treatment exercises
1Condition management
1Congenital heart defects reference
1Clinical examination guide
1Blood pressure measurement
1Driving guidelines for cardiac patients
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Table 3. Statistical data on the prices of apps in the commercial review.
MedianModeMean% free appsMax.Min.
Not freeTotalNot freeTotalNot freeTotal
1.790.890.8905.102.8943.28129.990iTunes
2.170.711.0406.873.4549.821000Google play
Figure 3. Classification of the apps of the commercial review by target users.
Discussion
Principal Findings
In light of the results presented in the previous section, several
interesting findings can be extracted. Focusing on the literature
review, the majority of the 406 articles found are about systems
that normally use a mobile phone or smartphone and only a
small percentage concerns mobile apps exclusively. In addition,
as Table 1 shows, 4 of the first 5 types of applications with more
papers are directly related to heart monitoring systems (including
vital signs) while the remaining one is related to algorithms for
selection/classification of ECGs or other measurable heart signs.
At the same time, other different types of heart monitoring
systems can be found in the classification. There were 198
papers about those systems, which is almost half of all the
publications found. This indicates that the most researched area
associated with cardiology is related to mobile heart monitoring
systems and the techniques involved in the classification of
heart signs in order to detect malfunctions.
An example of a heart monitoring system is the one proposed
by Yap et al (2012), which uses a chest-belt wireless ECG
measurement system in combination with an Android app for
monitoring ECG in real time [29]. In this case, there is an app
involved in a whole system, but, as mentioned above, there are
few articles focused exclusively on apps, such as the one written
by Leijdekkers and Gay (2008) about a heart attack self-test
app that allows possible victims to assess whether they are
suffering an infarction [30]. De Vries et al (2013) evaluated the
actual use and goals of telemonitoring systems [31], whereas
Seto et al (2012) developed a randomized trial of mobile
phone-based telemonitoring systems [32] to examine the
experience of heart failure patients with these systems [33]. An
algorithm for improving the classification of ECGs was
developed by Jekova et al (2011), which scores the noise
corruption level of ECG data by evaluating several features
[34]. It is important to indicate that most of these systems cited
were designed for patients’use with the knowledge and consent
of their professional caregivers, since they have an important
role in the correct functioning of the applications, either
monitoring remotely the patients’ heart or receiving alarms
when a heart problem occurs.
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Other systems with a number of papers are the following:
cardiac rehabilitation mobile systems [35,36], extremely
important in the recovery of heart attacks or in their prevention
in people with heart problems [37,38]; systems for measuring
blood pressure combined or not with heart rate monitors [39,40],
in order to avoid possible problems derived from hypertension
(or raised blood pressure), an important risk factor for coronary
heart disease or ischemic stroke and indirectly the cause of 9.4
million deaths every year [41,42]; and systems for the detection
of heart malfunctions, sometimes focused on certain problems
such as arrhythmia or atrial fibrillation [43] and sometimes
considering more than one disease [44]. Other important
contributions are done in the remote management or monitoring
of cardiac devices such as pacemakers, in order to assess their
correct operation and to perform periodic checks, which is
currently very common in modern health care facilities [45].
Examining the dates of publication of these papers, shown in
Figure 2, it is clear that research in mobile systems in the field
of cardiology has gained more and more importance in recent
years, beginning in 2003 and with many more published articles
by 2011 and 2012. This fact shows that the part of cardiology
associated with mobile technology has become the recent focus
of investigations—quite logically since cardiovascular diseases
and especially heart diseases are the leading causes of death
worldwide.
In the review of cardiology-related apps, many outcomes were
observed. The first notable conclusion from classification (Table
2) is the difference between the first two positions (ie, heart rate
monitors and calculators) and the rest, when taking into account
the number of apps for each category. There are far more apps
for heart rate monitoring and medical calculators or predictors
than for informative guides, which is in the third position. In
addition to these heart monitoring apps, there are those that use
an external device as well as those focused on exercising.
Figures 4 and 5 show snapshots of two examples of heart
monitoring apps: Runtastic Heart Rate & Pulse Monitor [46]
for iOS and Instant Heart Rate [47] for Android. Of the more
than 20 apps, we found the following types: apps for ECG
education and interpretation, cardiology news and journals,
blood pressure tracking, heart rate monitoring using an external
device, and apps with instructions about CPR. These categories
equal a total of 364 apps, which is more than half of the total
apps found.
Despite the fact that the classification shown in Tables 2 and 3
is subjective, we believe we obtained the most realistic
classification, performing several iterations until arriving at the
final one. As a result, those categories with similar patterns and
characteristics have been merged, whereas others with unique
features were not, in order not to lose information in the process.
As a result, there are many categories with few apps, some of
them highly useful and interesting, such as apps related to
resuscitation procedures, including apps with CPR and/or AED
instructions, essential for properly performing a resuscitation
and, hence, saving lives. There were also AED location apps,
which indicate the position of nearby AEDs for cardiac
emergencies with the help of the GPS (Global Positioning
System) included in every modern smartphone. Other
compelling apps are those designed to locate cardiac
emergencies, through the help of the users, either sending an
emergency alarm or receiving it in order to assist them on site.
The majority of these types of apps are free; therefore, their use
has no additional cost to the user. Since the outcomes they can
achieve are significant (eg, saving the life of a person suffering
a heart attack), it would be better if there were more available
and they were also free.
There are other categories with very few apps (or even no apps),
which could provide significant assistance and help. Examples
are guides for cardiac rehabilitation and apps for the
management of a cardiac condition, with only one app of each
type.
Since a rehabilitation program for people who have suffered or
suffer heart problems (or have had a heart surgery) is vital
[37,38] in order to avoid more worrisome consequences, it
would be beneficial for these individuals to have a guide with
exercises and instructions for complete rehabilitation of their
hearts. Similarly, apps for the management of heart conditions
can be useful for people suffering congenital heart defects
involving arrhythmia, angina, fibrillations, etc. In addition to
this, it is surprising that there are no apps for aiding people who
have undergone a heart transplant, since guidelines, exercises,
or even medication management would be of help.
Figure 3 shows the numbers of apps for a specific target public,
where it is clear that the users preferred by developers are
general users and health care professionals. Typical apps for
the general public are heart rate monitors, blood pressure
trackers, apps with health tips, educational apps, and
resuscitation (CPR and AED) guides. Common apps for
professionals are calculators and predictors useful for diagnosis
or treatment, specific educational apps and references
(angiography, catheters, surgery, etc), and guides, books, and
apps for assisting in the diagnosis. Educational apps about
medicine and apps for the preparation of medical exams are
usually designed for students. The apps intended for common
people, medical students, and professionals (category
“Everyone”) are usually educational and informative apps while
typical apps for patients are those for the care of their condition,
some with calculators to assess their state and informative
guides. The apps for pregnant women are fetal heart rate
monitors. Here we note that there are few apps designed
exclusively for patients. Nevertheless, there are many general
informative applications that can be used by patients; hence,
these apps can compensate for the lack of specific apps for
patients. However, a preferable option would be the creation of
a specific app for the treatment of a determined condition in
order to help the affected in a more appropriate way.
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Figure 4. Snapshot of Runtastic Heart Rate.
Figure 5. Snapshot of Instant Heart Rate.
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Conclusions
Comparing the results for each store, several conclusions can
be made. First, there are more apps related to cardiology in the
App Store, despite the fact that Android is more prevalent than
iOS [23,24]. Figure 3 shows that the numbers related to target
users obtained for Apple are consistent with the numbers for
Google play, suggesting that the developers for both stores have
similar approaches and ideas. The data shown in Table 3 reveal
interesting findings. Google play exceeds the App Store only
in the number of free apps. Despite the fact that the highest-price
app on the App Store is more expensive than the corresponding
on Google play, the mean price is lower than the one in Google
play, whether free apps are included or not. This was
unexpected, since there is a collective belief that iOS devices
(especially iPhones and iPads) are more exclusive (usually used
in the business environment) and expensive than Android
devices [48,49], and their apps are also considered to be higher
quality than apps for Android [27,50]. This seems not to be the
case in the cardiology field.
There are various lines of investigation for further research.
New applications are needed for the management and
monitoring of specific cardiac conditions, designed for the
patients affected by them, since there are few currently available.
The development of applications with this aim could be rather
valuable. Another potential field of research could be the
creation of an app with guidelines and information for people
who have undergone a heart transplant. Such an app could assist
them in their new condition and facilitate their new state.
Another field to supply is related to resuscitation guides and
instructions. Although there are several useful apps with such
functions, the creation of an app with different functionalities
parallel to the existing ones could be another beneficial field of
research, perhaps developing the idea of the location of cardiac
emergencies for people trained in resuscitation skills.
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Abstract The latest advances in eHealth and mHealth have
propitiated the rapidly creation and expansion of mobile appli-
cations for health care. One of these types of applications are the
clinical decision support systems, which nowadays are being
implemented in mobile apps to facilitate the access to health
care professionals in their daily clinical decisions. The aim of
this paper is twofold. Firstly, to make a review of the current
systems available in the literature and in commercial stores.
Secondly, to analyze a sample of applications in order to obtain
some conclusions and recommendations. Two reviews have
been done: a literature review on Scopus, IEEE Xplore, Web
of Knowledge and PubMed and a commercial review on Goo-
gle play and the App Store. Five applications from each review
have been selected to develop an in-depth analysis and to obtain
more information about the mobile clinical decision support
systems. Ninety-two relevant papers and 192 commercial apps
were found. Forty-four papers were focused only on mobile
clinical decision support systems. One hundred seventy-one
apps were available on Google play and 21 on the App Store.
The apps are designed for general medicine and 37 different
specialties, with some features common in all of them despite of
the different medical fields objective. The number of mobile
clinical decision support applications and their inclusion in
clinical practices has risen in the last years. However, devel-
opers must be careful with their interface or the easiness of use,
which can impoverish the experience of the users.
Keywords Mobile applications . Apps . Clinical decision
support . mHealth
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Introduction
The creation of the Internet, its extended use and the latest
advances in telecommunications and mobile technologies
have originated new forms of technology in every aspect of
life [1]. One of these aspects is health care, being telemedicine
or telehealth the technology most researched, specially the so-
called eHealth, defined by the International Telecommunica-
tion Union as the paradigm that encompasses all of the infor-
mation and communication technologies necessary to make
the health system work [2]. In this context and thanks to these
advances in communications, a new term arises: mHealth, a
component of eHealth. The Global Observatory for eHealth
(GOe) of the World Health Organization (WHO) defines
mHealth or mobile health as “medical and public health
practice supported by mobile devices, such as mobile phones,
patient monitoring devices, personal digital assistants
(PDAs), and other wireless devices” [3].
This mHealth has been supported by the incredibly expan-
sion of the market of smartphones and tablets, thanks to those
mentioned advances in mobile and communications technol-
ogies such as 3G, 4G, Bluetooth, Zigbee, Radio-frequency
Identification (RFID), etc. [4–9]. In numbers, there were in
2011 alone a total of 6 billion mobile subscriptions and more
than 1.7 billion mobile phones sold in 2012, being 712.6
million smartphones [10]. Regarding tablets, there are esti-
mated 117.1 and 165.9 million shipments in 2012 and 2013
respectively [11].
This fast spreading of mobile devices has propitiated the
creation and growth of the mobile apps market. Focusing only
on the most important app stores, in terms of the market share
of smartphone operating systems [12, 13], the App Store [14]
for Apple iOS has close to 20,000 apps in the category of
Health & Fitness and more than 14,000 in Medicine whereas
Android’s Google play [15] has more than 11,000 apps in the
Health & Fitness section and roughly 5,000 in the Medical
apps section [16].
The potential for mHealth applications is well-documented
[17–20], e.g.: continuous surveillance of vital or physiological
signs, move away from face-to-face visits at the doctor’s
office, access information relative to medications, view your
own electronic medical record and access to a wide array of
educational resources including information on disease-
specific topics and general self-management tools.
Recently, there are proliferating several apps destined for
medical professionals and dedicated to support these profes-
sionals in the clinical decisions they should make. Although
there are many informatics systems usually used in health care
facilities and organizations [21–24], the implementation of
these systems in mobile devices is relatively new and the
advantages it can provide are many: portability, possibility
of customization, always at hand, low cost, etc. Hence, these
new types of apps for medical decision support can enhance
the existing systems in this field, being inseparable tools for
physicians, nurses and specialists of health care.
Clinical Decision Support Systems (CDSS) link health
observations with health knowledge to influence health
choices by clinicians for improved health care. These systems
are aligned with the P4 Medicine objectives to personalized
diagnoses and treatments, predict the patient status and
follow-up based on multi-level observations, generate preven-
tive polices in risk patients and empower patients to actively
participate in their health.
High performance CDSS are usually based in two technol-
ogies: Rule-Based Systems and Machine Learning models.
Rule-Based Systems (RBSs) are computer-based systems that
represent knowledge by IF…THEN rules. In CDSS, RBSs
implement medical evidence linked to the patient conditions
observed in the clinical data. Machine Learning models are
mathematical functions to estimate the risk of patients given
the observations. They are usually trained from retrospective
data from real patients to solve diagnoses, treatments, or
prognosis.
The aim of this paper is to study the existing applications
for mobile devices dedicated to the medical decision support
in order to find the different types of apps in this field,
common features, and compare and analyse a representative
sample of these apps. To achieve this, a review of the literature
about existing mobile systems and applications, as well as
mobile apps currently available on the most used app stores
has been done.
The remainder of this paper is organized as follows. Next
section elaborates about the methods conducted in this study
and then there are shown the results obtained. Both sections
are separated into three subsections: the first subsection is the
literature review of applications and systems, the second is the
review of commercial apps and, the third subsection is the
analysis of the sample of apps selected. Finally, the last section
presents the discussion of the results.
Methods
In this research work, two different reviews were developed.
The first was a literature review and the second a commercial
applications review. Both were current as of September 2013.
Finally, five applications for each review were chosen for an
in-depth analysis. The methods used in these reviews and in
the analysis mentioned are shown in this section.
Literature review of mobile clinical decision support
applications
To perform the literature review, the following systems and
databases were used: Scopus, IEEEXplore, Web of Knowledge,
and PubMed. The search was finished in September 2013.
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The combination of words used for searching the publica-
tions were the following: mobile AND clinical AND decision
AND support. The results were limited to the last 7 years,
from 2007 forward.
Figure 1 shows a flowchart with the steps followed in both
literature and commercial reviews. All the systems and data-
bases returned a total of 405 results, of which 283 were
repeated or with an irrelevant title for this study. Out of these
papers, 30 were dismissed after reading their abstract or the
whole paper when necessary. Finally, a total of 92 papers were
selected as relevant.
To include a paper in this study it had to fulfil some criteria:
it had to be in English and about one or several mobile clinical
decision support applications, although it could include other
types of systems or issues. Hence, reviews about the general
status of medical systems or applications including decision
support systems were included, the same as evaluations about
these types of applications.
This process was done by reading the titles and the ab-
stracts of the results obtained in the different databases from
one of the authors. When there were doubts about the inclu-
sion of a paper, the whole article was read by all the authors in
order to reach an agreement to make a decision.
Review of commercial clinical decision support applications
The review of the commercial applications for supporting clin-
ical decisionswas developed in the two applications stores of the
most extended smartphone operative systems [12, 13]: Google
play for Android [15] and App Store (iTunes) for iOS [14].
The search strings used in both stores were the following:
“clinical decision”, and “medical decision”. The flow chart of
Fig. 1 also shows the steps followed in the commercial review.
A total of 578 apps were initially found. Three hundred fifty-
nine of these apps were repeated, had an irrelevant title or did
not have any decision support included, so only 219 were
evaluated, of which 27 did not fulfil the rest of the requisites
and, therefore, only 192 were included in the study.
The previous requisites were the following: the title and the
description of the app had to be in English or in the language of
the country where the search was done (Spanish in this case), it
had to be included in the categories of Medical or Health &
Fitness and be developed for medical professionals of any
specialization. Apps developed only for students were
dismissed, but those developed for students and medical staff
were included in the study. Apps that are guidelines for diagno-
sis and/or treatment and include some calculators or decisions-
tree in order to help the user with the decision making were
included in this study. Apps for veterinarians were dismissed.
During the search an issue was faced: on iTunes, apps for
iPod and iPhone were separate from the ones for iPad, hence
only apps for the first ones were searched since they offer
more results, excluding the apps exclusively designed for the
tablet of Apple.
This methodology followed was performed by reading the
description provided on the corresponding store and, when
necessary, the application was downloaded in order to decide
its inclusion in the study or not. In these cases, the
smartphones used were an iPhone 4 if the app was designed
for iOS and a Sony Xperia Z in the case of an Android app.
One author classified the apps by their public objective and the
field of health care they are destined to. The other two authors
checked the classification to be sure there were no mistakes.
Eligibility criteria of the applications for the analysis
and procedure
Five papers and five commercial apps were selected for an in-
depth analysis of features. The eligibility criteria are similar to
the used in a previous work [25].
Fig. 1 Flow chart of the steps
followed in the reviews
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For the mobile clinical decision support systems found in
the literature, only the studies published in 2013 were select-
ed. The next requisite for the selection was the highest impact
factor of the journal where the paper was published and, if the
articles were published in the same journal, the number of
citations was taking into account. Articles about reviews of
several apps or with insufficient information about the app
were dismissed.
To evaluate the papers, each author read them individually
and convened to discuss the different opinions they could
have until achieve a common agreement about the system or
application.
To select the five commercial apps to analyze, it was
decided to use the same commercial store and it was chosen
Google play, since Android is the most extended smartphones
operative system [13]. It was decided to select the five first
relevant free apps shown by the store with a rating by users of
four or more stars when searching for “clinical decision sup-
port”. The apps were tested on a Sony Xperia Z.
For the analysis of the applications the procedure followed
was similar to the one mentioned with the papers. One author
downloaded them on the mentioned mobile phone before
meeting with the rest of the authors to study the apps together
and complete a table of features.
Results
Mobile clinical decision support applications in literature
A total of 92 relevant papers were found in the systems
mentioned previously. Figure 2 shows the distribution of these
publications by their year of publication, indicating the num-
ber of documents per year. It can be observed an increasing
progression in this number of papers with the years.
Regarding to the type of papers found, several were ob-
tained. There are papers about the development of complete
and specific mobile decision support systems such as the
system developed by Savel et al. (2013), where an iOS-
based mobile application called PTT (Partial Thromboplastin
Time) Advisor is developed to offer clinicians a resource to
quickly select the appropriate follow-up tests to evaluate
patients with a prolonged PTT [26]. There are also many
papers about the evaluation and analysis of a mobile decision
support system; e.g. the evaluation of the application for iOS
iDoc [27], carried out by Hardyman et al. (2013) through
surveys for trainee doctors [28].
The results and effectiveness of these systems were also
studied in papers such as the one written by Lee et al. (2009),
where a trial is developed in order to compare the proportion
of obesity-related diagnoses in clinical encounters, docu-
mented by nurses using a personal digital assistant-based
log with and without obesity decision support features [29].
Only 44 papers out of 92 were focused only on mobile
CDSS.
Finally, there are two types of papers that include these
clinical support systems in a more global way. On one hand
there are reviews of these systems, such as the one devel-
oped by Divall et al. (2013), where the authors carried out a
systematic review of the use of PDAs in clinical environ-
ment, including the decision support [30]. On the other
hand, other papers simply expose the possibilities and
possible contributions that mobile clinical support systems
can provide [31].
Commercial mobile clinical decision support apps
A total of 192 commercial apps for supporting the clinical
decision were found. One hundred seventy-one from Google
play and 21 from the App Store. One hundred thirty-eight
results were found using the search keywords “clinical
Fig. 2 Number of papers found
per year of publication
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decision” and 172 using “medical decision”. One hundred
eleven apps were obtained using both search strings. Table 1
shows the number of apps sorted by the type of medical field
they are intended for. In Fig. 3 the percentage of apps classi-
fied by the objective public to whom they are developed is
shown.
Analysis of a sample of systems and applications
First we analyze the systems selected from the literature
review. These papers are the following: An analysis of the
development and implementation of a smartphone application
for the delivery of antimicrobial prescribing policy: lessons
learnt [32]; Unbiased andMobile Gait Analysis Detects Motor
Impairment in Parkinson’s Disease [33]; Mobile Monitoring
and Reasoning Methods to Prevent Cardiovascular Diseases
[34]; An end stage kidney disease predictor based on an
artificial neural networks ensemble [35]; Exploiting causal
functional relationships in Bayesian network modelling for
personalised healthcare [36].
In [32] the authors talk about the development, adoption
and implementation process of a smartphone application for
antimicrobial prescribing policy called ‘IAPP’ (Imperial An-
tibiotic Prescribing Policy). They designed the app in iterative
stages focusing on junior doctors and pharmacists. The app
was implemented in five teaching hospitals of West London
among junior medical staff. After a period of 12 months some
surveys were sent to the participants of the study to obtain
feedback. The app has clinical calculators and decision sup-
port, is native, initially username and password protected and
comprised a mobile evolved version of the policy with addi-
tional functionality, including therapeutic drug monitoring
and clinical calculators. The most appealing features of the
IAPP reported by clinical users were its usability, accessibility
at point of care, some clinical decision support features and
transportability. 81 % of the participants stated that using the
app helped them adhere to the policy.
In [33] the authors developed a mobile gait detector, useful
for diagnosing motor impairment in Parkinson’s disease (PD)
patients. This system is called Embedded Gait Analysis using
Intelligent Technology (eGaIT) and consists of accelerometers
and gyroscopes attached to shoes, data capture, wireless data
transfer, feature extraction, and pattern recognition algorithms
that record motion signals during standardized gait and leg
function. Since clinical scores such as the Unified Parkinson
Disease Rating Scale (UPDRS) or Hoehn&Yahr (H&Y) stag-
ing are time-of-assessment dependent, it was necessary to
Table 1 Classification
of apps in the commer-
cial review by medical
field
Medical field Number
General medicine 47
Drugs information 16
Emergencies 12
Pediatrics 11
Cardiology 7
Oncology 7
Psychiatry/mental health 7
HIV 6
Infectious diseases 6
Lab values 6
Neurology 6
Cardiovascular 4
Dermatology/wounds 4
Gynecology 4
Hematology 5
Radiation therapy/Radiology 4
Gastroenterology 3
Anesthesia 3
Hepatitis 3
Nutrition 3
Orthopedics 3
Respiratory system 3
Surgery 3
Urology 3
Diabetes 2
Geriatrics 2
Imaging 2
Albuminuria 1
Day time somnolence 1
Dysanatremia 1
Endocrinology 1
Hospital 1
Insomnia 1
Nephrology 1
News/research 1
Ophthalmology 1
Sclerosis 1
Fig. 3 Percentages of apps by objective users
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made the system mobile. To measure the efficacy of the
system, 42 patients and 39 controls were used, who underwent
three specific exercises. eGaIT was able to successfully dis-
tinguish PD patients from controls with an overall classifica-
tion rate of 81 % and was able to classify different H&Y
stages, or different levels of motor impairment. eGaIT was
proved to be able to complete and confirm the global assess-
ment by a clinician.
[34] is about a system that uses a mobile phone to monitor
the blood pressure of a patient and a reasoning engine to
calculate the Cardiovascular Disease (CVD) risk applying
the SCORE (Systematic Coronary Risk Evaluation) method
over the blood pressure values and other clinical factors. The
system uses a Bluetooth sensor for obtaining the blood pres-
sure data, which will be used taking into account the clinical
data of the patient/user to enable the estimation of CVD risk,
supporting clinical decisions. As the system depends on the
user actions (i.e., the patient must take the blood pressure
himself), the system includes notifications and reminders to
facilitate this fact. It is focused on adults over 45 years and it is
only valid for European regions. The authors evaluated the
system through interviews and user feedback after tested it
with 23 users, who reported a high satisfaction level but they
gave lower ratings to issues related to the way to input infor-
mation. In general, the usability of the mobile application
obtained a rate of acceptance of 69 %.
The authors of [35] developed a mobile tool for predicting
Endstage Kidney Disease (ESKD) in patients with IgA Ne-
phropathy (IgAN) disease, which is the most common prima-
ry glomerulonephritis worldwide and a leading cause of
ESKD thus requiring renal replacement therapy with dialysis
or kidney transplantation. The system uses a large and com-
plete dataset of IgAN patients (587) to provide a valuable
predictive tool for clinicians. It uses artificial neural networks
since they have been proven to be an excellent tool in terms of
predictive power as they have the ability to learn. It is embed-
ded in a decision support system called m-IgAN, composed
by a server application and two clients: a mobile application
and a Web application. Users have to insert the clinical data of
the patient, which are sent to the server which checks their
validity and, in case they are valid, it predicts the risk degree
and sends a set of information to the client containing the
prediction and a summary of the patient’s data. The system has
proved to be efficient as shows the fact that it is being used at
Polyclinic of Bari, Italy.
In [36], the authors argued that Bayesian networks offer
appropriate technology for the successful modeling of
medical problems, including the personalization of
healthcare and proposed ways to represent physiological
knowledge as part of engineering principles employed in
building clinically practical probabilistic models. These
principles have been used in implementing a Bayesian
network model for preeclampsia being a part of a mobile
home-monitoring system. The system is called eMomCare,
implemented for Android, and uses smartphones for
predicting possible problems. It collects data from the
patient and a blood pressure meter connected, which are
sent to a smartphone where the Bayesian model is stored,
and returns the results obtained from the data. The results
of the evaluation of the system were encouraging and
show the potential of exploiting physiological knowledge
for personalized decision-support systems.
Referring to the commercial review, the five apps selected
for the analysis are the following:
& Pediatric Clinical Pathways [37]. This app accesses to the
Clinical Standard Work (CSW) Pathways of the Seattle
Children’s Hospital, which are a documented standard
approach that guides practitioners when providing care
to specific patient populations, in this case children. These
pathways were developed by committees of experts from
different disciplines and are presented in an easy-to-read
algorithm format.
& Calculate by QxMD [38]. A medical calculator and deci-
sion support tool, with algorithms in several medical
specialties to impact diagnosis, treatment or determining
prognosis. These tools are developed by a collaboration of
clinician experts from diverse backgrounds.
& ACC Pocket Guides [39]. A support tool set from the
American College of Cardiology Foundation with ma-
terial adapted and enhanced for Android devices from
the full text version of ACC/AHA Practice Guidelines.
It contains several tools and calculators, but they have
to be downloaded by the user “manually”. Actually,
the app solicited to download another app called
Skyscape [40], which is the one to be used for the
user, with the resources obtained from ACC Pocket
Guides.
& NeuroMind [41]. Application for neurosurgery with 24
items of interactive clinical decision support and 113
scores that are relevant for neurosurgical practice. It has
even anatomical images for explanation to patients and a
safe surgery checklist developed by the WHO. The app is
supported for several important associations in the field of
neurosurgery.
& 2013 Medical Diagnosis TR [42]. An annual guide to all
fields of internal medicine intended to accelerate the
clinical decision making delivering at-a-glance summa-
ries of the signs, symptoms, epidemiology, etiology, and
treatment options for more than 1,000 diseases and dis-
orders. Although the app is free, it offers to the user a
free trial of 1 day, being forced to pay for its use after the
trial.
The analysis of features is shown in Table 2 whereas Fig. 4
shows some snapshots of these applications.
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Discussion
Findings
Several interesting findings can be extracted from the re-
sults presented previously, especially from the results ob-
tained from the commercial review. Nevertheless, focusing
on the literature review, it can be seen that there have been
a significant growth in the number of the researches in
mobile clinical decision support systems in the last 2 years,
with almost half of the papers found (43/92) being pub-
lished in these years.
The majority of the papers found are about the design,
development and implementation of innovative and new mo-
bile clinical decision support systems and their analysis. How-
ever, there are other types of papers less common, those about
the effectiveness of these systems, systematic reviews of the
ones being used currently and those talking about the possi-
bilities, advantages and contributions the implementation and
expansion of these tools can achieve.
In the analysis of the papers selected, we can obtain
some findings about the systems that are developed. First
of all, almost every mobile application found was intended
for research purposes, not being available in commercial
stores. All of them used a smartphone (as the only hard-
ware used in some cases or as a part of a more complex
system in others), which means that the smartphone is the
tool the researches focus in their works. However, the
purposes and the medicine fields these systems are intended
for are very different, existing, as we could see, systems for
predicting ESKD in patients with IgAN disease and others
for monitoring the blood pressure of a patient to calculate
the CVD risk applying the SCORE method, for example.
This fact shows that mobile CDSS can be applied to a
wide range of fields of the modern medicine. Furthermore,
we have seen that their reliability and acceptance among
the medicine professionals are very high.
Focusing now on the commercial applications, the first
thing that attracts our attention is that it seems that there are
manymore apps for Android than for iOS, as there were found
171 apps for Android and only 21 for iOS. This difference is
explained by the use of different search engines in the com-
mercial stores of Google play and the App Store. In light of the
results returned by the same search strings it is clear that the
engine of Google play is less strict than the one from the App
Store.
The most common medical field of these commercial apps
is general medicine, involving all the specific fields of health
care. Other fields with many clinical decision support apps are
drugs prescribing and contraindications, emergencies services
tasks and pediatrics. Cardiology, oncology, psychiatry, neu-
rology and infectious diseases (with special attention to HIV)
are among the specialties with more apps. Developers focused
their works on these medical specialties since some of the
most important causes of death (ischemic heart disease, HIV/
AIDS and trachea, bronchus and lung cancers), one of the
most prevalent diseases (unipolar depressive disorders), and
some of the most disabling diseases (Alzheimer, Parkinson)
are included in these specialties [43].
As it can be seen in Fig. 3, almost half of the applications
for clinical decision support are developed for medical spe-
cialists, such as the mentioned previously. This is logical
since, despite the fact that general medicine is the focus of
many apps, the majority of them are focused on specialties, as
it is shown in Table 1. Excluding specialists and physicians,
the rest of the applications are similarly distributed in apps
exclusively dedicated for nurses, pediatricians and emergen-
cies staff.
From the analysis of the sample of commercial apps,
several similarities and differences can be observed. Although
the apps studied are designed for different fields and different
types of users, all of them have similar interfaces, being quite
simple and based on the use of text. Only one has a more
complex interface and it is due to the fact that it is a part of
Table 2 Analysis of features of the sample of commercial apps selected
Pediatric Clinical Pathways Calculate by QxMD ACC Pocket Guides NeuroMind 2013 Medical Diagnosis TR
Rating 4.7 4.6 4.0 4.2 4.0
Class Pediatrics General medicine Cardiology Neurosurgery Internal medicine
Internet requirement Yes No Only login No Both possibilities
Form of decision support Algorithms, tables Calculators by steps Tables, logical trees Calculators Text
Data visualization Text, algorithms Text, numbers Text, tables Text, images Text, images
Context awareness No No No No No
Login No Yes Yes No No
Frequency of use Occasional Occasional Occasional Occasional Occasional
Interface Simple Simple Complex Simple Simple
Public Pediatricians Any professional Cardiologists Neurologists Any professional
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Fig. 4 Snapshots of a Pediatric
Clinical Pathways, bCalculate by
QxMD, cACC Pocket Guides, d
NeuroMind and e 2013 Medical
Diagnosis TR
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another bigger application. Similarly, all of them do not offer
any context awareness such as location, language or user,
although some of them require a login. The frequency of use
depends on the level of knowledge of the user and the difficuly
of the medical issue to cover. Typically, these systems are used
for very difficult questions, for training of novel doctors and to
review routinary cases semi-automatically.
Among the differences, the Internet requirement is proba-
bly the most clear. Some apps need the use of the Internet for
showing the information, others only need it for login or doing
the first download of information and there are those which
are stand-alone applications and do not use the Internet at all.
Even there are apps that let the user choose the method to
access the information. Referring to the form of showing the
decision support tools there are also differences: some use
algorithms in form of logical trees, some have calculators
which use the data introduced by the user and even only text
is used in other apps. These tools also influence the data
visualization, which can vary from tables to images, always
complementing text.
Recommendations
After checking the existing mobile applications for decision
support and trying a sample of them, we have some recom-
mendations to give to the developers of these types of appli-
cations. First of all, it is important to avoid using only text for
their interfaces. The feeling of these sorts of applications is
similar as reading a book. Developers must take advantage of
the interactivity the smartphones offer in order to develop a
decision support app with more involvement by users. It is
useful to use images and logical trees of decision, but we
found the best choice the one used in [38], which is using
algorithms to assist the diagnosis in several steps. In each step
the user has to input some data to finally reach the possible
solution. It is also recommended to make clear the steps and
the data introduced by the user.
Another aspect to take into account is the time the user
requires to interact with the CDSS. In order to reduce it, it is
worth to integrate mobile CDSS with EHR or apply incre-
mental forms, in order to reduce the manual input of values.
This principle should be mandatory to applications focused in
routinely medical problems, but optional for difficult
problems.
Another recommendation to developers is to develop
apps in the medicine fields with less apps of this type, such
as endocrinology, nephrology or ophthalmology, or even
focus on common diseases with difficult diagnosis. This
way, more specialists and physicians can take advantage of
the use of these systems and developers can cover an
unexplored field in this type of applications, resulting very
profitable.
Conclusions and future work
The number of mHealth apps with CDSS functionalities has
been speedily increased during the last 2 years. Several re-
search lines for different medical specialties are opened and
many commercial apps for mobile decision support systems
are available. Besides, it seems that the research has been
increasing in the last years, proving the good reception and
acceptance that these systems have obtained from the medical
world.
However, there are many applications released focused
only on the information contained but not on the interface or
the easiness of use and search by the users, which impoverish
the experience and, therefore, the valuation from them.
For future work several things can be done. A mobile app
for clinical decision support can be developed, focusing on a
medicine field with little research and following the recom-
mendations exposed previously. Another line of work can be
the evaluation of the Quality of Experience (QoE) from the
users of some of these applications using the tools obtained in
[44] to write a document with the main steps to be followed by
the developers of these types of systems. The purpose of the
document would be the design of high quality applications,
meeting the users’ expectations.
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The introduction of mobile devices in health care has facilitated the creation of a new 
software industry of health care apps for chronic conditions, such as heart diseases. Due to 
the lack of self-management apps, the authors created one, called Heartkeeper. The process 
of its creation is divided into three phases. The first one is a market study and the design of 
the app, the second one is its implementation and the final phase is its verification. The 
interface created offers an application based on image buttons, hence, easy to use from the 
first time. The response times of Heartkeeper operations are of the order of milliseconds. 
The app was successfully tested in 5 devices with different screen sizes (from 3.5 to 10.1 
inches), obtaining a good technical evaluation from the users. Heartkeeper has proved to be 
a good app.  
Keywords 
App, Heartkeeper, heart diseases, mobile application, self-management 
Page 2 of 24
http://mc.manuscriptcentral.com/HIJ
Health Informatics Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
2 
 
Introduction 
Non-communicable diseases (NCDs) are the leading cause of death in the world. Of the 
56.8 million deaths in 2008, 36 million were caused by NCDs according to a study from the 
World Health Organization (WHO). Specifically, chronic diseases are quite important part 
of this group, being cardiovascular diseases (CVDs) the deadliest diseases with 17.3 
million victims in 2008, which represent 30% of all deaths worldwide. Additionally, 
despite the advances in health care, these numbers are estimated to increase to more than 23 
million individuals by 20301-5.  
Among the CVDs, heart conditions and heart diseases have an important weight in the 
burden of deceases. Particularly fatal is coronary heart disease (or ischemic heart disease), 
responsible for 7.25 million deaths in 2008, which, in conjunction with other cardiac 
conditions, such as hypertensive heart disease and inflammatory heart disease, contributes 
with a significantly high percentage to the global burden of deceases5-6. However, not only 
the deaths caused by a disease are important, but also the disabilities created. Only coronary 
heart disease caused a total of 62,587 million Disability-Adjusted Life Years (DALYs) in 
2008, which give an idea of the huge number of DALYS that heart diseases provoke. These 
disabilities mean more hospitalizations and more medical interventions, which influence 
directly the costs of the health care systems, not to mention the economy costs that the lost 
productivity of the affected causes. Only in the United States, these global costs derived 
from the heart diseases were estimated at $448 billion in 20087-8. 
The advent of information technology in health care and the incredible expansion of the 
market of smartphones and tablets have created a new mobile health applications software 
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industry. These new health apps are continuously increasing: focusing only on the most 
important apps stores, there are more than 11,000 apps in the category of Health & Fitness 
and almost 5,000 in Medicine in Android’s Google play; and almost 20,000 apps in Health 
& Fitness section and more than 14,000 in Medicine in Apple’s App Store9. Focusing only 
on cardiology, 439 apps for iOS and 271 for Android were found in 2013 in a previous 
work of the authors5. 
Since heart diseases cause so many deaths and disabilities, it is obvious that there are many 
health apps focusing on these illnesses. Many of them are designed for patients’ use, such 
as those for monitoring the heart rate in order to detect abnormal rhythms and warn the 
user10, others for cardiac rehabilitation11, some for resuscitation in case of heart infarction12, 
and even those for auto-diagnosis13, among other types. There are also apps for health care 
professionals, such as those who must continuously monitor the patients14, those that use 
mobile phones in order to assist the professional in their decisions15, or even some who use 
smartphones for phonocardiography applications to evaluate the cardiovascular function16. 
Summing up, there are many apps in cardiology developed for different objectives and 
proved to influence positively on chronic diseases in general and heart diseases in 
particular2,17-18. However, the authors identified a lack of apps for self-management of heart 
diseases and conditions5, deciding to create one with this purpose, being the aim of this 
paper to present this app called Heartkeeper, showing the outcomes of its design, its 
development and its verification and acceptance by the users. 
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Methods and Procedures 
The global creation process for Heartkeeper can be divided into three phases. In the first 
phase, the authors discussed and obtained the design issues that the app must perform, such 
as the functional requirements and the general concept of the app. Once the design is 
concluded, the second phase, the implementation, can start. This phase was carried out as 
an iterative process until the app was refined. When a final version was reached, the third 
phase, the verification, started. 
Market Study and Design 
Before thinking about the design of the application to be developed, it was essential to 
research about the existing applications and systems in the cardiology field. This work was 
finished in July 20135 with the following main findings: A total of 710 relevant apps were 
found in the most important commercial app stores (271 for Google play and 439 for App 
Store for iOS); The majority of the applications found were designed for general users 
(affected or not) and health care professionals, being the distribution quite similar: 300 apps 
for general users (116 in Google play and 184 in the App Store) and 282 for professionals 
(112 in Google play and 170 in the App Store); The most common apps are heart rate 
monitors, calculators and predictors, informative guides, apps for assisting the ECG 
interpretation, apps with news and blood pressure trackers. One of the more striking facts 
was finding only one app for the heart condition management, aimed only to individuals 
with heart failure risk. 
In light of these results, it was decided to create an app for self-management of heart 
diseases while at the same time broadening the scope of the diseases assessed: from the few 
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usually tackled by other apps to including the most common of them based on the 
experience of one of the authors, cardiologist for more than 25 years. These diseases are 
ischemic heart disease, valvular heart disease, hypertension, and auricular fibrillation. Other 
important aspects that can influence heart health were included, such as the link between 
heart and pregnancy, heart and physical activity, and heart and diabetes. 
The app is divided into three sections: 
• An informative section with medical information that will help the patients to 
understand their disease, its symptoms and its treatment; and a patient guide in 
order to inform the users about best practices, prohibitions and life style they should 
adopt in order to improve their condition. 
• A section to record the user’s activities (good and bad for their conditions) and 
health measurements in order to act in consequence with them. Examples of these 
activities are rehabilitation, physical activity or excesses (in alcohol or food intakes, 
for example), whereas typical measurements are blood pressure, glucose or 
cholesterol. 
• A section for registering the users’ medications and the times when they should be 
taken, offering the possibility to set reminder alarms. These intakes should be 
registered in order to create a daily record stored in the calendar. 
Implementation 
Several operating systems were available for the implementation of the app: Apple iOS, 
Google Android, Microsoft Windows Phone OS, BlackBerry OS and Symbian. Android 
was selected as it is the most extended worldwide19, is open source and, additionally, there 
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are many tools and aid for the development of apps in this platform. Specifically, the tool 
used for the development of Heartkeeper was the Android Software Development Kit 
(SDK), which includes the Eclipse Integrated Development Environment (IDE) with built-
in Android Development Tools (ADT). 
Another important issue in the implementation phase was the security and privacy the app 
must offer, since the data used by the app (personal health data) is very sensitive20. This 
issue was considered very carefully by the authors and they studied the current laws about 
security and privacy applied to mobile health apps in Europe and the United States in order 
to fulfil the requirements exposed there. Hence, at the first launch Heartkeeper shows a 
disclaimer and information about the app and the treatment of data it does, along with an e-
mail address for contacting the authors. 
About the protection of the introduced data, it was decided to implement the data storage in 
the device itself rather than in a server or in the cloud. This implementation provides 
important advantages: the data will not circulate through Internet connections, avoiding 
external attacks typical of wireless links; since the storage is not in the cloud, illegitimate 
access to the data through Internet is also avoided; the only method to access the data is 
through the mobile device, so the only way to obtain the information is by stealing the 
device. In addition to these security motives, there is another more functional, which is the 
continued access to the app, even when there is no Internet connection available, quite 
useful for those devices with only Wi-Fi connection or for people who live in rural areas 
with no 3G coverage9,21. Additionally, the most sensitive data of the user was encrypted by 
a password-based algorithm that uses 256-bit SHA (Secure Hash Algorithm) techniques 
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with random data input that adds additional security, in order to make those data 
inaccessible in case of losing the device or if it is stolen. 
The authors were also especially careful with the implementation of the interface, as it has 
been proved that the interface design and its user-friendliness is essential in order to attract 
potential users9,22. It has to be simple, intuitive even at first use but also complete, which 
sometimes can be very difficult to achieve. 
The framework of the app is shown in Figure 1. Two layers are shown: on one hand the 
different modules with thei  submodules and, on the other, the services and libraries used in 
each module (or submodule).  
Figure 1. Framework of Heartkeeper. 
Verification 
The verification step was divided into two phases. The first was the testing phase, 
consisting in systematic and exhaustive procedures with Heartkeeper, executing all the 
operations permitted by the app in several devices with different screen sizes. These 
devices are the following: Samsung Galaxy Mini GT-S6500 (3,5 inches), Samsung Galaxy 
S SCL GT-I9003 (4 inches), Sony Xperia Z (5 inches), Google Nexus 7 (7 inches) and 
Samsung Galaxy Tab 3 (10.1 inches). In this phase the response times of the most time-
consuming operations of the app were also evaluated in all the mentioned devices in order 
to verify that Heartkeeper is a sufficiently fast app independently of the device used. This is 
due to the low computational complexity of Heartkeeper, with the exception of the 
encryption / decryption of the personal data stored, which is the most resource-consuming 
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operation. The remainder operations are mainly the generation of the graphics (displays, 
buttons, lists, texts, calendars, etc.) and the saving/loading data to/from the database, being 
those the basic operations that the majority of Android apps usually perform. 
The second phase is the app evaluation performed by its users. Heartkeeper was installed in 
the mobile devices of 16 common smartphone users in order to use it for one month, some 
of them with heart diseases, such as a murmur or hypertension. These volunteers were 6 
women and 10 man, all of them Caucasian, with an age of 28-40 years old. All of them 
were contacted by the authors and accepted to participate in the evaluation of Heartkeeper. 
Firstly, they were gathered and the steps of the evaluation were explained to them. Then the 
authors sent them the .apk file of the app by e-mail in order to be installed in their devices. 
They used it for a month, and later on, they answered some questions regarding several 
technical aspects about the application. The questionnaire and feedback collection was don 
through Google Drive. The questions are shown in Table 1 and the majority of them use the 
Likert scale being possible the following answers23: 1. Strongly disagree, 2. Disagree, 3. 
Neither agree nor disagree; 4. Agree; 5. Strongly agree. Question 8 is the only one that uses 
free text. 
Table 1. Questions used to evaluate Heartkeeper. 
Results 
Heartkeeper appearance 
Heartkeeper has got a main screen that shows several buttons that connects the different 
sections of the app. A screenshot of this menu is shown in Figure 2a whereas Figure 2b 
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shows a screenshot of the section for storing a medication and its doses. Figure 2c and 
Figure 2d show screenshots of the calendar of activities and the graphs generated in this 
case for the registers of pulse, respectively. 
Figure 2a. Screenshot of the main page of Heartkeeper. 
Figure 2b. Screenshot of the creation of a medication register and its doses. 
Figure 2c. Screenshot of the calendar of activities. 
Figure 2d. Screenshot of the graphs generated for the registers of pulse. 
Response times 
As mentioned, Heartkeeper has been tested in several ways. One of the tests performed was 
a measure of the response times of the application when executing different actions. This 
measure is important since the majority of app users do not tolerate launch or waiting times 
of more than 2 seconds according to a survey from Compuware22. Hence, it is totally 
necessary that the app is launched in less than 2 seconds, and every section is reached 
almost immediately. Table 2 shows the measure of response times in nanoseconds (ns) 
when performing different actions. The measures indicated are the mean value of 10 
measures for each action. 
Table 2. Mean times (ns) of a total of 10 measurements of some operations with 
Heartkeeper. 
Users were also asked about their devices and app performance in them in order to verify 
that the response times remain good in older devices. Answers show that almost every 
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operation was reasonably quick in old devices, except some specific operations, such as the 
encryption/decryption of the personal data and the drawing of the calendar when many 
medicines intakes were stored. In this operations, the response times in the oldest devices 
(LG L3 or Samsung Galaxy mini GT-S5570) were of about 4 or even 5 seconds, which are 
considered long times. In the case of the encryption/decryption operations, the authors 
prefer not to change the algorithm because they think that the security is more important 
than an addition of 2 or 3 seconds to the response time. In the case of the calendar, the 
authors are currently revising this part trying to improve its performance. 
Evaluation of the users 
As indicated before, Heartkeeper was tested by 16 different users for a period of one month 
and their opinions were collected through 6 different questions. Some values of the 
opinions obtained for each question using Likert scale (questions 1 to 5) are shown in Table 
3. 
Table 3. Statistical values obtained from the opinions of a sample of 16 users. 
Discussion and Conclusions 
In this paper the process of design, creation, implementation and testing of an app for the 
self-management of heart conditions have been explained. The essential steps an app 
developer should always do are the following. 
The first step was developing a market research to know the existing apps for cardiology in 
order to see possible opportunities or deficiencies that can be covered. This is probably the 
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most important step for the creation of a successful app. After this, the following phase is 
thinking the type of the app, its functions and design. Once the app is totally designed, the 
next step is its implementation, thinking thoroughly in which operating systems will the 
app be available (if not have been thought before in the design phase), since this decision is 
crucial for the success of the app. Is in this phase where the authors should think about 
security and privacy mechanisms that the app must implement according to the current laws 
of the countries in which it will be released20. Finally, it is very important to test and 
evaluate the app in order to fix errors and wrong behavior in different devices in order to be 
sure that the final version released will be totally operative without errors. It is also 
recommended to make a technical evaluation of the app by a sample group of users in order 
to obtain their feedback and be able to improve it before the release of the app. 
While developing Heartkeeper, the authors were especially careful with the appearance of 
the app, as it can be observed in the screenshots of Figure 2. This is important since users 
are fond of attractive, intuitive and simple interfaces. The authors tried to reduce 
explanations and irrelevant texts when possible, obtaining as a result a clear application 
easy to use at first time based on image buttons. 
Focusing on the response times of Heartkeeper, it is shown in Table 2 that the launch of the 
app takes about 2 milliseconds in the worst case (the oldest mobile device), much less than 
the 2 seconds indicated previously. The most time-consuming operation is the 
encryption/decryption of the personal data of the user, obtaining 2.2 and 2.3 seconds 
respectively with the oldest device, being less than 1 second in newer devices. Since these 
operations are only carried out occasionally, it can be concluded that Heartkeeper offers 
good response times in the majority of devices, which are excellent in the newest ones, 
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taken into account even the encryption/decryption operations. However, in old devices the 
performance of Heartkeeper is not optimum, as the response times of the 
encryption/decryption operations add up to 5 seconds. Nevertheless, the importance of the 
users’ personal data security trumps a few seconds delay, so the current algorithm was kept. 
Finally, analyzing the results of the technical evaluation by a sample of users of 
Heartkeeper, the following conclusions can be obtained: In general, the app is positively 
valued by the users, always over the mean value (3) in all the questions. However, there are 
aspects less valued than the rest, such as the intuitiveness of the interface or the attraction 
of the design. On the other hand, the security and protection that Heartkeeper offers are the 
most valued aspects of the users, as much as its response times and its user-friendliness. 
For future work there are several opened lines. It can be possible to improve Heartkeeper 
using the results of the users’ evaluation, for example making the interface more intuitive, 
which was the aspect that obtained the worst evaluation, as mentioned. These 
improvements can be implemented uploading an update of the app. Other option is to add 
new services to the app, such as including a function to pair an external heart pulse monitor 
by Bluetooth in order to obtain data in real time, or including a tool for assessing the risk of 
suffering a heart disease or condition. These new functions can also be added by an update 
of Heartkeeper. Finally, the authors will perform a medical evaluation of the use of 
Heartkeeper in a sample of heart disease patients in order to obtain the improvements that 
their health can experience with the inclusion and use of the app on daily bases. 
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Screenshot of the main page of Heartkeeper.  
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Screenshot of the creation of a medication register and its doses.  
67x112mm (300 x 300 DPI)  
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Screenshot of the calendar of activities.  
67x112mm (300 x 300 DPI)  
 
 
Page 21 of 24
http://mc.manuscriptcentral.com/HIJ
Health Informatics Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Screenshot of the graphs generated for the registers of pulse.  
211x352mm (96 x 96 DPI)  
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Question Description 
1 Is the design of the app attractive? 
2 Is the interface intuitive? 
3 Is the app easy to use? 
4 Do you feel that the app protects your security and privacy? 
5 Are the response times of the app fast enough? 
6 Would you change/improve/delete any aspect of the app? 
Table 1. Questions used to evaluate Heartkeeper. 
 
Page 23 of 24
http://mc.manuscriptcentral.com/HIJ
Health Informatics Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 Samsung GT-S6500 Sony Xperia Z Samsung Galaxy Tab 3 
Launch 211.826.000,24 110.205.078,20 56.673.023,80 
Encryption 2.200.953.999,60 788.012.696,50 728.293.863,35 
Decryption 2.319.032.666,40 708.050.537,40 650.942.188,80 
Activity DB writing  49.139.777,80 100.712.367,34 72,071391,29 
Activity DB reading  25.261.667,00 44.937.134,50 6.549.713,25 
Medicines DB reading 
with 9 registers 
15.697.500,95 14.175.415,20 10.826.702,42 
Blood test graph 
drawing with 11 
registers 
122.416.667,26 258.453.369,65 59.414.637,15 
Table 2. Mean times (ns) of a total of 10 measurements of some operations with Heartkeeper. 
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Minimum 
value 
Average value Maximum value Standard deviation 
Question 1 3 3.8 5 0,8618916074 
Question 2 2 3.46666 5 1,060098827 
Question 3 3 4.13333 5 0,6399404734 
Question 4 2 4.2 5 1,014185106 
Question 5 2 4.13333 5 1,060098827 
Table 3. Statistical values obtained from the opinions of a sample of 16 users. 
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Abstract The rapid spread of smartphones and tablets in the
last years has created a new software industry whose fast
growth has propitiated numerous low-quality applications to
be revised and improved. The main aim of this paper is to
develop a tool to assess the Quality of Experience (QoE) of
mobile Health (mHealth) applications in order to improve the
quality of the existing apps and the ones to be released. Firstly,
a review of the applications of mHealth has been done in order
to obtain a general classification. Secondly, the tool for mea-
suring the QoE is developed in the form of a survey with the
help of psychologists. Finally, this tool is evaluated using a
sample of applications selected with the aid of the classifica-
tion obtained. A survey with 21 questions using the Likert
scale and destined to users has been successfully created, and
its evaluation has been positive, resulting in a goodmethod for
measuring the QoE of the different features that the applica-
tions in the field of health care usually have. The tool created
can be very useful for developers in order to assess the quality
of their health care apps, indicating their positive aspects and
the ones which must be revised and improved, avoiding the
releasing of low-quality apps.
Keywords Evaluation . Likert . mHealth . Quality of
Experience (QoE) . Survey
Abbreviations
QoE Quality of experience
mHealth Mobile health
MOS Mean opinion score
Introduction
The most recent advances done in the last years in wireless
communications and mobile technologies have propitiated
new ways of providing health care [1–3]. Hence, it is even
possible to contact the doctor without going to the health care
center. This is conceivable thanks to the recently created
smartphones and tablets and their incredibly fast spread, es-
pecially in developed and developing zones. In numbers, there
are more than 6 billion mobile subscriptions andmore than 1.7
billion mobile phones sold only in 2012 of which 712.6
million are smartphones [4]. Regarding tablets, there are esti-
mated 117.1 and 165.9 million shipments in 2012 and 2013
respectively [5].
This outstanding distribution of smartphones and tablets
has propitiated the creation of a new branch in the industry of
software, the development of mobile applications or apps,
understood as programs for smartphones and tablets which
can be downloaded directly from a commercial store in the
device. This new industry has grown rapidly to the point that
there are currently more than 800,000 apps in each of the two
most important commercial stores [6] in terms of market share
[4, 5, 7], which are Google play [8] and Apple iTunes (or App
Store) [9].
The problem with the quick growth of this business is that
there is a huge number of apps with very low quality in many
aspects due to the desire of the developers to be the first in
designing and releasing an app to cover a certain unexplored
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field in order to attract the highest number of users possible. In
many cases, this results in the releasing of incomplete applica-
tions, apps withmany errors or apps with important deficiencies
for the user’s experience. In order to mend this, it seems
necessary the use of tools for assessing the quality of the apps
before releasing them in the market or even for improving the
existing ones. Furthermore, the best practice in this case is to
consider the users’ feedback or Quality of Experience (QoE),
since they are the ones who are going to use and pay the
applications. Thus, QoE can be defined as an assessment of
the human experience when interacting with technology and
business entities in a particular context [10].
The QoE measurement has been used for several aspects:
firstly it was created for telecommunication networks [10–12]
and then it was incorporated to other ambits such as health
care [13] and mobile systems [14] and applications [15]. The
aim of this paper is to develop a tool to assess the QoE of
mHealth applications in general, based on the previous stud-
ies. To achieve this, a general review of mHealth applications
has been carried out in order to achieve a classification and,
this way, be prepared for the design of a tool for obtaining the
QoE. Additionally, this tool has been used with a sample of
mHealth apps and the collaboration of patients and health care
staff. As a result, we obtained the evaluation of the different
characteristics representative of medical apps, which can be
very valuable for developers.
The remainder of this paper is organized as follows. Next
section elaborates about the methods conducted in this work
and later the results of the study are shown. Both sections are
separated into three subsections: in the first the classification
of mHealth applications obtained is shown, the second shows
the tools obtained for assessing the QoE, and the third sub-
section shows the results of their evaluation with a sample of
apps. Lastly, the last section presents the discussion of the
results.
Methods
As it is said before, the methods followed can be divided into
three parts, reflecting the procedures used in each part of the
study. In the first part, a research to determine the types of
mHealth applications was conducted in order to get a classifica-
tion. The second part is about the development of the tools to
assess the QoE of the apps. Finally, in the third part, these tools
are used with a certain number of apps in order to evaluate them.
Classification of mHealth apps
For the evaluation and classification of the existing mHealth
applications, three reviews have been done. This way, a re-
view of applications for research has been carried out in the
following systems and databases: IEEE Xplore, Scopus,
PubMed and Web of Knowledge; aimed to find general
mHealth applications and systems. A review of commercial
applications was also developed. For this study, some com-
mercial app stores were visited: Google play [8], Apple iTunes
[9] (or App Store) and BlackBerry World [16]. Finally, a
search on Google of open source applications was carried out.
With the data collected from these reviews, the authors
convened to make a classification of the mHealth applications
trying to make it in the most general way possible.
Development of the QoE tools
For the development of the QoE tools it was decided to
measure the QoE using the metric Mean Opinion Score
(MOS), traditionally used in telephone networks to obtain
the human user’s view of the quality of the network. In this
case, it will be used as a subjective measure that quantifies the
perceptual effect of different forms of degradation of the
service from the point of view of the end-users [17, 18].
Table 1 Applications selected
for the evaluation of the QoE tool Aim public Type of application Name of the application
Patients Treatment of diseases mobiCeliac (Scanner) [19]
Meds On Time [20]
SCORE Cardio Test [21]
Health awareness Hearing tests [22]
Instant Heart Rate [23]
Accupedo Pedometer [24]
Content diffusion Reanimación Cardiorespiratoria [25]
Doctoralia [26]
Prospectos [27]
Health care professionals Aid for professionals DAS28 - Rheumatoid arthritis [28]
Anesthesiologist [29]
Valores de laboratorio [30]
MedCalc 3000 [31]
9976, Page 2 of 8 J Med Syst (2013) 37:9976
Fig. 1 Diagram with a general classification of the mHealth applications
Table 2 Survey to measure QoE
Content quality
1 Does it make the function that you expected? 1 2 3 4 5
2 Can you do the same without the application? 1 2 3 4 5
3 Does the application receive updates regularly? 1 2 3 4 5
4 Do you think the data are reliable? 1 2 3 4 5
5 Can you identify with this application health problems? 1 2 3 4 5
6 Do you have possibility to send information about your status to your doctor? 1 2 3 4 5
7 Do you have better quality of life by using this application? 1 2 3 4 5
Security
10 Do you think that this application has appropriate security methods to protect data that are introduced? 1 2 3 4 5
11 Do you think that the data obtained with this application are sufficiently protected? 1 2 3 4 5
Ease of use
12 Do you find what you need? 1 2 3 4 5
13 Do you think that the traditional method used so far is more difficult or does not exist? 1 2 3 4 5
14 Is this application useful for monitoring the disease? 1 2 3 4 5
Availability
15 Do you have the guarantee of access to the application and its data at any time? 1 2 3 4 5
Performance
16 Do you think you might have a more optimized performance? 1 2 3 4 5
17 Do you find some kind of error or problem while using the application? 1 2 3 4 5
Appearance
18 Do you find adequate the appearance of this application? 1 2 3 4 5
19 Would you change or add something from this application? 1 2 3 4 5
Learning
20 Do you think that the time for learning the use of the application is appropriate? 1 2 3 4 5
Precision
21 Do you think the calculations done by this application are correct? 1 2 3 4 5
J Med Syst (2013) 37:9976 Page 3 of 8, 9976
The features of the applications that are measured are the
following:
& Content quality: users’ perception of the quality of the
content offered by the mobile application.
& Security: Data security level that the mobile application
provides.
& Use: Determines the difficulty of managing the applica-
tion by the user.
& Availability: Guarantee of access to the information at any
time.
& Performance: Errors, unexpected stops of running, re-
sponse time of the application.
& Appearance: Describes the general look of the product. It
is important to state that it is not the detailed design of the
interface, only the purpose of the external interface of the
application.
& Learning: Specifies the ease to learn how to use the
application.
& Accuracy: Quantifies the accuracy of the calculations of
the application.
The method for performing the QoE measurement consists
in surveys that cover the previous aspects, to be filled in by the
professionals or patients in order to obtain the evaluation.
These surveys have been developed with the collaboration
and advice of psychologists.
Evaluation of the QoE tools
Once finished the surveys for the QoE measurement, the next
step was to examine them with several mobile apps in order to
evaluate their usability. For this purpose, it was decided to use
apps from the same category of the classification settled;
hence the commercial category was chosen, since it is the
field where the use of these tools can provide the best results.
We also decided to use the most used commercial store [7],
which is Google play.
For the selection of the apps, we decided to choose a
representative sample of them, typical of the subcategories of
the classification obtained. We focused on apps for patients,
selecting 3 for each subcategory, but we also wanted to evaluate
a group of apps for health care professionals. In addition to this,
it was also considered in this selection the number of down-
loads and the rating of the users. The sample of apps used for
the evaluation of the QoE surveys is shown in Table 1.
To conduct the evaluation using the developed tool, col-
laborations of patients and medical staff were needed. In fact,
a total of 28 doctors and 112 patients collaborated filling in the
surveys provided.
Once finished the evaluations, the results of the surveys
were introduced in a powerful program for statistical calcula-
tion, IBM SPSS Statistics [32], in order to obtain the statistical
results of all the surveys.
Results
This section consists of three subsections corresponding to the
subdivisions of the Methods section. In the first part, the
classification obtained for the mHealth applications is shown;
in the second, the tools of QoE are presented; and the last part
shows the statistical results obtained for the sample of apps
selected in the evaluation of the QoE tool developed.
Table 3 Survey to measure QoE
of not finished applications
(research)
Content quality
1 Would you use the app if developed? 1 2 3 4 5
2 Do you think that in the future it can be useful to society? 1 2 3 4 5
3 Do you think it will improve the quality of life of the users? 1 2 3 4 5
4 Will this future application help in treating diseases? 1 2 3 4 5
Table 4 Results of QoE in the
categories of patients and
treatment of diseases
Treatment of diseases (Patients) mobiCeliac (Scanner) Meds On Time SCORE Cardio Test
Average Deviation Average Deviation Average Deviation
Content 2.9429 0.3996 3.2571 0.3857 3.2143 0.2357
Security 4.2 0.7528 3.65 1.0814 4.5 0.5271
Use 3.7 0.6564 4 0.56656 3.7667 0.58899
Availability 3.9 1.1005 4.8 0.4216 4.2 0.63246
Performance 3.3 0.97753 3.5 0.70711 2.95 1.09163
Appearance 3.85 0.62583 3.6 0.5164 4.05 0.55025
Learning 4.3 0.82327 4.6 0.69921 4.8 0.42164
Precision 3.7 1.56702 4.4 0.84327 3.7 1.05935
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Classification of mHealth apps
Figure 1 shows the classification obtained for the different
types of mHealth applications. It was decided to divide this
diagram in these categories because, after analyzing the
existing offer of applications, we thought it was the most
optimal way to classify all of them.
Development of the QoE tools
The QoE is a measure from end to end of the functioning of
the application, carried out in the service layer and from the
perspective of the user, which indicates the degree that the
application meets the needs of the user [17].
Table 2 shows the survey designed for measure the QoE of
mHealth applications. The way of evaluation is carried out
through the Likert scale: 1. Strongly disagree; 2. Disagree; 3.
Neither agree nor disagree; 4. Agree; 5. Strongly agree [33].
In the case of applications not finished, such as applications
for research under development, the survey centers only on
content quality, being in this case as Table 3 shows.
Evaluation of the QoE tools
The results of the application of the survey in the different
categories are shown in Tables 4, 5, 6 and 7. Figure 2 shows
snapshots of two of the applications used for the evaluation,
SCORE Cardio Test and Doctoralia.
Discussion
Some interesting conclusions can be obtained from the anal-
ysis of the results, especially those extracted from the evalu-
ation of the QoE for the apps selected.
The classification obtained is a general one with three
levels of categories. The first level consists in the types of
applications by their objective sectors, their purpose, if they
are commercial, open source or research applications. The
second level is formed by the types of applications according
to their aim public, which can be patients or health care
professionals. Finally, the third level is related to the types of
applications categorized by their function. Except the block of
Table 5 Results of QoE in the
categories of patients and health
awareness
Health awareness (Patients) Hearing tests Instant Heart Rate Accupedo Pedometer
Average Deviation Average Deviation Average Deviation
Content 3.7 0.82865 3.4 0.4619 3.04 0.4695
Security 4.5 0.5271 4.2 0.4216 4.4 0.8097
Use 3.9667 0.83813 2.6 0.4389 3.93 0.4661
Availability 4.5 0.52705 4.3 0.4805 4.4 0.5164
Performance 2.8 1.3581 3.98 0.59861 2.5 0.97183
Appearance 3 0.4714 3.65 0.52967 3.4 0.39441
Learning 4.8 0.42164 4.5 0.70711 4.7 0.48305
Precision 3.2 1.13529 3.5 0.70711 4.3 0.82327
Table 6 Results of QoE in the categories of patients and content diffusion
Content diffusion (Patients) Reanimación Cardiorespiratoria Doctoralia Prospectos
Average Deviation Average Deviation Average Deviation
Content 3.3333 0.4779 3.3 0.3752 3.5 0.4907
Security 4.75 0.5401 3.9 1.1005 4.5 0.8498
Use 3.7333 0.87206 3.4 0.9532 3.8 0.773
Availability 4.6 0.5164 3.2 1.8135 4.1 1.1972
Performance 2.55 0.72457 3.25 0.63465 2 0.94281
Appearance 3.6 0.5164 3.3 0.58689 3.55 0.49721
Learning 4.3 0.82327 3.8 1.39841 4.6 0.5164
Precision 3.7 0.94868 4 0.94281 4.3 1.05935
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the third level Health awareness and Aid for professionals, the
rest of the blocks are interchangeable among the 3 levels.
Thus, for example, an application for treatment of diseases
can be designed for patients with a commercial purpose; or
can be designed for professionals in a research environment.
This fact shows the generality achieved with these 3 catego-
ries used in the classification.
Focusing on the QoE tools, the method of surveys was the
one selected because it is well-known, rather extended, useful
and with an easy execution, as happens with the Likert scale,
used in numerous tests. The main difficulty presented in the
development of the surveys was obtaining the questions to
cover every aspect of an application without creating too
extended surveys for the users, who can get tired or bored
and, consequently, fill in the survey incorrectly. Hence, we
tried to minimize the questions per feature of the app, trying
always to cover the whole aspect. As a result, a total of 21
questions were obtained, achieving a survey with a normal
time of completion of 1–2 min, short enough not to annoy
the users. Another reason for using the Likert scale is the
possibility it offers for introducing the data obtained in
statistical programs in order to obtain numerical results
suitable to be treated in a statistical way, as it is shown in
Tables 4, 5, 6 and 7.
Table 7 Results of QoE in the category of health care staff and aid for professionals
Aid for professionals DAS28 – Rheumatoid arthritis Anesthesiologist Valores de laboratorio MedCalc 3000
Average Deviation Average Deviation Average Deviation Average Deviation
Content 3.6 0.2108 3.3167 0.3187 3.7 0.46348 3.7875 0.2286
Security 4 0.5774 4.4 0.9661 4.5 0.5271 3.3 0.2582
Use 4.23 0.4172 4.0667 0.1406 4.4667 0.35832 4.325 0.4257
Availability 4 0 4 0 4.6 0.5164 4.35 0.5798
Performance 3 0.4714 3.1667 0.36004 2.5333 0.28109 2.5333 0.17213
Appearance 2.95 0.36893 3.3 0.48305 3.15 0.33747 3 0.3333
Learning 4.7 0.4805 4.7 0.48305 4.7 0.48305 4.5 0.52705
Precision 4 0 4.2333 0.16102 3.9 0.22498 4.1667 0.17568
Fig. 2 Snapshots of (a) SCORE
Cardio Test and (b) Doctoralia
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We now focus on the analysis and discussion of the results
obtained in the evaluation of the survey developed (part 3 of
the Results section). As it can be seen in Tables 4, 5, 6 and 7,
the results found for all the applications studied are similar
excepting some particularities inherent to the apps, what means
that the designed tool obtains trusty and reliable results in order
to measure the QoE. In addition to this, the users were asked
regarding their opinion of the survey and the majority of them
(127 out of 140 users) were positive about it. Thus, we have
confirmed that the survey can be used for assessing the QoE.
Despite the fact that there are not enough data to establish
valuable hypothesis in the general experience of the users in
relation to the different categories of the classification done, we
will try to venture some suppositions related to mHealth appli-
cations. Examining the results, it is simple to see that the best
valued requirements are learning and security whereas the
worst are contents and performance. This means that devel-
opers are more concerned about designing secure apps easy to
use than about the correct running and the content of their apps.
It is worthwhile to highlight the case of the content, as it is
probably the main reason for a user to download an app and,
consequently, the main cause of disappointment if the content
is not the expected. Hence, developers must be careful with
the description of their apps in the commercial stores, com-
posing it in a detailed and clear way. The performance of an
app is another important feature for the feelings of the users.
Facts such as large response times, unexpected stops or
malfunctions of the app are significant reasons for the user
to delete an app forever. As a result, it is essential for devel-
opers to debug and check every possible case of running of
their apps in order to avoid these errors, which can mean not
only the difference between the success or the total failure of
the app, but also the failure and discredit of the developer or
the company as a whole.
It is appreciated from the results that the apps for health
care are very intuitive at first use, important for developers
since, if a user needs large periods of time to learn how to use
an application, he will probably stop using it and start looking
in the store for another app easier to handle. However, this
feature of an app does not seem as important as the previous of
content or performance since the case of learning is not as
critical as the others. The other characteristic with a positive
evaluation from the users is the security, what means that the
data entered in the application or the data the application
generates are not easy to obtain for another person who is
not the owner of the app. The causes for this is that the
majority of these types of applications generate information
that is not stored and, consequently, cannot be found by
anyone; moreover, when the app stores this information, in
general, they have methods to avoid unauthorized accesses
such as user’s authentication and data encryption.
For future work several considerations can be taken into
account. It is possible to develop a mobile app for a specific
aspect of health care and, once finishes, test the QoE of the app
with the tool achieved in order to get the necessary feedback to
obtain, after the required iterations, a product with a positive
evaluation in every aspect. Another possibility is to use the QoE
survey with a sample of apps related to a field of health care
sufficiently big to get trusty and reliable hypothesis about the
most and worst valued characteristics of the apps.
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Abstract 
Currently, many incomplete mobile apps can be found in the commercial stores, apps with 
bugs or low quality that needs to be seriously improved. The aim of this paper is to use two 
different tools for assessing the quality of a mHealth app for the self-management of heart 
diseases by the own patients named Heartkeeper. The first tool measures the compliance 
with the Android guidelines given by Google and the second measures the users’ Quality of 
Experience (QoE). The results obtained indicated that Heartkeeper follows in many cases the 
Android guidelines, especially in the structure, and offers a satisfactory QoE for its users, 
with special mention to aspects such as the learning curve, the availability and the 
appearance. As a result, Heartkeeper has proved to be a satisfactory app from the point of 
view of Google and the users. The conclusions obtained are that the type of tools that 
measure the quality of an app can be very useful for developers in order to find aspects that 
need improvements before releasing their apps. By doing this, the number of low-quality 
applications released will decrease dramatically, so these techniques are strongly 
recommended for all the app developers. 
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Introduction 
In the last years, the world has seen one of the most important changes in the 
technology field: the boost of mobile devices such as smartphones and tablets and 
the creation and incredibly quick expansion of the industry of mobile applications. 
These can be understood as programs for the mentioned mobile devices that can be 
downloaded in the device by using its commercial store. Currently there are more 
than 1.5 millions of apps for the two most important commercial stores [1] in terms 
of market share [2-4], which are Google play [5] and Apple App Store [6].  
Some aspects such as the great success of some well-known apps (Angry birds, 
WhatsApp,), the relatively ease to develop an app, the fact that the development 
tools are free, and the lack of barriers for releasing an app have propitiated that 
almost everyone with minimum IT knowledge can develop and release an 
application [7]. However, there are many apps with poor quality since they are 
developed by people with not enough software development skills or patience. As a 
result, these apps can present errors and bugs, be incomplete, improperly designed 
or with incorrect use of the language [8]. 
For avoiding the release of these low-quality apps, developers should use 
mechanisms to test their apps in the production phase, such as measuring response 
times, trying all the possible actions allowed in the app, or checking its visual aspect, 
among others.  
It is also important to be in line with the usability guidelines proposed for the 
operating systems where the apps are released. Hence, some guidelines with this 
purpose are available to developers [9-12]. Very interesting is the guideline 
proposed by Cruz Zapata et al. [13], obtained from the recommendations to 
developers made by the own Google (for Android) and Apple (for iOS): Android 
Design Guidelines [14] and iOS Human Interface Guidelines [15], respectively. They 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
4 
designed a questionnaire with a total of 13 questions in order to obtain information 
about the style, behavior and structure of the app. 
Another important aspect to have in mind is the use of a tool to measure the users’ 
Quality of Experience (QoE). The authors created one of these tools in a previous 
work [16], specially designed for assessing the QoE of mHealth applications. This 
tool is a survey that uses the Likert scale (1 to 5) in a number of questions that 
involves different aspects, such as content quality, security, ease of use, availability, 
performance, appearance, learning and precision of the mobile app.  
The aim of this paper is to apply the methods mentioned to a mobile app designed 
for Android named Heartkeeper [17], which was developed by the authors for the 
self-management of heart diseases and conditions by the own patients. Therefore, 
the surveys developed by Cruz Zapata et al. and Martinez-Pérez et al. in different 
works will be applied to a real mHealth application in order to evaluate the 
compliance with the recommendations established by Google for Android apps, in 
this case, and the users’ QoE. 
The remainder of this paper is organized as follows. Next section elaborates about 
the methods used in this study, then the results of the research are shown and, 
finally, the discussion and conclusions of the results will be presented. 
Methods 
Description of the app to study 
The app to study is named Heartkeeper, and its purpose is to allow heart patients 
the self-management of their diseases or conditions, assessing the most common, 
which are ischemic heart disease, valvular heart disease, hypertension, and 
auricular fibrillation. It also includes other relevant aspects for the heart health such 
as the relations between heart and pregnancy, heart and physical activity, and heart 
and diabetes. Heartkeeper was developed with the help of an important Spanish 
cardiologist and has the following sections: 
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 A section with medical information about the diseases and the aspects 
mentioned, and a patient guideline about best practices, recommendations, 
prohibitions and life style in order to improve their diseases. 
 A diary with the user’s activities and health measurements that can be 
relevant to his condition. The purpose is to have a control of their actions. 
 A section to record the users’ medication and the hours that they should 
have them. The app allows the creation of alarms to warn them of these 
hours. The intakes are registered and can be seen in a medication diary 
shown in a calendar. 
Heartkeeper was released in October 2014, it is free and it has currently 409 
downloads and a valuation of 4.73/5 with 15 opinions. 
Tool for measuring the compliance with Android guidelines 
The tool used to measure the compliance with the recommendations given by 
Google to Android developers is extracted from the work by Cruz Zapata et al. [13] 
and is based on the layers of web design style, behavior and structure [18]. The tool 
is presented in Table 1. 
Each question is scored as follows: 
 1 point if the answer is positive for more than 70% of use cases of the app. 
 ½ point if the answer is positive for 30%-70% of use cases of the app. 
 0 point if the answer is positive for less than 30% of use cases of the app. 
The method used for applying this questionnaire to Heartkeeper was the direct 
response of the authors of this work once the app was finished, who gathered to 
respond together trying to be as objective as possible. 
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Table 1 Questionnaire for measuring the compliance with recommendations by Google 
Q1. Style 
Q1. 1. Is the writing style simple and informal and is the second person used to talk to the 
user? 
Q1. 2. Are pictures used to explain ideas? 
Q1. 3. Are pre-defined icons used for common actions? 
Q1. 4. Does the app adapt to both horizontal and vertical orientations? 
Q2. Behavior 
Q2. 1. Are the user preferences learned over time? 
Q2. 2. Do the elements react to the user’s gestures by changing color or illumination? 
Q2. 3. Are there confirming messages showing warning information related to actions that 
the user needs to consider? 
Q2. 4. Are there acknowledging messages to let users know that the action they have 
invoked has been completed? 
Q2. 5. Do long tasks show non-stationary activity indicators? 
Q3. Structure 
Q3. 1. Is the app loaded immediately without any splash screen or startup experience? 
Q3. 2. Is the login delayed to allow the user to use a particular functionality first? 
Q3. 3. Are suggested structure patterns used: action/tool bar, tab bar, spinner or navigation 
drawer? 
Q3. 4. Is the navigation consistent when moving between hierarchical screens? 
 
Tool for measuring the users’ QoE 
The tool to assess the QoE of Heartkeeper is the one obtained in a previous work of 
the authors [16] and it is basically a survey that uses Likert scale and covers the 
aspects of content quality, security, ease of use, availability, performance, 
appearance and learning of the app. Two questions have not been used since they 
were not relevant for Heartkeeper. These questions were related to performing 
regular updates, not included since the objective is not to update until obtain 
feedback from the users; and the other question is related to the precision of the 
calculations done by the app, although Heartkeeper does not perform any type of 
calculation. The final survey used is shown in Table 2. 
The methods used to apply this survey are the following: Heartkeeper included a 
button linked to this survey in a Google form [19], and a paragraph motivating the 
users to fulfil the survey, so every user would be able to access it. The period 
available for doing this was from October 2014, when Heartkeeper was released, to 
February 2015 included, a total of 5 months.  
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Table 2 Survey for measuring the QoE 
CONTENT QUALITY 
1 Does it make the function that you expected? 1 2 3 4 5 
2 Can you do the same without the application? 1 2 3 4 5 
3 Do you think the data are reliable? 1 2 3 4 5 
4 Can you identify with this application health problems? 1 2 3 4 5 
5 Do you have possibility to share information about your status to your doctor? 1 2 3 4 5 
6 Do you have better quality of life by using this application? 1 2 3 4 5 
SECURITY 
7 Do you think that this application has appropriate security methods to protect data 
that are introduced? 
1 2 3 4 5 
8 Do you think that the data obtained with this application are sufficiently protected? 1 2 3 4 5 
EASE OF USE 
9 Do you find what you need? 1 2 3 4 5 
10 Do you think that the traditional method used so far is more difficult or does not exist?  1 2 3 4 5 
11 Is this application useful for monitoring the disease? 1 2 3 4 5 
AVAILABILITY 
12 Do you have the guarantee of access to the application and its data at any time? 1 2 3 4 5 
PERFORMANCE 
13 Do you think you might have a more optimized performance? 1 2 3 4 5 
14 Do you find some kind of error or problem while using the application? 1 2 3 4 5 
APPEARANCE 
15 Do you find adequate the appearance of this application? 1 2 3 4 5 
16 Would you change or add something from this application? 1 2 3 4 5 
LEARNING 
17 Do you think that the time for learning the use of the application is appropriate? 1 2 3 4 5 
 
Results 
Tool for measuring the compliance with Android guidelines 
The results obtained from applying the tool for measuring the compliance of 
Heartkeeper to Android guidelines are shown in Table 3. Moreover, the average 
score obtained per block is presented in Figure 1. 
Table 3 Results of the tool for measuring the compliance with Android guidelines 
Style Behavior Structure 
Q1. Q1. Q1. Q1. Q2. Q2. Q2. Q2. Q2. Q3. Q3. Q3. Q3. 
1. 2. 3. 4. 1. 2. 3. 4. 5. 1. 2. 3. 4. 
1 0 ½ 1 0 1 ½ 1 0 1 1 1 1 
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Fig. 1 Average score obtained per block with the tool for measuring the compliance with 
Android guidelines 
 
Tool for measuring the users’ QoE 
A total of 24 responses to the survey were collected.  Since they are not many, in 
Table 4 all the responses are shown indicating the number of responses obtained for 
each possible score.  
Table 4 Results of the tool for measuring the users’ QoE 
 # of 1 # of 2 # of 3 # of 4 # of 5 AVG ST DEV 
Q1 0 0 6 11 7 4.04 0.73 
Q2 2 6 6 8 2 3.08 1.11 
Q3 0 3 7 7 7 3.75 1.01 
Q4 0 1 7 12 4 3.79 0.76 
Q5 0 1 8 9 6 3.83 0.85 
Q6 0 1 7 14 2 3.71 0.68 
Q7 0 1 10 8 5 3.71 0.84 
Q8 0 1 8 11 4 3.75 0.78 
Q9 0 4 9 8 3 3.42 0.91 
Q10 1 2 7 12 2 3.50 0.91 
Q11 0 2 3 13 6 3.96 0.84 
Q12 0 2 8 7 7 3.79 0.96 
Q13 1 6 6 9 2 3.21 1.04 
Q14 2 0 3 13 6 3.88 1.05 
Q15 0 1 6 11 6 3.92 0.81 
Q16 0 6 2 11 5 3.63 1.07 
Q17 0 0 8 8 8 4 0.82 
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Fig. 2 Score average obtained per block with the tool for measuring the users’ QoE 
The second to last and the last rows show the average score and the standard 
deviation respectively for each question. In Figure 2 the score averages obtained for 
each block of the survey are shown. 
Discussion 
The results obtained are very interesting in order to know the level of quality of the 
app studied, Heartkeeper. Focusing on the results found from the tool for the 
compliance with Android guidelines, Heartkeeper is inside the High Quality Group 
proposed by Cruz Zapata et al. [13], as can be seen in Table 5, which shows the 
needed scores obtained from this tool for each quality group. Since Heartkeeper 
obtained a score of 9, it is included in the High Quality Group as mentioned. This 
means that Heartkeeper is an app that obeys in many cases the recommendations 
for Android given by Google. 
Table 5 Quality Groups by the score obtained from the tool for measuring the compliance 
with Android guidelines 
Score Quality Group 
12-13 Very High 
8.5-11.5 High 
5-8 Moderate 
1.5-4.5 Low 
0-1 Very Low 
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However, analyzing the scores obtained for the different blocks studied, some 
differences can be observed. Heartkeeper has a score of 62.5% in Style, only 50% in 
Behavior and 100% in Structure. These numbers indicate that the work done with 
the structure of the app is perfect, but some changes and updates are needed with 
the style used and especially in the behavior of Heartkeeper. Besides, the authors 
are able to identify the specific aspects that have to be revised and modified thanks 
to this tool, such as using pictures to explain the information given or using non-
stationary activity indicators when long tasks are being performed. 
The tool for measuring the users’ QoE gives very interesting results about 
Heartkeeper. Generally, the average scores obtained for each answer are good, all of 
them over 3, which is an indicator of the satisfactory QoE that Heartkeeper provides 
to its users. Besides, this tool offers much more information. For example, Q1, Q15 
and Q17 are the questions with the best punctuation obtained, which means that 
Heartkeeper do what is supposed to do as it is indicated in the description of the app 
in Google Play, its general appearance is nice and adequate and the learning curve of 
the app is appropriate for the users. 
However, there are other aspects less valued, such as Q2, Q9, Q10, and Q13, what 
means that a number of users can do the same without the app or that there are 
other traditional methods to do a similar function, many of them find it difficult to 
locate some sections in the app, and some think that Heartkeeper can have a more 
optimized performance. This feedback is very valuable for developers since they can 
work in the less-valued aspects by the users. 
Additionally, developers can see a comparison among the different aspects that the 
tool study. In this case, the learning aspect is the most valued, followed by the 
availability of the app and the general appearance of the interface. On the other 
hand, the performance of Heartkeeper is the less valued, followed by the ease of use 
and the content quality. This last aspect can be directly linked with the lack of 
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pictures to explain the information given, what implies that both tools can 
complement each other perfectly. 
However, there are some limitations in the study. The tool for measuring the 
compliance with Android guidelines is applied only by the authors of this work, so 
there is a subjective component in the results. Nevertheless, this component is 
implied by the own tool and it only can be minimized by obtaining feedback from a 
high number of people. Additionally, the opinion of the authors was given from the 
most objective point of view possible.  
Another limitation is the small number of responses obtained from the tool for 
measuring the users’ QoE in order to obtain relevant statistical conclusions. It would 
be much better to have a bigger sample to obtain statistical results, but only 24 
users responded in 5 months. Hence, the results presented cannot be considered as 
final and decisive, but they give an idea of the assessment of the different aspects. 
In conclusion, this work has shown that the use of tools for assessing the quality or 
the QoE of mobile apps are very useful for developers in order to find and improve 
the aspects that needs enhancements according to the feedback obtained. The 
authors recommend insistently the use of these type of tools because they can 
improve globally their apps and the valuation of the users, incrementing the number 
of downloads and, as a result, the benefits. 
For future work, it is planned to upgrade and make new developments in 
Heartkeeper in order to improve the less valued aspects obtained in the two tools 
used. Additionally, these tools will be applied again once Heartkeeper is updated in 
order to measure the impact of the new developments in the users’ point of view. 
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Abstract In a world where the industry of mobile applica-
tions is continuously expanding and new health care apps and
devices are created every day, it is important to take special
care of the collection and treatment of users’ personal health
information. However, the appropriate methods to do this are
not usually taken into account by apps designers and insecure
applications are released. This paper presents a study of secu-
rity and privacy in mHealth, focusing on three parts: a study of
the existing laws regulating these aspects in the European
Union and the United States, a review of the academic litera-
ture related to this topic, and a proposal of some recommen-
dations for designers in order to create mobile health applica-
tions that satisfy the current security and privacy legislation.
This paper will complement other standards and certifications
about security and privacy and will suppose a quick guide for
apps designers, developers and researchers.
Keywords Apps . Recommendations . Laws .Mobile health
(m-health) . Privacy . Security
Abbreviations
AES Advanced Encryption Standard
BSN Security and privacy in Body
Sensor Network
BYOD Bring-Your-Own-Device
COPPA Children’s Online Privacy
Protection Act
EHR Electronic Health Records
EU European Union
FTC Federal Trade Commission
HIMMS Healthcare Information and
Management Systems Society
HIPAA Health Insurance Portability and
Accountability Act
IMEI International Mobile Equipment Identity
IT Information Technology
NCVHS National Committee for Vital and Health Statistics
PHI Personal Health Information
PKI Public Key Infrastructure
RFID Radio Frequency Identification
RSA Rivest, Shamir and Adleman
SIM Subscriber Identity Module
TLS Transport Layer Security
USA United States of America
VPN Virtual Private Network
Introduction
In the last years, the significant advances in telecommunica-
tions and informatics have propitiated an incredible boost of
mobile communications andwireless networks [1–8], as well as
an extensive use and expansion of mobile phones, especially
smartphones with new features that use these new networks
such as 3G and 4G [9–11] and the combination of technologies
such as transistor miniaturization, high quality graphs or com-
pac t des ign [12–15] . Hence , the In te rna t iona l
Telecommunication Union estimated that currently, there are a
nearly 7 billion mobile subscriptions (May 2014) [16] and a
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study by Gartner said that global mobile phone reached 1.8
billion units in 2013. From those, close to 1 billion units were
smartphones [17], and the numbers are increasing continuously.
The smartphones market created a new software industry:
one of apps for smartphones. This industry has expanded
exponentially and it is continuously in progress. In fact, there
are more than 800,000 apps created only for the two most
important smartphone operating systems, Apple iOS and
Google Android [18, 19]. One of the different fields that have
used these new devices and industry is health care. Only
taking into account those mentioned operating systems, the
Apple iOS’ App Store [20] has more than 31,000 apps related
to medicine, health and fitness whereas Android’s Google
play [21] has more than 16,000 medical and health care apps
[22]. All these apps are included in what is known as mHealth
or mobile health, defined by the World Health Organization
(WHO) as “medical and public health practice supported by
mobile devices, such as mobile phones, patient monitoring
devices, personal digital assistants (PDAs), and other wireless
devices” [23].
However, in this run to be the first in developing and
releasing a new app, some aspects have not been properly
considered. Among them, privacy and security have a singular
importance, especially in those apps that deal with personal
and non-transferrable data, such as health applications that
store patients’ Electronic Health Records (EHRs) or several
data regarding their health status. According to the definitions
adopted by the National Committee for Vital and Health
Statistics (NCVHS) of the US Department of Health and
Human Services,“health information privacy is an individ-
ual’s right to control the acquisition, uses, or disclosures of
his or her identifiable health data. Confidentiality, which is
closely related, refers to the obligations of those who receive
information to respect the privacy interests of those to whom
the data relate. Security is altogether different. It refers to
physical, technological, or administrative safeguards or tools
used to protect identifiable health data from unwarranted
access or disclosure” [24].
In addition, clinicians and patients are adopting mobile
technologies faster than providers can protect security and
privacy, which is a significant problem. According to a recent
survey from Healthcare Information and Management
Systems Society (HIMMS) [25], clinician use of mobile tech-
nology to collect data at the bedside rose to 45 %, up from
30 % last year, and 93 % of clinicians already use their
personal smartphone to access EHR, but only 38 % did so
under a formal mobile policy. The reality is that physicians
and medicine students are unaware of the privacy and security
aspects of the mobile applications that they use in their daily
activity, as shows the study performed by Whipple et al.
(2012). Such study concludes that some education in these
issues is necessary because the knowledge about them is very
low [26]. Not only the physicians must know about security,
but also the health care organizations that have readily accept-
ed the Bring-Your-Own-Device (BYOD) approach because
of the convenience and potential cost savings associated
with allowing employees to bring their own devices to
work [27, 28].
Besides, in the mHealth field significant work is needed in
order to overcome legal and cultural differences over privacy
between nations and global regions. In this field two types of
devices –medical and telecommunications– are converging,
and regulators are struggling to keep up, since there are several
governments and international bodies that have realized there
is a problem to solve, and have moved to address the chal-
lenges of personal security and privacy in the era of
smartphones and mobile applications [29].
Although there are some researches talking about privacy
and security in mHealth in general [30–32], these papers do
not deepen into the complexity and the global problem these
aspects involve. In addition, there are few researches regard-
ing privacy and security laws for mobile health [33, 34], but
many about specific privacy or security techniques in this field
[35–39]. Hence, the aim of this paper is to evaluate the current
status of these features and make some guides to be followed
by designers when creating an app, to satisfy the needed
requisites of privacy and security. For this purpose, the authors
will develop firstly a review of security and privacy laws in
mHealth in developed countries, focusing on the European
Union (EU) and the United States of America (USA) in order
to know the main aspects to be taken into account by apps
designers. Secondly, it will be developed a systematic re-
view of the existing bibliography about the concerns and
issues found over privacy and security in mobile health
applications, to see the open research lines. Finally, with
the knowledge obtained from the previous reviews, some
recommendations regarding privacy and security aspects will
be redacted, in order to satisfy the requirements stated by the
considered laws.
Materials and methods
In this paper, the authors have focused only on laws of North
American and European countries because of the difficulty of
covering both American/European and Asian/others countries
since, generally, laws from Asian countries are different from
American/European (more restrictive) and it is necessary to
separate them into different studies. In following works, the
authors will cover security and privacy laws of Asian coun-
tries such as China or Japan, in order to assist designers to
create apps for those zones. Similarly, the authors decided to
focus only on the EU and USA, in order to simplify this work,
selecting them for being probably the most representative
zones of the occidental developed countries and two markets
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that are the objective of an important number of apps
designers.
Another limitation is that this paper has taken into account
only legal laws concerning security and privacy in mobile
health, not certifications or frameworks, since there are frame-
works for organizations (commercial companies, government
agencies, non-profits) useful for obtaining specific certifica-
tions but written in light of the existing laws, which are the
critical aspect to take into account by designers. Besides, in
the industry of mobile apps, there are many apps created
individually by people with no company or organization, just
the person itself, so it may not be necessary getting one of
those certifications. This study can also complement the
existing standards in security and privacy such as ISO/IEC
27001/2013 about information security management [40],
which is considered ‘the foundation’ by security experts
worldwide. However, in this case the authors only focused
on mHealth aspects.
Once exposed the limitations of this study, the methods
carried out were the following: For the first part of this study,
the review of security and privacy laws in mHealth in the EU
and USA, the steps followed were identifying these laws and
reading them carefully in order to extract the main points of
each of them, trying to acknowledge common aspects and
main differences. As it is mentioned before, the final objective
is to summarize the laws that every apps designer should take
into account when designing mHealth applications, at least for
these countries. The process of identifying the laws, reading
them and extracting the main points were performed by one
author. The results were given to another author, who also read
the laws, in order to revise the results, completing them if
necessary.
The following part of this paper was the literature review of
privacy and security aspects used in mobile applications in
order to obey the laws. For this, the authors sought for pub-
lished papers retrieved from the systems IEEE Xplore,
Scopus, Web of Knowledge and PubMed, using the following
search keywords: privacy AND security AND mobile AND
health; privacy AND security AND health AND apps; privacy
AND security AND health AND smartphones. All types of
papers returned by the search were included in the study:
security and privacy in apps, encryption, authentication, se-
cure data transfer techniques, system proposals, privacy re-
views, etc. Although the terms security and privacy are
completely different, the authors sought for them together
for two reasons: the first is that they wanted to focus on the
relations between them, and the second is that, this way, the
results were limited, simplifying the work. When searching
for both terms separately, the results obtainedweremanymore
and, therefore, much more difficult to handle.
The only requisites needed to include a paper in the study
were the following: only papers published in English were
studied, the search was limited to the last 8 years, from 2007 to
2014, and the applications included must have health pur-
poses. Figure 1 shows a flow chart of the papers selection
process. Initially the systems returned a total of 570 papers,
being 334 repeated. Out of the remaining papers, 67 were
dismissed since they did not address the issues of this study,
resulting a total of 169 relevant papers.
Since the inclusion/exclusion of papers depends on the
subjective opinion of the author who performs the review,
being sometimes not easy since the abstract is not clear and
it can be misunderstood, we enhanced the assessment process
with independent verification, as it was done in other works
[41, 42]: one author developed the search of literature papers
and the rest inspected the results in order to check possible
errors. The authors also made a classification of the papers
found following the mentioned method.
Finally, the last part of the study, the creation of privacy and
security recommendations for mHealth apps designers, was
performed using the results obtained in the previous parts of
this research. Known the specific laws that the apps must
satisfy and the techniques and technologies used for this
aspects of security and privacy, the authors convened to dis-
cuss what techniques must at least be used and which of them
are the most suitable in order to fulfil the laws studied.
Results
Study of the security and privacy laws in the European Union
and the United States of America
The EU has one law regarding security and privacy in
mHealth: the EU Data Protection Directive 95/46/EC of
1995 [43]. This is a general directive that sets the principles
that theMember States should apply in their laws. Recently, at
the beginning of 2012, the EU approved a draft, the General
European Data Protection Regulation [44], which will substi-
tute the previous directive in 2016 if it succeeds. There will be
no need of implementing this regulation in the laws of the
Member States since it will apply generally over all of them.
Fig. 1 Flow chart of the steps used in the literature review
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With this new regulation all the Member States will be at the
same stage of security and data protection.
Contrary at what happens in the EU, USA provides
several laws regarding privacy and security in mHealth.
The main law that applies to mHealth issues is the Health
Insurance Portability and Accountability Act (HIPAA) of
1996 [45]. This law protects the privacy of the digital
health information. Another important law is the Federal
Trade Commission (FTC) Act [46] with its section 5. This
law recently regulated aspects of mHealth privacy in the
report “Mobile Privacy Disclosures: Building Trust
Through Transparency” [47]. There is another significant
law only applicable to children under 13, the Children’s
Online Privacy Protection Act (COPPA) of 1998 [48],
which forbid the gathering of personal information from
these children without express consent from a parent or a
legal tutor. Finally, there are also State laws, but they will
not be considered in this study.
Table 1 gathers a summary of the most restrictive points of
the mentioned laws, sorted by the different requirements based
on a study performed by Thompsons Reuters [49]. This is,
when a law is more restrictive than the others with regard to a
specific requirement, Table 1 shows the information of this
law. If the laws are very similar regarding a requirement, then
Table 1 shows the common aspects extracted from them.
Security and privacy literature review
As mentioned in the Methods section, a total of 169 relevant
papers regarding privacy and security in mHealth were found.
The classification of these papers by their content is shown in
Table 2, which also shows the number of articles for each
category in the second column.
As Table 2 shows, there are several research lines found.
Below some of the most researched are enumerated, with an
example of each line:
& Secure systems or solutions proposal. Sorber et al.
(2012) created a wrist-worn device called Amulet
that enables a trustworthy and secure path for
mHealth devices to communicate with the wearer’s
mobile phone [50].
& Authentication techniques. Wei et al. (2012) viewed some
weaknesses in two authentication methods proposed by
other authors and suggested another scheme for telemed-
icine information systems that solves the weaknesses
shown by the others [51].
& Security and privacy aspects in BSNs. In the study of
Sahoo (2012), a three tier security architecture for
mHealth applications is proposed, using light weight data
confidentiality and authentication protocols to preserve
the patients’ privacy [52].
& General security or privacy aspects. Green (2013)
established the necessary steps that healthcare finance
leaders must satisfy to develop a good strategy to secure
PHI accessed, stored, or transmitted via smartphones or
tablets [32].
& Security and privacy in monitoring systems. Shin (2012)
designed and evaluated a framework for securing health
monitoring systems despite the security flaws of common
Table 1 Laws requisites regarding privacy and security in mHealth applications
Cover data The data which must be covered are that information that can be used to identify a person. It includes ID
numbers, physical, physiological, mental, economic, genetic, social, medical, cultural factors regarding the past,
present or future of the patient.
Information requirements Before providing their Personal Health Information (PHI), users must be informed about the identity of the
person/entity that will use the PHI, the purposes of the collecting, the entity’s privacy practices, whether the
provision is compulsory or voluntary, the rights they have to access/modify the data and a contact method
for more information or complaints. This information must be given directly to a parent or legal tutor in case
of children under 13.
Consent requirements The user/patient’s consent to the data collecting must be obtained by the entity, when this collecting cannot be
justified by a statutory ground. The entity is enhanced to obtain this consent written. In the case of children
under 13, they cannot consent their data collection, being their parents or legal tutors the ones to do so.
Data retention Generally, PHI should be kept only the necessary time for the purpose which was collected and must be erased
once the purpose is reached. Entities must also include a clear data retention policy as part of their security
procedures.
Security The entities are required to implement and maintain appropriate technical, administrative, physical and
organizational security measures to protect PHI form accidental or unlawful loss and unauthorized access
or disclosure. Since health data is very sensitive, the security must be higher.
Breach notification obligations In case of a personal data breach, the entities must notify it to the competent authority as well as the user whose
data has been compromised without unreasonable delay, especially when the breach may have adversely
affected to the user. In cases of massive breaches, the media should be also notified.
Data transfers Entities need the users’ consent to transfer their personal data to another entity or a third party, even when this
transfer is necessary to complete one of the purposes of the data collecting, unless the transfer is allowed by law.
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personal devices, building a realistic risk model for
sensor-data quality [53].
Security and privacy recommendations in mHealth
applications
After reviewing the papers found, the authors were in condi-
tions to make some recommendations to apps designers.
Hence, in Table 3 there are shown the requisites that apps
designers must satisfy in order to guarantee the security and
privacy of the users’ PHI. The table is divided into minimum
requirements, those that designers must always satisfy; and
recommended requirements, those which should be satisfied
in order to improve security and privacy.
In addition to the requirements shown in Table 3 it is
recommendable to perform periodical audits, preferably exe-
cuted by external companies, of the security and privacy
policy carried out by the entity (the designers). This way,
designers can certify that their policies satisfy the legal requi-
sites in privacy and security.
Discussion
Several interesting conclusions can be obtained from the
analysis of the results. First of all, in light of the results of
the review of the existing laws in privacy and security in
mHealth it is clear that there is not a strong line and well-
defined statements about this topic, at least in the EU and
USA. In addition, the laws were approved long time ago (the
EU Data Protection Directive in 1995 and the HIPAA in
1996), when even the term mHealth did not exist. Thus, the
statements are based on the obsolete technology of these years
and were applicable only in the eHealth field, but currently
extended to mHealth. In practice, these laws are too open and
too old, and need to be revised and reformulated taking into
account the current technologies, industries and health care
fields, focusing especially on mHealth and the mobile apps
industry, which is continuously expanding. Although this is
already happening in some cases (the General European Data
Protection Regulation of the EU), the regulations are still too
generalist and it seems necessary to create more specific rules
mentioning possible technical mechanisms to solve security
problems.
Focusing on the results of the literature review, it is easy to
see that the most researched fields are those proposing secure
systems (generalist or in a specific context or place), or tech-
niques used for security and privacy such as authentication,
encryption, data transmission, etc. with special mention to the
aspects and techniques of BSNs, very extended lately. These
new ideas are very important, but there are other very inter-
esting fields that do not have enough research. For example,
there are few security and privacy recommendations or re-
views of the existing mechanisms, which is the reason of
writing this paper. Location privacy also should be more
researched, as the violation of this privacy is not only a
violation in health care but also in every general aspect.
Papers about security and privacy in mobile apps deserve
special mention, since new health apps are created every day,
and they do not usually have enough security and privacy
mechanisms in order to protect the users’ data, such as lack of
privacy policies or users’ consent collection [55]. In the liter-
ature review, only seven papers focused on apps were found,
four with proposed guidelines and three about security and
privacy in general terms. It is really interesting the article of
Albrecht et al. (2013), which proposes an app-synopsis with
some guidelines for designers in order to offer transparent
information about their apps, including security and privacy
information [56].
Finally, with the information obtained from the litera-
ture review, it was possible to write some recommenda-
tions for apps designers about the security and privacy
methods that they should follow in order to satisfy the
laws of the EU and USA. Although taking into account
only the minimum requisites exposed is enough for that
Table 2 Classification of the results of the literature review
Type of content # papers
Secure system/solution proposal 23
Authentication technique/system 19
Security and privacy in Body Sensor Networks (BSNs) 11
Security and privacy in cloud computing 11
General security and/or privacy aspects 9
Security and privacy in a monitoring system 9
Security and privacy laws 9
Security in a specific place/context 7
Encryption technique 6
Security and privacy analysis of a system 6
Security and privacy in mHealth emergencies system 6
Security and privacy knowledge evaluation 6
Data transmission privacy and security 5
Security and privacy in Radio Frequency
Identification (RFID) systems
5
Security and privacy evaluation of a system 5
Security and privacy in mHealth social networks 5
mHealth security guidelines 4
Security and privacy guidelines for apps 4
BSNs encryption technique 3
BSNs authentication technique 3
Health Information Technology (IT) review 3
Privacy mechanism 3
Security and privacy general aspects in apps 3
Secure data storage technique 2
Location privacy 2
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purpose, we strongly recommend the use of the requisites
indicated in the third column of Table 3 when possible,
since PHI is very sensitive and it must be intensely
protected. It is also important to mention that, although
we have proposed several technical security mechanisms
such as AES, RSA, VPN, etc., there are also other
methods equally valid for the same goal. The authors
chose those because they are well studied and commonly
repeated in the papers reviewed, but the final decisions
correspond to the designers.
For future work there are several research lines. It can be a
good idea to extend this work by studying the laws regarding
privacy and security in other zones, especially in Asian coun-
tries, in order to obtain more complete recommendations.
Additionally, this work has focused on the security and priva-
cy aspects of mobile health apps, but it does not include other
important issues, such as interoperability between different
systems. Hence, it can be a good idea to combine both aspects,
in order to obtain a secure system but also interoperable,
which implies a more complex process and study. Another
Table 3 Security and privacy recommendations for mHealth applications
Property Minimum requirements Recommended requirements
Access control The access control to the PHI must be patient-centric.
The users should be able to allow or forbid access to
their information at any moment.
It is preferable to create a role-based access, giving
reading possibilities to some roles and adding limita-
tions to other ones.
Authentication The authentication must be done with a unique ID and a
password only known by the user. This ID can be
linked to a Public Key Infrastructure (PKI), preferable
Rivest, Shamir and Adleman (RSA) system and/or a
symmetric key used for encryption.
The password used must be complex, with at least seven
characters and a combination of letters and numbers,
including one capitalized letter and a special character.
It is better to employ multifactor authentication to
complement the ID/password identification when
possible: using an item the user possesses (smart key)
or a physical feature such as fingerprint.
Security and confidentiality Use Advanced Encryption Standard (AES) to encrypt
PHI. The cryptographic key used must have at least
128 bits. This method offers better encryption times
than other techniques [54].
It is better to improve the security using a key of 192 or
256 bits.
Integrity At least, a symmetric key-based authentication code
must be used, for example AES.
A public key-based digital signature is preferred. Under
no circumstances watermarking methods must be
used with medical images since they can deteriorate
their quality and even provoke bad diagnoses.
Inform patients Before the collection and use of PHI, the app should
present a privacy policy informing the patients about
the identity of the entity that will use the data, the
purpose of the collection, the privacy methods used,
the rights they have and a contact method. If the users
accept this policy they give their consent to the data
collection. It must include a section for minors,
requiring the consent of a legal tutor.
The policy should be easy to understand, concise and
clear, since users are not fond of reading large legal
documents in an app. It is highly recommended to
leave the policy accessible for the user at any moment
in the app.
Data transfer Use Transport Layer Security (TLS) with 128-bit en-
cryption methods. It is also possible to use Virtual
Private Networks (VPNs).
It is preferable to use TLS with 256-bit encryption
methods. It is also very recommendable to show an
icon in the app notifying the transfer of data.
Data retention The retention policy should be included in the privacy
policy to inform the patients. The data should be kept
only the necessary time for the initial purpose.
When the purpose is achieved, the PHI must be erased
and the user should be notified. The entity should
provide a mechanism to let the user check that the data
has been deleted.
BANs communication At least cryptographic methods must be used in securing
the BSNs for authentication and key distribution. The
mobile device (smartphone) can be identified and
authenticated by its International Mobile Equipment
Identity (IMEI) or its Subscriber Identity Module
(SIM) card number.
The user’s biometric patterns user can be utilized to
encrypt and decrypt the symmetric key, which can
facilitate the connection of the BSNs to the mobile
device.
Breach notification In case of a PHI breach, the competent authority as well
as the affected user must be notified as soon as
possible (1–3 days). The entity must help the user in
order to relieve the consequences the breach may have
caused.
It is important to compensate the affected user in order to
restore the possible damage done. In cases of breaches
affecting a significant number of users, the media
must be notified to inform about the problem.
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future line can be the inclusion of the recommendations pro-
posed in a real mobile app in order to evaluate the complexity
and the problems that can appear in the process, trying to
figure out if the disadvantages of this “extra work” (processing
times, higher work load, etc.) can cause that designers opt for
not integrating them in their apps, or it is simply lack of
awareness of the security and privacy laws.
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Abstract Currently, cardiovascular diseases are the deadliest
diseases with a total of 17 million deaths worldwide. Hence,
they are the focus of many mobile applications for
smartphones and tablets. This paper will assess the ex-ante
economic impact as well as will determine the cost-
effectiveness analysis that the use of one of this app,
CardioManager, by patients with heart failure will have in a
Spanish community, Castile and Leon. For this, a cost-
effectiveness analysis using the hidden Markov model were
performed in a hypothetical cohort of patients diagnosed with
heart failure, based on the information of epidemiological
parameters and the costs derived from the management and
care of heart failure patients by the Public Health Care System
of Castile and Leon. The costs of patient care were estimated
from the perspective of theMinistry of Health of Spain using a
discount rate of 3 %. Finally, an estimation of the ex-ante
impact that would suppose the introduction of CardioManager
in the Health Care System is performed. It is concluded that
the introduction of CardioManager may generate a 33 %
reduction in the cost of management and treatment of the
disease. This means that CardioManager may be able to save
more than 9,000 € per patient to the local Health Care System
of Castile and Leon, which can be translated in a saving of
0.31 % of the total health expenditure of the region.
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Introduction
According to the World Health Organization (WHO), more
than 25 % of the population has problems related to heart
disease. Out of this percentage, 1 % - 10 % is at risk of
suffering severe heart failure (HF). Only in Spain there are
more than 1,200,000 people with severe HF. There are several
causes for HF, being the most important hypertension and
ischemic heart disease, especially in developed zones. Out of
the 17 million deaths a year that cause cardiovascular diseases
(CVDs), complications of hypertension account for 9.4 mil-
lion deaths worldwide every year. On the other hand, ischemic
heart disease is the leading cause of death among CVDs and is
responsible for 7.3 million deaths only in 2008. The increas-
ing prevalence of these CVDs is due to population growth,
ageing and behavioral risk factors, such as unhealthy diet or
sedentary lifestyle [1–6].
From a technological point of view, the fast spreading of
smartphones and tablets in the last years has propitiated the
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creation of a new software industry: the development of
mobile applications (or apps). Currently there are more than
800,000 apps in each of the two most important commercial
stores in terms of market share which are Google play and the
Apple’s App Store [7, 8].
This new industry is included in what is known as mobile
health, defined by the WHO as “medical and public health
practice supported by mobile devices, such as mobile phones,
patient monitoring devices, personal digital assistants (PDAs),
and other wireless devices” [9, 10].
There are many mobile applications developed and
researched for treating heart conditions [11–13]. One of these
applications is Cardiomanager, a medical app developed by
the authors in order to allow heart diseases patients to self-
manage their own conditions. It includes the most common of
them based on the large experience of renowned cardiologists.
These diseases are ischemic heart disease, valvular heart dis-
ease, hypertension, cardiorenal syndrome and auricular fibril-
lation. It was included other important aspects that can influ-
ence in the heart health such as the relations between heart and
pregnancy, heart and physical activity, and heart and diabetes.
The app is divided into three sections depending on the
function carried out. There is an informative section with
medical information about the diseases that will help the
patients to understand their disease; and a patient guide in
order to inform them about best practices, prohibitions and
advice they should adopt in order to improve their condition.
Another section is used to record the user’s activities (which
can be good and bad for their conditions) and health measure-
ments in order to act consequently with them. Some examples
of these activities are rehabilitation, physical activity or ex-
cesses (in food intakes, for example), whereas typical mea-
surements are blood pressure, glucose and cholesterol. There
is also a section for registering the users’ medications and the
hours that they should have them. The app offers the possi-
bility of setting alarms to warn them at those hours.
Since the most important factor for the adoption of infor-
mation and communication technologies by healthcare pro-
fessionals is the benefit they would provide [14], the objective
of this paper is to develop an economic impact assessment of
the use of CardioManager by people with HF, similarly as
other studies have done [15–18], which will complement
those qualitative analysis of mobile applications already done
[19–21]. To reach this objective, the authors developed an ex-
ante impact assessment, obtained from the cost-effectiveness
analysis of the app and, afterwards, analyzing the impact in
terms of saves in the sanitary expenditure that its use by
patients and professionals of the Public Health Care System
provides.
To do this, given the variety of heart diseases and condi-
tions that constitute the CVDs, it is necessary to limit the
analysis to only one specific disease in order to define the
pattern of the patient behavior as well as the number of visits
to health care professionals, hospitalizations, derivations to
other specialists and undergone tests. Hence, ischemic heart
disease will be the one selected due to its relevance in causing
HF.
Similarly, the key factors that will be necessary to obtain
after the analysis are related to costs savings, care quality,
monitoring and follow-up of the user/patient, user satisfaction,
and the efficiency of the processes of information storage and
communication from the app to the hospitals and health care
centers.
Besides, it is needed to define the current expenditure in the
sanitary system of the region studied, which will be the
community of Castile and Leon in Spain, in order to develop
an analysis of the savings impact in that system when intro-
ducing the app.
Health care expenditure
According to several studies, and if forecasts of economic
growth of the economy by the International Monetary Fund
(IMF) are correct, no Spanish autonomous community has
guaranteed medium-term financial sustainability of its Public
Health Care System, understood as the evolution of the dy-
namics of public health expenditure and government revenue.
The average annual growth of Spanish public health ex-
penditure expected for the period 2013–2016, in the absence
of reforms that significantly alter the growth trend observed in
previous years, is estimated at 4.4 %, although there is con-
siderable variability between regions [22].
According to the Ministry of Health, Social Policy and
Equality of Spain [23] the level of public expenditure in the
country in 2011 was nearly 68 million euros. Between 1991
and 2010 public health spending in Spain has grown at an
annual rate far from negligible, reaching nominal terms by
over 7 % over the period.
Both in terms of Gross Domestic Product (GDP) and per
capita spending, there is a remarkable dispersion among au-
tonomous communities. In the first case, the regions with the
most expending are those with a lower level of development,
because their GDP is lower. However, the dispersion in per
capita spending between communities is also important and is
maintained even after adjusting spending levels for the differ-
ent needs relative to population structure (sex and age) of each
region.
In the case of the selected region for this study, Castile and
Leon, the GDP of 6.5 % of Spain‘s total GDP and per capita
spending of 1,413 € [22]. Also, Table 1 breaks down the
health care costs in euros in the main items that comprise it.
In recent years, strategies to improve the quality and sus-
tainability of public health systems are being developed by
empowering primary health services, as well as decreasing the
spending of specialized and hospital services.
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In the specific field of CVDs, all together account for an
average of 17.7 % of total health care expenditure. But spe-
cifically HF represents 14.7 % of total health expenditure,
which means in a community like Castile and Leon with
health costs of 3,332 million euros, almost 490 million euros.
Table 2 shows the characterization of HF in Castile and Leon,
where there are described the major elements that impact on
the cost of health services by HF patients.
Therefore, based on this information, it is relevant to know
what would be the impact of introducing the mobile applica-
tion CardioManager, able to optimize the management of HF
patients, in the public health system in Castile and Leon.
Methods
Description of the analysis
For the ex-ante economic impact assessment of themobile app
Cardiomanager a sample similar to the selected by Naveiro-
Rilo et al. (2012) will be used [25]. This sample consists of
patients with documented chronic HF in the clinical history of
primary care, seen through hospital discharge report done by a
specialist or by the family doctor physician, and based on
Framingham criteria diagnosis and additional tests such as
electrocardiogram, chest radiography and echocardiography
with characteristic signs of chronic HF. These patients
belonged to the sanitary area of Valladolid, which has a
population of more than 200,000 individuals over 39 years,
of which over 35 % live in the rural area. Patients whose HF
was attributable to a reversible cause were excluded.
With the patient records of each physician, an anonymous
census was elaborated with 2,000 patients (900 in rural areas),
of which a sample was proportionally selected of the urban
and rural strata membership to ensure an equal probability of
being selected in each stratum, by systematic random sam-
pling. The sample size was calculated to estimate dichoto-
mous variables with an overall accuracy for the health area of
4 % and 95 % confidence, in proportions of 50 %. The result
was a size of 630 patients.
To perform the economic impact assessment (ex-ante)
[26–29] of the introduction of CardioManager, an economic
evaluation type cost-effectiveness [30–32] will be performed
on a structured Markov model, using a static deterministic
hypothetical cohort with annual cycles and considering the
clinical states shown in Fig. 1, composed of a sample of 630
patients diagnosed with HF [25]. In this figure, arrows indi-
cate the possibility of moving to another state. Being an ex-
ante assessment we will use a model that simulates the evo-
lution of HF disease, describing the different states that the
patient will pass through along his illness.
We considered the cost of the tool worth 100 euros, 90 € for
the mobile device with 10 € overhead, whereas the app is free.
For health care costs, we used the guide of costs of the Ministry
of Health, Social Policy and Equality [33], which imputes direct
healthcare costs such as consultations in primary care, emergen-
cies telephone consultation medication, home visits, diagnostic
procedures and hospitalization. Non-sanitary direct costs were
also included (transport, management overhead etc.). All costs
have been adjusted to values in euros for 2011.
At the beginning of the diagnosis of the disease, the patient
may have high risk of HF in the future but without structural
heart disease in the present (stage A), so that the action is
based on a preventive treatment of development of the dis-
ease. Likewise, the diagnosis may be on Stage B (structural
heart disorders without symptoms of any degree; patients with
expulsion fraction of 50%, normal cardiac output), which also
requires a preventive treatment for the detection and treatment
of the disease [34–36]. However, when the patient has symp-
toms of HF in the present or at some point in the past -in the
context of a basic structural heart problem and treated medi-
cally, cardiac output slightly reduced and Frank-Starling
mechanism used as compensation, fatigue or dyspnea with
large or moderate exercise present- (stage C), it is required
regular treatment and transfer to a primary or specialized
health center for monitoring and stabilization. The last stage
of the disease (stage D) requires a hospital support, a heart
transplant or palliative care (cardiac output slowed, fatigue
Table 1 Breakdown of public health expenditure by category. Source: Ministry of Health, Social Policy and Equality [23]
2007 2008 2009 2010 2011
Hospital and specialized services 32.612 € 37.018 € 39.132 € 38.743 € 39.493 €
Primary health care services 9.429 € 10.456 € 10.831 € 10.651 € 10.217 €
Public health care services 839 € 784 € 1.158 € 761 € 750 €
Collective health care services 1.828 € 1.907 € 2.074 € 2.058 € 2.086 €
Pharmacy 11.884 € 12.690 € 13.415 € 13.381 € 12.237 €
Transportation, prosthetics and therapeutic devices 1.081 € 1.230 € 1.298 € 1.351 € 1.332 €
Capex 2.638 € 2.833 € 2.557 € 2.183 € 1.512 €
Total 60.310 € 66.918 € 70.464 € 69.128 € 67.626 €
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and dyspnea at rest) so it is frequent hospitalization for stabi-
lization, destabilization readmissions and high probability of
death. Because Markov models [37] assume that state transi-
tions occur at the end of each cycle, a correction has been
made assuming that the mean of the cohort transits in the
middle of the cycle.
Probabilities considered in the model
Data on HF incidence has been obtained from the Statistics
Central of the Ministry of Health, Social Policy and Equality
[38, 39]. The remaining transition probabilities introduced
into the model in relation to mortality, health care and
disease-related events that occur during the year of observa-
tion considered are shown in Table 3. The probabilities of
death were calculated based on the age-specific mortality rate
for 2011 published by the National Statistics Institute [39–41].
Analysis
The results of the cost-utility analysis have been calculated
using the incremental cost-effectiveness ratio (ICER),
expressed as cost per additional quality-adjusted life year
(QALY) obtained. In addition, a univariate sensitivity analysis
has been carried out to assess the robustness of the results
when modifying certain variables in a given range (to include
the introduction of CardioManager).
The variable efficacy of the introduction of the tool into the
sample (introduction of technology efficiency) was analyzed.
For the construction and the model analysis the software Tree
Age Pro Suite 2009 was used.
Results
Cost analysis
The cost analysis is done from the perspective of the funder of
the Health Care System, which, in this case, would be the
Ministry of Health, Social Policy and Equality, as these costs
are those that has to assume in the process of management and
development of the disease: direct costs (direct medical and
nonmedical costs such as administration, general services,
etc.) [26, 33, 45–47]. Costs are adjusted to the year 2011.
The characterization of the cost of a heart failure patient has
been made taking into account the technical paper by the
Ministry of Health Care, Social Policy and Equality [48].
Also, to calculate the cost of development and introduction
of CardioManager in the public health system in Castile and
Leon it is done a projection of which would be to provide each
patient with the necessary technology for the management and
monitoring of their disease using the application.
The breakdown of costs associated can be seen in Table 4.
In the treatment, the cost of drug treatment is excluded, being
Table 2 Characterization of HF
in Castile and Leon [24] Total Men Women Average stay (days)
Total deceases 17,089 5,954 11,135 10.03
Hospitalizations 29,743 16,748 12,995 8.8
Re-entry rate Mayor emergency 12 25.08
Rest 5,451 1,908 3,543 9.83
Fig. 1 State diagram of the adapted Markov model
96, Page 4 of 7 J Med Syst (2014) 38:96
charged only the costs of travel to the health center and the
cost per visit.
The introduction of CardioManager in the studied popula-
tion would generate not only benefits in the health treatment,
but also the following savings:
& Testing control in the patient‘s home, saving travels to the
hospital or health center for its realization.
& Decrease of the patient displacements derived from de-
compensations in the patient’s health status.
& Improving the information obtained by the patient,
which will mean a better knowledge and control of
the disease and, consequently, fewer relapses and
hospitalizations.
& Decrease in referrals (from health centers to hospitals,
etc.).
& Decrease in hospital admissions due to better health status.
According to [48], the combination of telemedicine and
education (main objective of CardioManager) is able to reduce
the number of hospitalizations by 60 % and the average stay
by 73 %.
Table 5 shows the cost analysis of the two scenarios:
without the introduction of the application and with it. It
shows that from the perspect ive of introducing
CardioManager, the app achieves greater savings in the man-
agement of the disease that would cost without it. Likewise,
the ICER obtained measures what it would cost an additional
QALY if the application was introduced compared to the
scenario of no introduction.
Sensitivity analysis
The effect of the changes in the behavior of patients resulting
from the use of the tool on the cost-utility considered in the
base case, corresponds to a 33 % reduction in the cost of
management and treatment of the disease. This cost reduction
would be accompanied by an increase in the efficiency in the
management and monitoring of the disease, since higher
education combined with tech support [48], substantially im-
proves the patient's response to disease.
Discussion
The most important limitation of the model is attributable to
the nature of the target of this paper: perform an ex-ante
economic evaluation which would mean to introduce an app
like CardioManager on a sample of patients with HF.
However, despite not having these data, this lack does not
infringe the consistency of the model and the validity of the
results, since the analysis was performed following the results
obtained in previous studies and reviews of secondary
sources. Another important limitation to consider is the per-
spective of the study, which is the funder. It should take into
account the perspective of society, which would allow not
only to know what the economic impact (cost savings) of
introducing the technology is, but also its social impact.
That said, the results obtained from the ex-ante assessment
throw that for the required investment for the implementation
of CardioManager of 63,000 € (630 patients x 100 €/patient),
a saving of approximately 6 million euros would be generated
for the Public Health Care System of Castile and Leon, which
can be translated in a saving of 0.31 % of the total health
expenditure of Castile and Leon [49].
Namely, the introduction of a mobile application for the
control of HF has an impact not only in increasing quality of
life and patient autonomy [25, 45, 49], but in turn, provides
efficiency to the public health care administration, since it
generates savings exceeding 33 % of the total cost of the
management of the disease.
This saving will have an impact on both the Health Care
System and the economy, since not only there are saves on
Table 3 Transition probability matrix for the Markov model based on [39, 42–44]
Diagnosis HF Treatment Hospitalization Monitoring Health stabilization Death
Diagnosis 0,9960 – 0,1400 – – – –
HF – – 0,9231 – – – –
Treatment 0,9651 0,2079 – – 0,4765 – –
Hospitalization 0,4400 0,2795 0,1987 – – 0,9233 0,1470
Monitoring – 0,9665 0,6620 – 0,1400 0,034 –
Health stabilization – – – 0,8581 – –
Death – – – 0,1470 – – 1,0000
Table 4 Analysis of the cost of health states of the established Markov
model
States Unitary cost
Treatment –
Hospitalization (including health stabilization) 13.889,79€
Outpatient care 1.413€
Re-entry 12.434,4€
Monitoring 577,92
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costs but there are also gain in efficiency of the system, being
able to use the amount remaining for the improvement and
sustainability of the future Public Health Care System.
In this case, it would be interesting to carry out an impact
assessment using the same sample but giving it the opportu-
nity to use the app so that can be obtained a much more
adjusted spending per patient model. Thus, it would be possi-
ble to accurately measure not only cost savings, but also
quality of life which is achieved by the introduction of the
tool. Therefore, the next research line is to test the tool in a
sample.
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